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Abstract
Protein-protein interactions (PPI) mediated through short linear motifs (SLiMs) are ubiquitous
throughout the human proteome and are involved in many essential cellular processes. One
such type of SLiM is the classical nuclear localization sequence (cNLS), which facilitates
nuclear import by binding importin-α (Imp-α). This pathway is indispensable to many cellular
processes and is extensively used by viral proteins that function within the nucleus of infected
cells. Based on this, I demonstrated that the classical nuclear import pathway inhibitor,
ivermectin, can inhibit replication of human adenovirus. Treatment with ivermectin blocks
nuclear localization of the E1A protein, an essential viral nuclear protein that functions early
during infection. I also demonstrate, for the first time, that ivermectin inhibits the Imp-α/cNLS
interaction. Interestingly though, despite the classical nuclear import pathway being
extensively studied, up to 50% of Imp-α cargo in yeast do not have a cNLS, as one would
expect. However, whether this is true with humans remained unclear. To address this, I used
currently available databases and datasets for human Imp-α PPIs and computationally searched
for cNLSs. Using my approach, I found that 20–50% of Imp-α interactors do not have
predictable cNLS. Furthermore, I found that the majority of proteins in the Mediator complex
associate with Imp-α without having a predictable cNLS. Based on these findings I
hypothesized that components of Mediator are likely to be using a “piggybacking” mechanism.
These findings also demonstrated a need for identifying piggybacking mechanisms and/or
novel NLSs. To explore these questions, I developed a yeast-based genetic selection to identify
peptides conferring nuclear import. This system uses a large recombinant protein to express
randomly generated peptides that can be subsequently selected for based on their ability to
facilitate nuclear import in yeast. Peptides that I identified in this selection were also able to
localize EGFP to the nucleus and interact with Imp-α in human cells. This approach also
represents a novel strategy to identify SLiMs in a high throughput fashion, an area of SLiM
discovery that currently lacks high throughput experimental methods.
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Summary for Lay Audience
A human cell can be broken down into several different compartments. The two largest
compartments are represented by the nucleus and the cytoplasm, which are physically separate
from each other by the nuclear envelope (NE). This separation ultimately means that all human
genes are expressed within the nucleus and translated into proteins within the cytoplasm.
Proteins are generally regarded as the functional molecules of a cell and are responsible for
carrying out cellular processes in every compartment, including the nucleus. For proteins to
enter the nucleus, they must contain a nuclear localization sequence (NLS). Importantly, many
viral proteins have NLSs as well, allowing these proteins to enter the nucleus and promote viral
replication. Here, I show that nuclear import can be targeted by the drug ivermectin to block
the replication of human adenovirus, a clinically important virus which currently lacks specific
antiviral treatments. Additionally, I demonstrated that many nuclear proteins in humans do not
have an NLS. Looking specifically at these proteins without an NLS, I provided evidence that
proteins can “piggyback” into the nucleus. This means that a protein with an NLS can
physically interact with a non-NLS protein and carry it into the nucleus. In particular, I provide
evidence that an important cellular protein complex, Mediator, is likely to use piggybacking
as a strategy. Since many nuclear proteins do not have an NLS, strategies for finding how they
are transported into the nucleus are needed. To address this, I developed a genetic selection in
yeast. This approach used an engineered protein that is too large to enter the nucleus unless it
has an NLS. Expressing this protein in yeast with random protein sequences allowed me to
select for those that could mediate nuclear import, since only these yeast were able to survive.
Using this selection, I identified several protein sequences that look nothing like current NLSs.
Interestingly, two of these NLSs were also able to function in human cells. Together, my
findings demonstrate that additional strategies to gain access to the nucleus exist and that the
nuclear import pathway can be targeted to inhibit viral replication.
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Chapter 1
1

Introduction

1.1

General Introduction

The human proteome is composed of a collection of proteins that range in shape, size and
form. These proteins function together to form complex biological networks that link
underlying genetic information with the diverse phenotypes observed in human health and
disease. Since the completion of the Human Genome Project it has become widely accepted
that there are approximately 20,000 protein-coding genes; however, how this relates to the
size of the human proteome is currently under question (Aebersold et al., 2018; Yates et
al., 2020; Zahn-Zabal et al., 2020). Through cellular events like alternative splicing, RNA
editing and post-translational modification (PTM), a combinatorial explosion of possible
protein forms, or proteoforms, can be expressed from a single gene (Figure 1.1) (Aebersold
et al., 2018; Hornbeck et al., 2019; Lau et al., 2019). Consideration of these factors, along
with other sources of proteomic variation, has led to the estimation of up to 1,000,000
possible proteoforms within a cell at a given time (Aebersold et al., 2018). Understandably,
how these proteins and proteoforms participate in protein-protein interactions (PPI) and
how these PPIs are regulated is of particular importance to understanding many aspects of
cell biology and systems biology.
Proteins represent the molecular workhorse of the cell and are involved in nearly every
cellular task. Essential cellular processes such as signal transduction, transcription and
translation require a myriad of PPIs to occur in specific and context-dependent settings.
Importantly, physical interactions between proteins enable a cell to integrate information
from both external and internal stimuli, which in turn allows a cell to make an appropriate
decision based on that information. Therefore, to understand how the proteome functions
as a whole, it is critical to understand how PPIs are mediated. Physical interactions between
proteins can be thought of as a form of communication and how they communicate is
embedded within their amino acid sequence. How the sequence of amino acids is arranged
within a protein will determine the overall physical structure, which will ultimately impact
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Figure 1.1 Sources of proteomic diversity.
A single gene can give rise to multiple different proteoforms through various cellular
processes such as alternative splicing, RNA editing and post-translational modification.
Alternative splicing and RNA editing of mRNA can give rise to multiple different
spliceforms that differ in their primary amino acid sequence. Structural regions or regions
mediating PPIs can be lost, giving rise to unique proteins with different functions or
localizations. Additionally, the primary amino acid sequence can be chemically modified
to produce a variety of different proteoforms which may bestow unique or highly specific
functions. P = phosphorylation, Ub = ubiquitination, Me = methylation, Ac = acetylation.
Created with BioRender.
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the type of possible PPIs. In general, within the proteomic landscape, proteins can range
from being highly structured to completely disordered. The latter are referred to as
intrinsically disordered proteins (IDPs); however, many proteins are a mosaic of structured
regions and intrinsically disordered protein regions (IDPRs) (A K Dunker et al., 2001; P E
Wright & Dyson, 1999).
Well-folded globular domains represent highly structured interaction modules and
represent the majority of studied interaction interfaces (Mosca et al., 2014; Pawson &
Nash, 2003). Interestingly, prediction models dating back to 1998 demonstrated a
significant portion of proteins from diverse species contain disordered regions, providing
further evidence that a protein’s function is not just dependent on possessing a stable
structure (Romero et al., 1998). Today it is appreciated that approximately one-third of the
human proteome is comprised of IDPRs; however, most of these regions are
uncharacterized compared to globular domains (A K Dunker et al., 2001; Mosca et al.,
2014). Despite their lack of characterization, it is now well understood that these regions
represent an important regulatory framework by facilitating various cellular processes
which include PPIs and more recently phase separation (Brocca et al., 2020; Peter E Wright
& Dyson, 2015). The most common protein interaction module within IDPRs is the short
linear motif (SLiM), sometimes referred to as a molecular recognition feature (MoRF), or
minimotif, which are implicated in directing various cellular processes including PTM,
protein localization, cleavage, docking and degradation (Mi et al., 2012; Mohan et al.,
2006; Van Roey et al., 2014). There are an estimated 100,000 SLiMs (excluding PTMs) in
the human proteome; however, only a few thousand of these have been identified to date
(Kumar et al., 2020; Tompa et al., 2014). This disparity highlights a significant knowledge
gap in our understanding of SLiMs and their importance to basic cell biology.
Fascinatingly, the nature of SLiMs and how they have emerged evolutionarily has more or
less made them an Achilles heel. Pathogens, such as viruses have co-evolved to exploit
host-SLiMs through molecular mimicry, allowing them to integrate into, and take
advantage of host pathways (Davey et al., 2011). Since a diverse range of viruses can infect
the same host, they are often faced with the same set of host factors. This level of selective
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pressure is likely why diverse viruses have convergently evolved mechanisms to usurp key
cellular processes like protein nuclear import and evade the host immune system (Via et
al., 2014). These observations also highlight the importance of studying viral processes, as
many SLiM-mediated interactions were first discovered through viral PPI studies (R. E.
Jones et al., 1990; Daniel Kalderon et al., 1984).

1.2

Short Linear Motifs (SLiMs)

1.2.1 SLiMs are a class of protein-protein interaction
PPIs can be mediated through a range of binding modules that exist on a continuum
between highly structured globular domains and intrinsically disordered SLiMs. In general,
three classes of protein interaction modules have been proposed and these include: globular
domains, intrinsically disordered domains (IDD) and SLiMs (Table 1.1) (Tompa et al.,
2009; Van Roey et al., 2014). Globular domains are easily distinguished from IDDs and
SLiMs based on their ability to form a stable tertiary structure in the absence of a binding
partner (Han et al., 2007). In contrast, both IDDs and SLiMs are found within IDPRs and
lack a well-defined tertiary structure under native conditions (Tompa et al., 2009). It is
worth noting that even though SLiMs are almost exclusively found within IDPRs, they can
also be found within disordered loops of globular domains. For example, phosphorylation
sites have been frequently identified in this context (Via et al., 2009; Zanzoni et al., 2007).
Additionally, both SLiMs and IDDs preferentially bind globular domains. However, IDDs
have also been shown to bind other IDDs, such as with the p53 tetramerization domain,
where two disordered regions adopt an ordered structure upon interaction (Fichó et al.,
2017; Jeffrey et al., 1995).
Of the three classes, SLiM-mediated interactions are the weakest, with binding affinities
in the low micromolar range, compared to IDD and globular domain interactions, which
fall in the nanomolar and picomolar ranges, respectively (Hirschi et al., 2010; Kastritis et
al., 2011; C. W. Lee et al., 2010). Although IDDs and SLiMs have several similarities,
such as being found within IDPRs and forming transient interactions, a major
discriminating factor is their sequence length (Davey et al., 2012). IDDs are substantially
longer and range from 20-50 amino acids, while SLiMs are typically less than 10 amino
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acids (Davey et al., 2012; Tompa et al., 2009). Finally, SLiM interaction interfaces are
almost always monopartite and can function independently (Van Roey et al., 2014). This
is an important distinction from IDDs, which interact in a multipartite fashion, meaning
there are several distinct units that contribute together towards the function of an IDD.

1.2.2 Attributes of SLiMs
A distinguishing feature of SLiMs is their ability to make highly specific yet transient
interactions using only a limited number of amino acids. Firstly, due to the inherent
properties of SLiMs, their amino acid sequence information is most easily conveyed using
the single-letter amino acid code in the form of a regular expression. To date, nearly 300
classes of SLiMs have been identified from a diverse range of biological processes and
these are currently deposited within the Eukaryotic Linear Motif (ELM) resource (Kumar
et al., 2020). In general, SLiMs almost exclusively bind globular domains; however, it’s
worth mentioning that examples of RNA binding and lipid binding motifs have also been
documented (Kojima et al., 2004; Phan et al., 2011). Importantly, the ELM resource
represents motifs that have been manually curated and experimentally validated over the
past 20 years, greatly expanding our knowledge of SLiMs and allowing for comprehensive
analyses of their attributes (Davey et al., 2012).
Analysis of motifs from the ELM resource have demonstrated that the majority of SLiMs
are between 3–10 amino acids in length; however, instances of motifs over 20 amino acids,
such as the bipartite nuclear localization signal (NLS), are well documented (Davey et al.,
2012; Kumar et al., 2020). On average, only 2 to 4 amino acids within a motif are defined
positions. These can be either fixed or degenerate, meaning certain positions, depending
on the type of motif, can be substituted with highly similar amino acids. Additionally, the
majority of motifs have several wild card positions, allowing for the accommodation of
potentially any amino acid. In contrast, some positions within a motif cannot tolerate
particular amino acids, particularly those that are physically and/or chemically
incompatible with their corresponding binding site. This can be demonstrated with the
monopartite NLS, which cannot accommodate aspartic acid or glutamic acid within or
adjacent to the core motif (Kosugi et al., 2009). As a whole, most classes of SLiMs are
found internally within a protein’s linear amino acid sequence; however, certain classes
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Table 1.1 Properties of protein-protein interaction modules.

Globular domain

Intrinsically disordered
domain (IDD)

Short linear
motif (SLiM)

Length (amino acids)

50–200

20–50

3–10

Conformation

folded

disordered

disordered

Binding mode

multipartite

multipartite (linear)

monopartite

Affinity (with globular
domain)

nanomolarpicomolar

nanomolar

micromolar

globular domains,
IDDs, SLiMs

globular domains, IDDs

globular
domains

stable

transient

transient

Property

Binding partner

Binding dynamics
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such as the PDZ domain binding motif or IAP-binding motif are specifically found at the
C- and N-termini, respectively (Kumar et al., 2020).

1.2.3 Functions of SLiMs
It is well recognized that IDPRs play a significant role in cell signalling and regulation
(Peter E Wright & Dyson, 2015). This can largely be attributed to the function of SLiMs,
which are the most commonly found interaction module within IDPRs (Diella et al., 2008;
Fuxreiter et al., 2007; Van Roey et al., 2014). According to the ELM resource, SLiMs can
be categorized into one of six categories based on function (Figure 1.2) (Kumar et al.,
2020). These classes include cleavage, degradation, docking, ligand binding, modification
and targeting. SLiM-mediated interactions are involved in a multitude of diverse cellular
processes as they can provide the necessary functional plasticity for multifunctional
proteins (Kumar et al., 2020; Zanzoni et al., 2019). Additionally, SLiMs allow for the
integration of different signals, acting as molecular switches to precisely control protein
localization and/or function (Van Roey et al., 2013). One way this can be achieved is
through PTMs like phosphorylation. For example, phosphorylation adjacent to the
NFATC1 NLS by PKA acts a priming event for binding of GSK3 which results in further
phosphorylation that completely blocks NFATC1 nuclear localization (Sheridan et al.,
2002). Many examples of such switches exist and others have been implicated in regulating
protein stability temporally and/or spatially and directing the assembly of signalling
complexes, for example (Van Roey et al., 2013). Interestingly, many PTM classes found
within IDPRs are specifically associated with regulatory or signalling regions, in contrast
to PTMs targeted to ordered regions, which are mainly involved in changing catalytic
function or conformational stability (Darling & Uversky, 2018; Xie et al., 2007).
Importantly, PTMs like phosphorylation are reversible, allowing for SLiM functions to be
turned on or off in the appropriate contexts, a key property of signalling pathways (Ardito
et al., 2017).
Perhaps the most important aspect of IDPRs and their embedded SLiMs is their enrichment
within hub proteins, or proteins which interact with hub proteins
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Figure 1.2 Categories of SLiMs.
SLiMs can be broadly categorized into six different categories based on function. Selected
examples are depicted with corresponding SLiMs where “X” represents any amino acid
and amino acids within square brackets can be substituted with one another. Cleavage
motifs are recognized by enzymes, such as caspases, which irreversible cleave the protein.
Degradation motifs are recognized by ubiquitin ligase complexes, such as the anaphase
promoting complex (APC/C), and mediate proteosomal degradation. Docking motifs
generally act as enzyme recruitment sites and increase substrate specificity. In the example
above, cyclin binding to its docking motif increases substrate specificity for cyclindependent kinases (CDK). Ligand binding motifs are a broad category mediating
interactions that do not result in modification upon binding, whereas modification sites
themselves are directly chemically modified. Targeting motifs fall within the ligand
binding category, however; their interactions result in localization to specific subcellular
compartments such as the nucleus via NLSs. Created in BioRender.
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(Dosztányi et al., 2006; A Keith Dunker et al., 2005; Haynes et al., 2006; Hu et al., 2017;
Jespersen & Barbar, 2020). Within an interactome, proteins can interact with one another
to varying degrees (Huttlin et al., 2015). Some proteins are highly connected, participating
in possibly tens to hundreds of interactions, while others are less connected with only a few
binding partners. These highly connected proteins have come to be recognized as hub
proteins (A Keith Dunker et al., 2005; Ekman et al., 2006). Their importance in organizing
PPI networks is based on evidence that genetic deletion of these proteins is most often
lethal. This concept has been coined as “lethality and centrality” and is underscored by
experimental evidence showing that highly connected proteins, which represent a small
percentage of total PPIs, are most often essential for survival (Hu et al., 2017; Jeong et al.,
2001; Zotenko et al., 2008). The presence of IDPRs within hub proteins provide a flexible
backbone allowing them to dynamically sample the interaction space, a necessity for these
multifunctional proteins. This can be exemplified with the highly disordered portions of
the p53 protein (Uversky, 2016). Widely regarded as the “guardian of the genome” due to
its tumor suppressor qualities, p53 is involved in a range of cellular processes (Lane, 1992;
Sionov & Haupt, 1999). It’s N- and C-terminal regions are highly disordered, enriched in
PTMs and facilitate numerous SLiM-mediated interactions. The overall intrinsic disorder
of p53 gives rise to multiple proteoforms which will favour certain interactions and PTMs
(Uversky, 2016). Importantly, the lack of structure in IDPRs allows each proteoform to
dynamically respond to cellular conditions and make the necessary PPIs without being
locked in a particular conformation, demonstrating an important quality of hub proteins
(Jespersen & Barbar, 2020).

1.2.4 SLiM evolution
Intrinsic disorder is a conserved feature of proteins among all living organisms, as well as
viruses (Xue et al., 2012). Interestingly, computational studies have demonstrated that
eukaryotes, both unicellular and multicellular, display a greater amount of intrinsic disorder
than prokaryotes or archaea (A K Dunker et al., 2000; Ward et al., 2004; Xue et al., 2012).
Why this is the case is likely due to the need for greater cell signalling and regulation in
higher eukaryotes, as this is evidenced by signalling proteins having the greatest degree of
IDPR enrichment (Iakoucheva et al., 2002). Since SLiMs are almost exclusively found
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within IDPRs, their evolution is inextricably connected to the presence of IDPRs within
proteomes.
In contrast to structured domain evolution, which predominantly involves gene duplication,
IDPRs have been shown to evolve much more rapidly (Brown et al., 2002; Vogel et al.,
2004). The presence of SLiMs within these rapidly evolving regions has now led to the
interesting concept of ex nihilo evolution, meaning “from nothing” (Davey et al., 2015).
Considering SLiMs only possess 2–4 critical amino acids that contribute the majority of
affinity and specificity in binding, it seems reasonable that a single point mutation, or small
insertion/deletion, could create a novel motif from nothing (Stein & Aloy, 2008). Through
random mutation, identical motifs have convergently evolved ex nihilo in unrelated
proteins, such as the PxIxIT calcineurin-binding motif and many others (Figure 1.3A)
(Davey et al., 2015; Kumar et al., 2020). Post-duplication, if a protein does not acquire an
advantageous function it can be eliminated from the gene pool due to genetic drift or
negative selection. Therefore, through ex nihilo motif generation, homologous proteins
have the ability to rapidly diversify their function post-duplication, as was the case with S.
cerevisiae Ace2 and Swi5 (Figure 1.3B) (Nguyen Ba et al., 2014).
It’s well documented that many disease-causing mutations are a result of point mutations
which eliminate a motif (Kumar et al., 2020; Uyar et al., 2014). Interestingly though,
several diseases have been attributed to ex nihilo motif generation. One such example is an
a S→G mutation at position 2 of SHOC2, resulting in Noonan-like syndrome (Figure 1.3C)
(Cordeddu et al., 2009). This mutation creates a novel N-myristoylation site in SHOC2,
resulting in aberrant targeting to the plasma membrane and impaired nuclear import.
Another example involves the generation of dileucine motifs within cytosolic tails of
several transmembrane proteins; CACNA1H, GLUT1 and ITPR1 (K. Meyer et al., 2018).
Investigation of GLUT1 demonstrated novel interactions with AP-1 and AP-2, resulting in
an intracellular localization of GLUT1 (Figure 1.3D). Both of these examples highlight the
ease at which a single point mutation can generate a novel SLiM.
In addition to novel motif evolution, the same process can allow for “tuning” of existing
motifs (Davey et al., 2015). An important attribute of SLiMs is their ability to mediate
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Figure 1.3 Ex nihilo evolution of SLiMs.
Due to the low sequence complexity of SLiMs, they can be gained or lost through single
amino acid substitutions. Ex nihilo, meaning “from nothing”, implies the generation of a
motif from a peptide sequence otherwise devoid of SLiMs. (A) An example of ex nihilo
evolution can be observed with the calcineurin docking motif of the yeast Elm1 protein
(green). This motif likely evolved from a common ancestor of Saccharomyces cerevisiae
and Saccharomyces paradoxus. (B) SLiMs can also be rapidly lost, altering a proteins
functionality. Following whole genome duplication, S. cerevisiae Ace2 and Swi5 were
retained; however, the Cbk1 docking motif and phosphorylation sites were lost in Swi5.
(C and D) Single amino acid substitutions can also “knock in” motifs that cause disease.
This has been documented with human SHOC2, where an S2G mutation creates an Nmyristoylation site resulting in Noonan-like syndrome due to aberrant localization.
Likewise, a P485L mutation in human GLUT1 creates a dileucine motif that is recognized
by adapter proteins (AP), also causing aberrant intracellular localization. Created with
BioRender.
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transient interactions, an important attribute of signalling pathways in general. These
transient binding properties have evidently been selected for, as artificially optimizing
motifs for higher or lower affinity have a proportional effect on their respective signalling
pathways (Marles et al., 2004; Roy et al., 2007). These observations highlight the idea that
biological systems are optimized for efficiency. Through ex nihilo evolution, SLiMs can
be acquired and then be further optimized, or tuned, in an evolutionarily rapid process.

1.2.5 Pathogenic molecular mimicry of SLiMs
The term molecular mimicry refers to structural or sequence similarities between pathogens
and host proteins. This term was historically applied to shared antigens (antigenic mimicry)
which results in cross-activation of the immune system (Kohm et al., 2003). However, this
term is also broadly used to describe the sharing of any sequence/structure between
pathogen and host (Damian, 1964). Pathogens like viruses, as well as some bacteria and
parasites, replicate intracellularly within their host and therefore require an intimate
relationship with host proteins to influence cellular processes such as cell cycle,
metabolism, or detection by the immune system, for example. Since pathogens from
diverse taxonomies infect the same organism, they are all faced with a similar range of host
factors. Based on this, it is not surprising that they have acquired similar strategies, through
convergent evolution, to manipulate host cellular processes. One widely used strategy that
will be discussed further is the mimicry of host SLiMs by viral proteins (Davey et al.,
2011).
As obligate intracellular parasites, viruses have evolved an intimate relationship with their
host. As a result of their dependence on host cells for replication, viral genomes have
evolved in a lockstep manner with their host (Simmonds et al., 2019). Importantly, each
step of the viral replication cycle typically involves extensive host-pathogen PPIs, which
is evident based on the number of viral PPI studies that dominate the literature compared
to non-viral pathogens. These interaction studies have demonstrated the widespread
presence of all six classes of SLiMs, as defined in the ELM resource, within viral
proteomes (Davey et al., 2011; Kumar et al., 2020). In fact, early viral studies pioneered
the discovery and characterization of SLiMs (R. E. Jones et al., 1990; D Kalderon et al.,
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1984; Lyons et al., 1987). These early examples involved discovery of NLSs in human
adenovirus (HAdV) E1A and simian virus 40 (SV40) large T antigen (TAg), as well as the
retinoblastoma-binding SLiM in human papilloma virus (HPV) E7. Through extensive use
of SLiMs, diverse viruses are able to target similar host pathways (Davey et al., 2011).
These include intracellular transport via nuclear localization and export signals, immune
evasion through signal transduction, altering host protein levels via proteosomal
degradation, cell cycle regulation through transcriptional regulation and others such as host
and viral PTM (Deng et al., 2004; Felsani et al., 2006; Horwitz et al., 2008; Stanley et al.,
2008; Tessier et al., 2019; Thorley-Lawson, 2001; Welcker & Clurman, 2005).
Since cellular hub proteins are relatively few in number, the logical consequence of a
random loss of a PPI is statistically less likely to have a detrimental effect on the overall
system (Albert et al., 2000). The benefits of such a system are clear; however, this situation
exposes a critical disadvantage where hub proteins can represent an Achilles heel within a
signalling network, giving rapidly evolving pathogens, including viruses, the ability to
hijack cellular pathways (Davey et al., 2011; Yu et al., 2007). It’s now well established that
viral proteins have evolved to specifically target cellular hub proteins (Calderwood et al.,
2007; de Chassey et al., 2008; Dyer et al., 2008; Garamszegi et al., 2013). Computational
analyses comparing endogenous (host-host interactions) and exogenous (virus-host) PPI
binding surfaces revealed that viral proteins preferentially target SLiM-binding domains
(Garamszegi et al., 2013). In fact, the probability of a cellular protein being a viral target
positively correlates with the number of PPIs it makes endogenously, as well as with the
number of SLiM-binding domains present within proteins that make a similar number of
PPIs (Garamszegi et al., 2013). Together, this demonstrates that viral proteins have evolved
to preferentially target cellular hub proteins with SLiM-binding domains. Furthermore,
these viral proteins are enriched for disorder promoting amino acids and SLiMs on a per
residue basis compared to human proteins.
Fascinatingly, some viral proteins participate in so many interactions that they themselves
act as a hub protein. This is best demonstrated with the HAdV E1A protein which employs
a multitude of SLiM-mediated interactions (Figure 1.4). Remarkably, using only
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Figure 1.4 Molecular mimicry of SLiMs by HAdV-C5 E1A.
Depicted is the full length (289 amino acid) HAdV-C5 E1A protein. E1A is almost entirely
disordered, allowing it to interact with a wide range of cellular proteins. Using a variety of
SLiMs E1A can interact with host cellular proteins involved in different cellular processes
such as intracellular transport, post-translational modification, transcriptional regulation
and cell cycle regulation. Additionally, E1A is a classic example of how viral genomes,
which have limited coding capacity, encode for proteins with extremely high functional
density, as depicted by the many overlapping SLiMs. Created with BioRender.
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289 amino acids, E1A can make up to 32 primary PPIs which are involved in altering cell
cycle progression, transcriptional regulation, nuclear localization, relocalization of cellular
targets to the nucleus, global PTM, and endogenous protein levels (King, Zhang, et al.,
2018). However, in addition to E1As role as a viral hub protein, E1A can also target and
manipulate cellular hub proteins such as CREB-binding protein (CBP) which participates
in several hundred PPIs itself (Ferrari et al., 2014; Hu et al., 2017). These examples, along
with others like human immune deficiency virus 1 (HIV-1) Nef, Epstein-Barr virus (EBV)
LMP1 and SV40 TAg, highlight the ease at which viral proteins can usurp cellular
processes through systematic targeting of cellular hub proteins and even function as hub
proteins themselves (Davey et al., 2011).
In terms of viral SLiM evolution, the same process of ex nihilo motif generation used by
cellular proteins can be applied. Given the high mutation rates for both RNA and DNA
viruses, this process is probably accelerated and it’s not unlikely that new motifs could
rapidly emerge if a particular mutation is beneficial (Duffy et al., 2008; G. M. Jenkins et
al., 2002). Since virus-host evolution is highly intertwined, it is not surprising that both
have convergently evolved highly similar SLiMs (Davey et al., 2011). Analysis of
Influenza A virus (IAV) H3N2 hemagglutinin protein from 1968 to 2003 is a fascinating
example of this, where the number of Nx[TS] glycosylation motifs increased from 2 to 7
over this nearly 40 year period (Igarashi et al., 2008). Additionally, substitution of a single
amino acid can dramatically alter SLiM-binding specificity. Rabies virus protein G from
VIR and ATT viral strains both possess a PDZ-binding SLiM; however, VIR protein G
promotes neuronal cell survival and ATT protein G results in neuronal cell death (Préhaud
et al., 2010). These phenotypic differences are the result of a single amino acid change in
their PDZ-binding SLiMs, allowing VIR (QRTL) and ATT (ERTL) protein G to
outcompete cellular MAST2-PDZ and PTPN4-PDZ targets, respectively. In addition to
altered specificity, viral SLiMs often differ in affinity compared to their cellular
counterparts. For example, the HIV-1 Nef SH3 domain binding motif, PxxP, has a higher
affinity for cellular Hck than host motifs due to additional contacts made outside of the
core motif (Stangler et al., 2007). Likewise, the HAdV-C5 E1A protein is able to
outcompete binding of cellular AKAP7 to PKA (King, Cohen, et al., 2016). In these
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examples, a higher binding affinity was required for their respective function. However, a
higher binding affinity is not always necessary and this has been shown with the HPV E6
interaction with cellular MAGI1, which binds with the same affinity as its cellular targets
(Fournane et al., 2011).
One of the proposed properties of viral SLiMs that differentiates them from their eukaryotic
counter-parts is the degree of intrinsic disorder within their core motif (Duro et al., 2015).
Both human and viral SLiM containing regions show similar levels of intrinsic disorder
when comparing the core SLiM region and flanking amino acids together. Interestingly,
however, viral SLiMs tend to show greater disorder in their core motif compared to the
flanking regions, presumably giving them greater local flexibility. Furthermore, human
SLiMs tend to show a greater bias towards undergoing a disorder-order transition upon
binding, while viral SLiMs appear more likely to remain unstructured upon binding (Duro
et al., 2015). This has been demonstrated with the C-terminal domain of measles virus
nucleoprotein, which remains disordered while bound to viral phosphoprotein (Bourhis et
al., 2005). This ability to remain disordered while bound has been termed “fuzziness”
(Tompa & Fuxreiter, 2008). Reconsidering viral proteins like HAdV E1A, which makes
dozens of primary PPIs with only 289 amino acids, sufficient conformational adaptability
is likely a requirement. By using “fuzzy” motifs viral proteins can exist in multiple
proteoforms that are compatible with a wide range of PPIs.

1.2.6 SLiM detection methodologies
Both computational and experimental approaches have contributed significantly to the
discovery of SLiMs. Computationally, significant challenges arise due to the limited
information content embedded within SLiMs. With only 2 to 4 positions critical for
binding, some of which have flexibility for similar amino acids, the number of falsepositive matches hinders computational discovery (Davey et al., 2012; Gibson et al., 2015).
One factor common to all computational approaches is the false discovery of motifs within
structured regions. Since SLiMs are almost exclusively found within disordered regions,
adding this filter is essential to reduce the number of false positives. Programs, such as the
ELM resource, filter results through SMART, Pfam and GlobPlot to identify protein
domains, as well as IUPred for identifying regions of predicted disorder. In general,
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computational approaches can be categorized into i) identifying novel SLiM instances of a
known motif or ii) identifying SLiMs de novo. Many software programs and packages such
as MEME Suite and SLiMSuite have been developed for these purposes (Bailey et al.,
2009; Edwards & Palopoli, 2015).
Identifying instances of SLiMs can be as straight forward as matching regular expressions
of known or putative SLiMs against a protein sequence, or more complex using programs
like SLiMSearch, which can filter instances based on their intrinsic disorder score and
evolutionary conservation (Krystkowiak & Davey, 2017). Conversely, computational de
novo SLiM discovery is not as straightforward. One of the most common approaches relies
on convergent evolution, or the independent evolution of shared motifs from unrelated
proteins (Edwards & Palopoli, 2015). Importantly, this approach most often leverages
either user generated or publicly available PPI data. Commonly used programs such as
SLiMFinder and DILIMOT will take a group of proteins that share a common binding
partner and attempt to identify statistically significant SLiMs that are shared among those
proteins (Davey et al., 2010; Edwards et al., 2007; Neduva & Russell, 2006). However,
due to the limitations of computational methodologies in general, experimental validation
is required. These approaches have been previously used, with experimental follow up, to
identify novel SLiMs from several different model organisms, as well as humans (Neduva
et al., 2005).
Experimental approaches for discovering novel SLiMs can be categorized into either
genetic or biochemical screens (Blikstad & Ivarsson, 2015; K. Meyer & Selbach, 2020).
Common genetic screening techniques have employed yeast two-hybrid (Y2H) and phage
display (Blikstad & Ivarsson, 2015). In both cases, bait proteins are typically SLiM-binding
domains, and these are screened against a library of peptides (prey). With Y2H, both bait
and prey are expressed within yeast, unlike phage display where baits are immobilized and
peptides are displayed externally on phage. The main advantage of both techniques is the
ease at which large prey libraries can be constructed. More recently, advances in phage
display has resulted in the specific expression of peptides representing particular regions
of the proteome, a method referred to as proteomic peptide phage display (ProP-PD)
(Davey et al., 2017). As an example, peptides specifically representing disordered regions
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of the human proteome were displayed on phage and screened against several different
immobilized baits (Davey et al., 2017). Importantly, both Y2H and phage display
techniques have a similar bottleneck, as they are both limited by the number of bait proteins
that can be tested.
Common biochemical strategies have mostly involved the use of peptide arrays or protein
microarrays (K. Meyer & Selbach, 2020). The major advantage of peptide arrays over
protein microarrays is the ability to synthesize hundreds different peptides at high density
on cellulose membranes through SPOT-synthesis (Hilpert et al., 2007). From here,
recombinantly expressed bait proteins can be incubated with the membrane to identify
interacting peptides. Through the use of mass spectrometry, throughput of prey
identification can be significantly increased by incubating peptide arrays with highly
complex whole cell lysates. This was first done using immobilized peptides and has now
evolved into testing over 200 peptides, via SPOT-synthesis, against cell lysates using a
recently developed method termed protein interaction screen on peptide matrix (PRISMA)
(Dittmar et al., 2019). However, even though significant advances have been made, each
of these approaches remain relatively low throughput at either the bait or prey level. Given
that there are likely thousands of additional motif classes to be discovered, the need for
developing high throughput methodologies to identify these novel SLiMs is a fertile area
of research.

1.3

Protein Nuclear Transport

1.3.1 Separation of nuclear and cytoplasmic compartments
Within eukaryotic cells the nuclear envelope (NE) provides a physical barrier that spatially
separates the contents of the nucleus and cytoplasm. The NE confines key cellular
processes like transcription and translation to the nuclear and cytoplasmic compartments,
respectively. This separation allows for complex regulation of gene expression, as well as
a variety of other distinguishing factors between prokaryotic and eukaryotic organisms
(Devos et al., 2014; Martin & Koonin, 2006). Newly transcribed mRNA must be exported
from the nucleus to the cytoplasm to be translated, while nuclear proteins such as
transcription factors and histones must be imported into the nucleus. For complex
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biological processes like signal transduction to occur, there must be dynamic spatial and
temporal regulation of proteins and other macromolecules between the cytoplasmic and
nuclear compartments, which ultimately requires passage across the NE in either direction.
The exchange of proteins and molecules between compartments occurs exclusively
through nuclear pore complexes (NPC) which are embedded throughout the NE (Wente &
Rout, 2010). NPCs are large macromolecular structures with an aqueous central channel
that facilitates bidirectional movement of molecules. Importantly, the biochemical and
physical properties of the central channel establish a permeability barrier that allows the
NPC to act as molecular sieve (Hoelz et al., 2011). Small proteins can diffuse through the
NPC; however, as protein size increases this becomes increasingly difficult (Timney et al.,
2016). To maneuver the NPC, cells employ a variety of nuclear transport receptors (NTR)
called karyopherins. These proteins facilitate bidirectional transport of proteins through the
NPC in a rapid, energy-dependent, process (Cautain et al., 2015).

1.3.2 The nuclear pore complex
The NPC is an impressive biological structure built upon a framework comprising multiple
copies of roughly 30 different nuclear pore proteins called nucleoporins (Nups) (Beck &
Hurt, 2017; Schwartz, 2016). In general, Nups can be categorized as either scaffold Nups,
which function in an architectural capacity, or FG-Nups that make up the inner aqueous
channel (Beck & Hurt, 2017). The basic architecture of the NPC is composed of different
substructures that are organized in a highly modular fashion. Using only a few common
domain folds, Nups can oligomerize into stable higher-ordered structures, giving rise to an
overall architecture that can be broken down into several elements which include: the inner
pore ring, nuclear and cytoplasmic rings, nuclear basket and cytoplasmic filaments (Figure
1.5).
Depending on their role within the NPC, Nups can be classified as either scaffold- or FGNups (Beck & Hurt, 2017). Scaffold-Nups are primarily composed of folded protein
domains and contribute to the overall architecture of the NPC. The inner ring and Ycomplex substructure, which is the main component of the nuclear and cytoplasmic rings,
are believed to provide the main scaffolding element of the NPC
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Figure 1.5 Structural organization of the nuclear pore complex.
The nuclear pore complex (NPC) is responsible for facilitating bidirectional transport of
all molecules across the nuclear envelope (NE). Architecturally, the NPC can be
categorized into several structures that include the cytoplasmic filaments, cytoplasmic ring,
nuclear basket, nuclear ring and inner pore ring. The NPC is composed of nucleoporins
(Nups) which are organized into various substructures, or modules, that fit within the NPCs
overall architecture. Here, the various modules and corresponding Nups are colour coded
and correspond to their location within the NPCs architecture. The Y complex and inner
ring complex primarily make up the NPC scaffold, which is anchored to the NE via
transmembrane Nups. Within the central channel is the Nup62 complex, which is primarily
composed of phenylalanine glycine (FG) repeat containing Nups that bind NTRs and
provide the permeability barrier of the NPC. Additionally, Nups within the nuclear basket
and cytoplasmic complex contain FG Nups and aid in nuclear import and export. Figure
adapted from Beck and Hurt, 2017 (Beck & Hurt, 2017). Created with BioRender.
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(Beck & Hurt, 2017; Bui et al., 2013; Vollmer & Antonin, 2014). In contrast, FG-Nups
contain large regions of intrinsic disorder that are rich in phenylalanine (F) and glycine (G)
repeats (Terry & Wente, 2009). These repeats, which can range from 5–50, are separated
by hydrophilic linker regions and come in several different flavours such as FxFG or
GLFG. FG-Nups are found within both the cytoplasmic filaments and nuclear basket,
which emanate from the cytoplasmic ring and nuclear ring, respectively, and are primarily
responsible for recognizing NTRs (Bayliss et al., 2002). Additionally, FG-Nups line the
inner pore ring within the central channel and create a sieve-like barrier. Here, FG-repeats
interact with one another, forming a liquid phase separation that is proposed to contribute
to the selectivity of the NPC (Celetti et al., 2020; Schmidt & Görlich, 2016).
Interestingly, it has been recently shown that connectivity within and between NPC
subcomplexes is largely organized by SLiMs. Biochemical studies of the interactions from
the inner ring complex of C. thermophilum demonstrated that SLiMs within the N- and Ctermini of Nup53 mediated different interactions with other inner ring Nups (Amlacher et
al., 2011). Furthermore, the inner ring Nup, Nup192, tethers to other Nups located within
the outer ring scaffold and central channel FG-Nups (Fischer et al., 2015; D. H. Lin et al.,
2016). An additional function of disordered FG repeats has also been implicated in
stabilizing the structure of the NPC (Onischenko et al., 2017). As mentioned previously, a
key feature that SLiMs bestow on their proteins is the possibility for regulation by PTM.
This is indeed the case as many Nups are phosphorylated within disordered regions,
resulting in the breakdown of the NPC during mitosis (Laurell et al., 2011). Non-mitotic
phosphorylation of FG-Nups can also influence the permeability barrier of the NPC by
decreasing the affinity between FG-repeats as well as decrease their affinity for NTRs
(Kosako & Imamoto, 2010; Mishra et al., 2019). Overall, despite SLiMs interacting in a
linear fashion they contribute significantly to the overall 3-dimensional structure of the
NPC and are key regulators of NPC function.

1.3.3 Overview of nucleocytoplasmic transport cycle
Passage of proteins through the NPC is aided by NTRs called karyopherins, which can be
functionally classified as either importins or exportins depending on the direction they
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carry their respective cargo. It’s also worth noting that not all karyopherins have been
studied equally, therefore some of their roles are unclear. For example, exportin-7 has been
historically assigned nuclear export functions, but has now recently been shown to be
responsible for import of several cargos (Aksu et al., 2018). Most karyopherins belong to
the highly conserved karyopherin-β (Kapβ) superfamily, which vary in number depending
on the organism, ranging from 14 in the yeast Saccharomyces cerevisiae to at least 20 in
humans (Harel & Forbes, 2004). Kapβ family members are composed 19-20 HEAT
repeats, giving them an overall solenoid structure that allows them to interact directly with
FG-Nups within NPC (Bayliss et al., 2002; Christie et al., 2016). Kapβ’s can bind their
cargo directly through the recognition of either a distinct NLS or nuclear export signal
(Figure 1.6: left and right panel) (NES) (Xu et al., 2010). Alternatively, they interact with
cargo via adapter karyopherins, such as importin-α (Imp-α), which also recognize distinct
NLS sequences (Figure 1.6: middle panel) (Goldfarb et al., 2004b).
Interactions between karyopherins and their cargo is modulated through the binding of
RanGTP, which is predominately localized within the nucleus, to the N-terminal HEAT
repeats of Kapβ proteins (Vetter et al., 1999). The asymmetric localization of RCC1
(nuclear), a RanGTP exchange factor, and RanGAP1 (cytoplasmic), which stimulates the
conversion of RanGTP to RanGDP, is responsible for establishing nuclear RanGTP and
cytoplasmic RanGDP levels (Cavazza & Vernos, 2015; Stewart, 2007). Importantly, the
distribution of RanGDP/GTP across the NE is essential for dictating the directionality of
transport (D Görlich et al., 1996). Importin Kapβ’s associate with their cargo in the
cytoplasm and are rapidly transported through the NPC and subsequently release their
cargo via conformational changes stimulated through binding of RanGTP (Christie et al.,
2016). Conversely, exportin Kapβ’s form a complex with RanGTP and their cargo within
the nucleus and subsequent hydrolysis of RanGTP within the cytoplasm, stimulated by
RanGAP1, causes the release of RanGDP and cargo dissociation (Bischoff et al., 1994). In
order to drive further nuclear transport cycles, RanGDP is imported into the nucleus by
NTF2, where RCC1 replenishes the RanGTP population (Ribbeck et al., 1998).
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Figure 1.6 Protein nuclear import and export through the nuclear pore complex.
Proteins are transported through the nuclear pore complex (NPC) by binding importin or
exportin karyopherins. Protein nuclear import is facilitated by importin karyopherin β’s
that recognize a proteins nuclear localization signal (NLS) within the cytoplasm (left
panel). Of the importin karyopherin β’s, Importin-β1(Imp-β1) recognizes it’s cargo
through the adapter Importin-α (middle panel). This pathway is formally known as the
classical nuclear import pathway and is assumed to handle the majority of nuclear import.
The nuclear import cycle is completed upon binding of RanGTP to Importin-β, causing
cargo or Importin-α dissociation. Protein nuclear export primarily uses exportin-1 (XPO1),
which recognizes a cargos nuclear export signal (NES), along with RanGTP, within the
nucleus (right panel). In the cytoplasm, RanGTP hydrolysis is stimulated by the Ran
GTPase activating protein 1 (RanGAP1), causing cargo release. Created with BioRender.
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1.3.4 Imp-α dependent nuclear import: Classical nuclear import
Kapβ’s are able to recognize their cargo directly through recognition of their NLS;
however, Imp-β1 is unique in that it uses Imp-α as an adapter to bind cargo in addition to
being able to bind cargo directly (Lam et al., 1999; Lange et al., 2007). This pathway has
long been regarded as the classical nuclear import pathway, as both Imp-α and Imp-β1
were the first importins to be isolated and have thus contributed significantly to our
mechanistic understanding of transport (Dirk Görlich et al., 1994; Lange et al., 2007;
Moroianu et al., 1995). In this pathway, Imp-α recognizes a cargos NLS, which then allows
Imp-β1 to bind Imp-α/NLS, forming a ternary complex that can move through the NPC
(Figure 1.6: Middle panel). Components of the classical nuclear import pathway are also
highly conserved across eukaryotes: S. cerevisiae express a single Imp-α, D. melanogaster
express three isoforms, and the human genome encodes seven Imp-α isoforms (Pumroy &
Cingolani, 2015). Importantly, the classical nuclear import pathway is generally regarded
to handle the bulk of protein nuclear import.
Imp-α isoforms can be subdivided into three subfamilies known as α1, α2 and α3, all of
which have a highly conserved architecture (Pumroy & Cingolani, 2015). The C-terminal
portion of Imp-α isoforms are composed of 10 armadillo (ARM) repeats, which form the
NLS-binding region while the N-terminal 70 amino acids function as an Imp-β binding
(IBB) domain (Figure 1.7A) (Goldfarb et al., 2004a). The NLS-binding region is formed
by two pockets between ARM repeats 2–4 and 6–8, which are referred to as the major and
minor grooves, respectively (Fontes et al., 2000). Aside from linking Imp-α to Imp-β1, the
IBB domain also plays an autoinhibitory role by binding these NLS-binding grooves,
preventing futile import of empty Imp-α/β1 heterodimers (Kobe, 1999; Lott & Cingolani,
2011). In S. cerevisiae, the autoinhibitory function of the IBB domain is essential for
survival; however, whether this is true for human Imp-α is unclear (Harreman, Hodel, et
al., 2003). The autoinhibitory function of the IBB domain from different Imp-α isoforms
can vary greatly. For example, Imp-α3 and -α7 have been shown to have reduced
autoinhibition compared to Imp-α1 and this has been attributed to its affinity for the minor
groove pocket (Pumroy et al., 2015; Pumroy & Cingolani, 2015). In general, efficient
nuclear import requires complex interactions involving NLS recognition and Imp-β1
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Figure 1.7 Classical nuclear localization sequence recognition by Importin-α.
(A) Importin-α (Imp-α) contains an N-terminal Importin-β binding domain (IBB) followed
by a series of ARM repeats. Within the ARM repeat region two pockets are formed that
recognize classical nuclear localization sequences (cNLS). ARM repeats 2–4 and 6–8 form
the major and minor groove binding sites, respectively. When unbound, the ARM repeats
of Imp-α are occupied by the IBB domain, preventing import of unloaded Imp-α. When
recognizing a cargos cNLS, Imp-α is engaged by Importin-β1, forming a ternary complex
that can shuttle through the nuclear pore complex. (B) cNLSs can be monopartite or
bipartite with one or two clusters (in bold) of basic amino acids, respectively. Monopartite
cNLSs typically bind the major binding groove of Imp-α, while bipartite cNLSs bind both
the major and minor binding grooves. For bipartite cNLS recognition, the smaller basic
cluster engages the minor site, while the larger C-terminal cluster engages the major site.
Created with BioRender.
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binding; however, the order in which these events occur may be dependent on additional
factors including the IBB domain and/or NLS affinity. NLSs recognized by Imp-α are
referred to as classical NLSs (cNLS) and represent a distinct class of SLiM. cNLSs are rich
in basic amino acids and come in two forms, monopartite or bipartite (Figure 1.7B) (Lange
et al., 2007). Monopartite cNLSs are comprised of a single cluster of basic amino acids
while bipartite cNLS have two clusters of basic amino acids separated by a linker region
of variable length and composition. These motifs can be exemplified by the SV40 TAg,
PKKKRKV, and nucleoplasmin (NP), KRPAATKKAGQAKKKK, cNLS, respectively (D
Kalderon et al., 1984; Robbins et al., 1991). Monopartite motifs primarily bind the major
groove. However, several NLSs, both cellular and viral, can bind the minor groove
exclusively (Kosugi et al., 2009; Lott et al., 2011; Nakada et al., 2015; Pang & Zhou, 2014).
In contrast, bipartite cNLSs occupy both the major and minor grooves, with the smaller Nterminal basic cluster bound to the minor groove and the larger basic cluster bound to the
major groove (Conti & Kuriyan, 2000).

1.3.5 Imp-α independent nuclear import: Non-classical import
Of the 20 or so human Kapβ proteins, roughly 10 mediate nuclear import, with an
additional two (Importin-13 and exportin-4) capable of bidirectional transport (Kimura &
Imamoto, 2014). Proteomic analysis of their cargos also suggests Kapβ members are linked
to distinct cellular pathways (Kimura et al., 2017). However, unlike classical nuclear
import mediated by Imp-α, only weak consensus NLSs have been defined for a few of these
transport receptors (Chook & Süel, 2011; B. J. Lee et al., 2006; Maertens et al., 2014).
Consequently, despite many cargos being identified for the Kapβ family members,
including those from different species, little is known regarding the characteristics of the
NLSs they recognize.
The most well characterized Kapβ import pathway is mediated by transportin 1 (TNPO1)
and its yeast homolog Kap104p (Aitchison et al., 1996; Twyffels et al., 2014). This
pathway is responsible for transporting numerous cargos into the nucleus, many of which
are RNA binding proteins (Chook & Süel, 2011). TNPO1 recognizes proline-tyrosine
NLSs (PY-NLS), which unlike compact and well-defined cNLSs, are defined by a set of
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physical criteria and a loose consensus sequence (B. J. Lee et al., 2006; Soniat & Chook,
2015). The PY-NLS is composed of an N-terminal motif that can be either hydrophobic or
basic and a C-terminal RX2-5-PY motif. Due to the presence of either a hydrophobic or
basic N-terminal region, the PY-NLS has been subdivided into two classes on this basis
(Soniat & Chook, 2015). Additionally, these motifs are found within intrinsically
disordered regions and have an overall positive charge. However, as more TNPO1 targets
have been structurally resolved, additional variants have been identified that have a PL in
place of PY, or even lack the PY motif altogether, highlighting the complexity of PY-NLSs
(Soniat et al., 2013; Soniat & Chook, 2016). A highly similar Kapβ, named transportin 2
(TNPO2), was coincidentally discovered during the cloning of TNPO1; however, due to
their similarity the majority of structural and biochemical work has been focused on
TNPO1. An additional transportin, transportin 3 (TNPO3), has been shown to import
cargos with arginine-serine (RS) repeat NLSs (Kataoka et al., 1999). Cargos of TNPO3
tend to be serine/arginine-rich (SR) splicing factors, which contain RS domains that consist
of up to 50 RS dipeptide repeats that can be recognized by TNPO3 (Chook & Süel, 2011).
However, it appears that many RS domains need to be phosphorylated (Yun et al., 2003).
Furthermore, recent analysis of Cold Inducible RNA Binding Protein (CIRBP), which has
no cNLS or PY-NLS, shows that it is able to bind both TNPO1 and TNPO3 (Bourgeois et
al., 2020). Investigation of CIRBP showed that an RG/RGG (arginine-glycine) and RSY
(arginine-serine-tyrosine) motif confers binding to TNPO1 and TNPO3, respectively, and
binding is modulated by arginine methylation of the RG/RGG motif.
Additional transporters that function analogously to Imp-α as an adapter have also been
shown to mediate nuclear import. One example is that of snurportin, which also functions
as an Imp-β1 adapter, but is involved in the import of uridine-rich small ribonucleoprotein
(U snRNP) (Mitrousis et al., 2008; Strasser et al., 2005). Snurportin has an N-terminal IBB
domain like Imp-α; however, no other structural similarities exist (Huber et al., 1998).
Fascinatingly, import by snurportin-1/Imp-β1 appears to be Ran-independent (Huber et al.,
2002). An additional adapter responsible for the synchronous nuclear import of yeast
ribosomal proteins Rpl5 and Rpl11, named symportin-1 (Syo1), has more recently been
discovered (Bange et al., 2013; Kressler et al., 2012). Syo1 acts as an adapter to Kap104
(yeast homolog of TNPO1) by binding through an N-terminal PY-NLS. Interestingly,
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structurally it appears to be a hybrid of Imp-α and Kapβ, as it contains a series of ARM
repeats followed by a series of HEAT repeats (Kressler et al., 2012). Additional work on
Syo1 is still limited to yeast and whether or not other cargo, or a functional human homolog
exists remains unclear.

1.3.6 Alternative nuclear import pathways
Several unique nuclear import pathways that do not use Imp-α or any Kapβ have more
recently been discovered. The first pathway utilizes an evolutionarily conserved protein
called Hikeshi, which is responsible for nuclear import of Hsp70 during heat shock induced
stress (Kose et al., 2012). During the heat shock response, Imp-α is retained within the
nucleus, resulting in downregulation of the classical nuclear import pathway (Furuta et al.,
2004). Additionally, RanGTP distribution is altered during cellular stressors, possibly
inhibiting Kapβ mediated transport as well (Kelley & Paschal, 2007). However, during the
heat shock response Hsp70 is imported into the nucleus by Hikeshi, which binds the NPC
directly (Kose et al., 2012). The second novel nuclear import pathway was discovered
through studies of the RanGDP nuclear import pathway mediated by NTF2 (Lu et al.,
2014). Here, it was shown that several ankyrin repeat (AR) containing proteins are able to
bind RanGDP via their ARs and complex with NTF2 indirectly.
Additional evidence of alternative nuclear import mechanisms has also come out of
studying the classical nuclear import pathway. Bioinformatic analysis of nuclear proteins
from several organisms has shown a large number of proteins do not have a predictable
NLS (Bernhofer et al., 2017; Lange et al., 2007; Tessier et al., 2020). In addition, up to
50% of proteins that interact with Imp-α in yeast do not have a predictable cNLS (Lange
et al., 2007). These examples highlight the possible existence of novel NLSs that can bind
Imp-α directly, or piggyback on Imp-α cargo. In fact, both scenarios have already been
shown to exist. For example, it’s been shown that Senataxin and Smarca4 are able to bind
Imp-α directly at ARM repeats 9-10, demonstrating that additional binding sites other than
the major and minor grooves exist (Arjomand et al., 2014). Additionally, nuclear import of
TAF10, a component of transcription factor II D, requires TAF3 or TAF8 to bind Imp-α/β1
(Soutoglou et al., 2005). Since TAF10 does not contain an NLS, piggybacking on TAF3
and TAF8 is required for efficient nuclear import.
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1.3.7 Protein nuclear export
Protein nuclear export mainly utilizes the Kapβ CRM1, also known as exportin-1 (Xpo1),
which recognizes leucine-rich NESs in the presence of RanGTP. These sequences are
generally 8–15 amino acids long and contain 4–5 regularly spaced hydrophobic residues
(Fornerod et al., 1997; Xu et al., 2012). In fact, the first NESs identified were of viral origin,
and were originally discovered within the Rev proteins of HIV-1 and other lentiviruses (B.
E. Meyer et al., 1996). Hydrophobic residues within an NES act as anchors that bind a
hydrophobic pocket formed by HEAT repeats 11 and 12 of CRM1 (Fung et al., 2015,
2017). Interestingly, NES binding to CRM1 is generally conformationally unrestrained, as
there is lack of contact with the NES backbone that allows hydrophobic anchor residues to
bind in a variety of conformations. In addition, NESs are unusual in that they are able to
bind CRM1 in either the N- to C-terminal or C- to N-terminal orientation, further enhancing
the diversity of potential NESs (Fung et al., 2015, 2017).
Proteomic analysis of CRM1 cargo suggests it has a major role in helping maintain the
separation of nuclear and cytoplasmic proteins (Kırlı et al., 2015). The NPC is not a perfect
barrier, allowing cytoplasmic proteins to leak in, therefore, having active nuclear export
pathways to sort these proteins, such as translation factors, back to the cytoplasm is integral
to maintaining many cellular processes. Several other members of the Imp-β family are
associated with nuclear export of protein or RNA, and these include exportin-2, exportin5, exportin-6, and exportin-7, as well as bidirectional transporters importin-13 and
exportin-4 (Kimura & Imamoto, 2014). However, in contrast to CRM1, the cargo proteins
recognized by these karyopherins have not been as extensively studied (Kimura &
Imamoto, 2014).
Nuclear export of mRNA on the other hand is typically handled by NXF1, which is not a
karyopherin member, via the transcription-export (TREX) adaptor (Williams et al., 2018).
During the early stages of mRNA biogenesis, TREX associates with the 5’ end of mRNA.
Following maturation, the TREX-mRNA complex can be exported via NXF1 (Cheng et
al., 2006). Additionally, some mRNA also use CRM1-mediated export; however, CRM1
does not bind mRNA directly and instead uses adapters (Williams et al., 2018). Other
subtypes of RNA, such as microRNA, can be directly bound by exportins, as is the case
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with exportin-5 which represents the canonical microRNA export pathway (Bohnsack et
al., 2004). Similarly, exportin-t is responsible for the export of 5’- and 3’-end processed
tRNA and can bind those RNAs directly (A. Gupta et al., 2016).

1.4

Viral Manipulation of Protein Nuclear Transport

Each component of the nuclear transport system potentially represents a viable target that
can be appropriated by a virus during infection to allow entry of viral genomic information,
export of viral mRNA, and passage of viral proteins bidirectionally across the NE (Figure
1.8A–C ). A common theme among many viruses is their limited coding capacity and,
therefore, their absolute dependence on host proteins and pathways for a productive
infection. Given this, it is unsurprising that viral proteins have evolved ways of interacting
with the many components that make up the nuclear transport system.

1.4.1 Viral protein-karyopherin interactions
The most direct approach for viral proteins to traverse the NE is to target the NPC itself.
Generally, this phenomenon is reserved for capsid interactions to bring viral genomic
information into the nucleus. Herpes simplex virus 1 (HSV-1) UL36 is a preformed
tegument protein, which aids in docking the viral capsid to the NPC by bridging the capsid
with Nup358 of the NPC (Copeland et al., 2009). Similarly, the capsid protein of HIV-1
interacts with Nup153 to mediate import of the preinitiation complex (PIC) (Matreyek et
al., 2013). For the most part, genomic studies have been primarily responsible for
identifying components of the NPC important for the life cycle of many viruses; however,
because of the nature of these experiments, it is often unclear which interactions directly
involve the NPC (Le Sage & Mouland, 2013). Some viral proteins interact with the NPC
directly, and several instances of viral proteins that are not components of the capsid
directly binding the NPC have been documented. These include BGLF4 from EBV and
HIV-1 Vpr (Chang et al., 2012; Fouchier et al., 1998; Y. Jenkins et al., 1998). In vivo and
in vitro experiments demonstrated that the C-terminus of BGLF4 can directly associate
with Nup62 and Nup153. Vpr, on the other hand, interacts with a poorly characterized
nucleoporin CG1, also known as nucleoporin-like protein 2 (NUPL2) (Le Rouzic et al.,
2002). During HIV-1 infection, Vpr is essential for nuclear import of the PIC, an essential
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Figure 1.8 Viral manipulation of host nuclear transport pathways.
Viruses can use a number of strategies to manipulate host nuclear transport pathways. This
allows them to achieve transport of viral proteins and/or perturb transport of host cellular
proteins. (A) Viruses are known to utilize the classical Imp-α/β1 pathway as well as bind
Imp-β1 directly, the nuclear pore complex (NPC), or transportin through a PY-nuclear
localization signal (PY-NLS) for nuclear import as well as CRM1 for nuclear export. (B)
Preventing nuclear import, or promoting export, of cellular proteins such as signal
transducer and activator of transcription 1 (STAT1), interferon regulatory factor 3 (IRF3),
or nuclear factor-kappa B (NF-κB) can block the antiviral innate immune response. (C)
Viral proteins can perturb global nuclear transport by altering the dynamics of the NPC
though the degradation or phosphorylation of nucleoporins (Nups). Created with
BioRender.
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step for replication in nondividing cells that also involves Vpr binding Imp-α (Bukrinsky
et al., 1992; Kamata et al., 2005; Nitahara-Kasahara et al., 2007). Docking the PIC at the
NPC is facilitated by Vpr’s ability to bind the NPC through CG1 as well as Imp-α,
essentially making it a functional mimic of Imp-β1 (Vodicka et al., 1998). A simple yet
effective approach to targeting cellular importins is through molecular mimicry of a cNLS,
which would allow viral proteins to interact with Imp-α (Figure 1.8A). Because of the
sequence characteristics and predictability of these peptide motifs, many viral cNLSs have
been discovered in a diverse range of viruses. For example, IAV nucleoprotein and PB2,
HIV-1 integrase and Vpr, HAdV E1A, HPV E2, HSV-1 pUL30, and many more contain
viral cNLSs (Alvisi et al., 2007; Ao et al., 2010; Bian & Wilson, 2010; Cohen et al., 2014;
Hudjetz & Gabriel, 2012; Kohler et al., 2001; Nitahara-Kasahara et al., 2007; Pumroy et
al., 2015).
An alternative approach for viral proteins to target the nuclear import machinery is to
directly bind Imp-β (Figure 1.8A). Multiple viruses have been shown to bind Imp-β1
directly, surpassing the need for the adapter Imp-α. HIV-1 Rev was the first identified
example of this, although similar examples can be seen with HIV-1 Tat, human T-cell
leukemia virus (HTLV) Rex, HSV-1 capsid protein, hepatitis B virus (HBV) core protein,
and HAdV protein VII (Arnold et al., 2006; C. Chen et al., 2016; Henderson & Percipalle,
1997; Ojala et al., 2000; Palmeri & Malim, 1999; Truant & Cullen, 1999; Wodrich et al.,
2006). Additionally, there are other members of the Imp-β family, namely transportins,
which can mediate import of proteins into the nucleus. The IAV M1 and human
cytomegalovirus (HCMV) UL79 proteins both contain PY-NLSs that allow their
interaction with the transportin nuclear import pathway (Miyake et al., 2019; Wang et al.,
2012). Many viral proteins have been shown to utilize transportin; however, many have no
identified PY-NLS. Specifically, HAdV core proteins pV and pVII, HIV-1 Rev, as well as
HPV L2 and E6 have all been shown to interact with the transportin pathway, though none
of these have identified PY-NLSs (Arnold et al., 2006; Darshan et al., 2004; Hindley et al.,
2007; Le Roux & Moroianu, 2003; Wodrich et al., 2006).
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1.4.2 Viral immune evasion through manipulation of nuclear import
A critical step in the viral replication cycle is avoiding detection by the immune system
and one way this is frequently achieved is through disruption or manipulation of cellular
protein trafficking (Figure 1.8B). Central to the innate antiviral immune response is the
activation of the type I interferon (IFN) and NF-κB signaling pathways, which lead to the
expression of IFN stimulated genes (ISGs) and the production of an array of
proinflammatory cytokines that ultimately work to halt or delay viral replication. The
production of type I IFN is triggered by the relocalization of interferon regulatory factor
(IRF) 3, IRF7, and/or NF-κB transcription factors from the cytoplasm to the nucleus. The
canonical type I IFN response involves activation of the Janus kinase (JAK) and the signal
transducer and activator of transcription (STAT) pathways upon binding of IFN to its
receptor. This triggers translocation of activated STAT proteins into the nucleus resulting
in transcription of hundreds of ISGs (Ivashkiv & Donlin, 2014).
One set of components that can be targeted to block innate antiviral responses are the
karyopherin proteins, which are directly responsible for cargo recognition. An example of
this is the hepatitis C virus (HCV) NS3/4A protease, a well-studied protein involved in
evading innate immunity (Morikawa et al., 2011). NS3/4A functions by interacting with
and subsequently cleaving Imp-β1, resulting in its loss of function (Gagne et al., 2017).
This study also demonstrated that Imp-β1 was the main nuclear import receptor for IRF3
and NF-κB, which are key transcription factors controlling antiviral innate immunity as
described above. Thus, cleavage of Imp-β1 reduces nuclear transport of IRF3 and NF-κB
p65 at early time points during infection, effectively delaying the IFN response.
A less direct way of blocking nuclear translocation of cellular proteins involved in innate
immune signaling is through simple competition for Imp-α. Ebola virus VP24 can compete
with tyrosine-phosphorylated STAT1, whose nuclear import is essential for transcriptional
activation of ISGs, for binding to Imp-α5, α6, and α7 (Mateo et al., 2010; Reid et al., 2007).
Japanese encephalitis virus NS5 protein is able to bind Imp-α3 and α4 to compete with
IRF3 and NF-κB p65 binding, preventing their nuclear import and limiting their ability to
activate IFN signaling (Ye et al., 2017). More recently it was shown that the 4b protein of
Middle East respiratory syndrome coronavirus (MERS-CoV) is able to out compete NF-
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κB p65 for binding to Imp-α3 (Canton et al., 2018). Beyond the examples listed here,
numerous other viruses have evolved similar mechanisms to target importins, allowing
them to evade host innate immunity. This can include sequestering importins in the
cytoplasm and even expressing microRNAs that downregulate Imp-α expression (Frieman
et al., 2007; Y. Liu et al., 2016; Yarbrough et al., 2014).

1.4.3 General disruption of host nucleocytoplasmic transport
Beyond evading innate immunity, the viral replicative cycle may require localization of
cellular proteins to subcellular compartments different from their normal localization. In
some cases, relocalization is specific to certain proteins, while in others this is implemented
broadly, effecting a multitude of proteins (Figure 1.8C). Picornaviruses, such as human
rhinovirus (HRV) and poliovirus (PV), target Nup153, a component of the NPC nuclear
basket, as well as the FG-rich nucleoporins Nup62 and Nup98 and proteolytically cleave
them via virally encoded 2A proteases (2Apro) (Gustin & Sarnow, 2001, 2002; Watters et
al., 2017). More specifically, 2Apro from HRV and PV specifically cleaves the FG-rich
region from Nup62, a region involved in recognizing karyopherins and forming the inner
channel of the NPC (Park et al., 2010).
Although less well-studied, other viruses such as IAV, EBV, and Venezuelan equine
encephalitis virus (VEEV) have similarly evolved strategies for targeting components of
the NPC. EBV, a DNA virus, encodes the Ser/Thr protein kinase BGLF4, which induces
phosphorylation of Nup62 and Nup153 (Figure 1D) (Chang et al., 2015). In the presence
of BGLF4, nuclear targeting of Imp-β1 was attenuated, broadly inhibiting cNLS-mediated
nuclear import. In contrast, the nuclear import of several non-NLS containing EBV lytic
proteins was promoted in the presence of BGLF4. IAV, an RNA virus that replicates within
the nucleus, induces enlargement of the NPC by exploiting cellular caspase activity
(Muhlbauer et al., 2015). Caspase activation at later timepoints during infection results in
degradation of Nup153, altering the structural integrity of the NPC and likely aiding in
passive diffusion of ribonucleoprotein complexes across the nuclear envelope.
Establishing a state conducive to viral infection can also involve precise nucleocytoplasmic
redistribution of select cellular proteins, a process best demonstrated by the HAdV E1A
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protein. E1A itself has no intrinsic DNA binding or enzymatic capabilities and therefore
relies on host proteins to carry out such functions (King, Zhang, et al., 2018). During HAdV
infection, E1A interacts with the regulatory RIα and RIIα subunits of protein kinase A
(PKA) and preferentially relocalizes them to the nucleus from the cytoplasm. Normally,
the subcellular localization of PKA is regulated by cellular A-kinase anchoring proteins
(AKAP). However, during infection, E1A appropriates this role through direct competition
with cellular AKAPs by functioning as a viral AKAP itself (King, Cohen, et al., 2016;
King, Gameiro, et al., 2018).

1.5

Thesis Overview

The central theme of the work presented within this thesis is focused on the analysis of
SLiM-mediated PPIs. SLiMs are involved in a diverse range of cellular processes (Van
Roey et al., 2014); however, the interactions under investigation here mainly involve those
mediating protein nuclear import. I first show that targeting SLiM-mediated interactions in
the classical nuclear import pathway is a viable antiviral strategy. Using HAdV-C5 as a
model, I showed that ivermectin, an inhibitor of the classical nuclear pathway, inhibits viral
replication. Additionally, I demonstrate ivermectin inhibits the interaction between E1A
and Imp-α. Secondly, I tried to determine to what extent proteins piggyback into the
nucleus, as the role of piggybacking in the classical nuclear import pathway remains
understudied. To address this, I analyzed currently available PPI databases and datasets
and showed that many nuclear proteins, which bind Imp-α, do not have an identifiable
cNLS. Finally, building on the theme that many nuclear proteins do not have an identifiable
NLS, I designed a novel yeast-based genetic system to identify SLiMs by exploiting the
nuclear import process. Importantly, this system has several advantages over current
experimental SLiM discovery approaches.

1.5.1 Chapter 2: Inhibition of human adenovirus replication by the
importin α/β1 nuclear import inhibitor ivermectin
In this study, we explored the effect of the drug ivermectin on HAdV replication.
Ivermectin is an inhibitor of the classical nuclear import pathway and is proposed to inhibit
the interaction between Imp-α and Imp-β1 (Wagstaff et al., 2012). All HAdV utilize the
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classical nuclear import pathway, particularly the E1A protein, which possesses a potent
bipartite cNLS (Cohen et al., 2014; Lyons et al., 1987). Therefore, targeting an important
host cellular process, like nuclear import, could represent an effective anti-viral approach.
Using HAdV-C5 as a model, we show that ivermectin inhibits viral progeny production in
a dose-dependent manner. Subcellular localization studies of HAdV-C5 infected cells
treated with ivermectin showed an abrogation of nuclear import for key viral proteins,
including E1A and DBP. Investigation of viral gene expression and protein synthesis
during HAdV-C5 infection revealed a reduction of several viral early gene transcripts, as
well as reduced early and late protein production. Additionally, viral genome replication
efficiency was determined and ivermectin was shown to inhibit replication of both HAdVC5 and -B3. Interestingly, co-immunoprecipitation experiments of E1A shows that
ivermectin inhibits the Imp-α/cNLS interaction, and not the Imp-α/β1 interaction as
previously proposed.

1.5.2 Chapter 3: Piggybacking on classical import and other nonclassical mechanisms of nuclear import appear highly
prevalent within the human proteome
How nuclear proteins without a cNLS use the classical nuclear import pathway remains an
outstanding question within the field. Previous studies have established that many nuclear
proteins in humans and yeast do not have a cNLS, and many yeast proteins that interact
with Imp-α also do not possess a cNLS (Bernhofer et al., 2017; Lange et al., 2007). The
focus of the work in this chapter aimed to estimate how widespread is the use of alternative
mechanisms of nuclear import, such as piggybacking on classical nuclear import
machinery. Importantly, I used currently available datasets and databases that were either
not available at the time of previous studies or have not been used since. Using a list of
nuclear proteins from The Human Protein Atlas I show that nearly 50% of human nuclear
proteins do not have predicted mono or bipartite cNLS. For the first time, I also showed
that 20–50% of cargo for each of the human Imp-α isoforms do not have a predictable
cNLS. Using recently published data from the Human Reference Interactome project, I
confirmed that many Imp-α cargo do not have an identifiable cNLS. In order to extend our
analysis to Imp-α cargo that are not available in public interaction databases, I reanalyzed
publicly available raw mass spectra files, which identified hundreds of Imp-α cargo. Many
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of these cargos do not have an identifiable cNLS and interestingly, several of these proteins
have already been shown to utilize piggybacking. Furthermore, I determined that the
majority of proteins belonging to the Mediator complex do not have a cNLS yet bind Impα. Based on these findings I propose that Mediator utilizes piggybacking mechanisms.

1.5.3 Chapter 4: A novel protein nuclear import-based methodology
for discovery of short linear motifs
In the final chapter, my goal was to exploit the nuclear import process in yeast to discover
novel SLiMs. Using a genetic selection system, I expressed a library of recombinant
proteins that were too large to diffuse into the nucleus and were fused with a randomly
generated 10 amino acid peptide. If a peptide was able to mediate nuclear import, either
through directly binding import machinery or indirectly piggybacking, it could be selected
for genetically. This system is sensitive to many different cNLSs, as well as bipartite
cNLSs. In a small-scale proof-of-principle experiment I identified several peptides that can
mediate nuclear import in yeast. Expressing several of these peptides in a mammalian
system as enhanced green fluorescent protein (EGFP) fusions showed nuclear localization,
and this was confirmed using nuclear/cytoplasmic fractionation. Additionally, using coimmunoprecipitation I show that some of these peptides can interact with Imp-α.
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Chapter 2
2

Inhibition of human adenovirus replication by the
importin α/β1 nuclear import inhibitor ivermectin

2.1

Introduction

The continuous flow of molecules between the cytoplasm and nucleus of eukaryotic cells
is essential for many cellular processes. Transport of macromolecules, especially proteins,
across the nuclear envelope is a highly regulated process that requires passage through the
NPC (Bauer et al., 2015; Cautain et al., 2015). As protein size increases, so does the
difficulty in passing through the NPC. Larger proteins, typically over 40–50 kDa, require
active transport mechanisms. This includes the classical protein nuclear import pathway
which utilizes the Imp-α and Imp-β1 proteins. Imp-α recognizes a proteins NLS, while
Imp-β1 serves to bridge the Imp-α/NLS complex with the NPC (Lange et al., 2007). Seven
Imp-α isoforms exist in humans, all possessing a conserved IBB domain located on their
N-terminus (Cingolani et al., 1999; Kelley et al., 2010; Pumroy & Cingolani, 2015). The
IBB domain forms an intramolecular interaction with the NLS binding groove, preventing
binding of Imp-β1 to an unloaded Imp-α, reducing futile nuclear translocation of empty
import complexes (Lott & Cingolani, 2011). The Imp-α/β1 pathway defines classical
nuclear import, where Imp-α recognizes NLSs containing a cluster of basic amino acids.
These are collectively referred to as cNLSs (Kelley et al., 2010; Lange et al., 2007; Mason
et al., 2009). By coevolving with eukaryotic hosts, viral pathogens have developed diverse
mechanisms to usurp this important and highly coordinated pathway. These include
mimicry of cellular NLSs by viral proteins and manipulation of these host factors at the
molecular level (Tessier et al., 2019).
HAdVs are ubiquitous in the human population, particularly in children and young adults,
and contribute to a significant portion of respiratory and gastrointestinal illnesses
worldwide (Ghebremedhin, 2014; King, Zhang, et al., 2016; Lion, 2014). The most
common HAdV species associated with disease are HAdV-C, -B and -E (Lion, 2014). In
particular, HAdV-B3 and -B7 are commonly associated with acute respiratory illness and
have been reported in several outbreaks worldwide (Jin et al., 2013; Lai et al., 2013; J. Lee
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et al., 2010; W. J. Lee et al., 2015; Wo et al., 2015). HAdV-B55 has recently emerged as
an epidemic strain in both Europe and Asia, causing acute respiratory illness in adults and
outbreaks within civilian and military populations (Ko et al., 2019; Lafolie et al., 2016;
Salama et al., 2016; Walsh et al., 2010). Additionally, immunocompromised individuals,
such as transplant recipients, are at particular risk for severe illness or death from numerous
HAdVs, including HAdV-C, -A, and -B (Khanal et al., 2018; Lion, 2014). Aside from
cidofovir, a nucleotide analogue approved for cytomegalovirus-induced retinitis, and the
cidofovir derivative brincidofovir, there are no antiviral drugs with clinically relevant
activity against HAdV (Alvarez-Cardona et al., 2020; Khanal et al., 2018). Notably, HAdV
gene expression, genome replication and virion assemble all take place within the nucleus
and many of its gene products carry out crucial functions in this compartment to enhance
its viral replication cycle (Berk, 2013; Pied & Wodrich, 2019). This raises the possibility
that drugs interfering with nucleocytoplasmic transport might inhibit HAdV replication. In
addition to providing new molecular insights into the replication stages of HAdV
infections, understanding the relationship between HAdV and host nuclear import
machinery may identify target points for anti-adenoviral therapies.
Ivermectin is a broad-spectrum anti-parasitic approved for use in humans to treat a variety
of neglected diseases, such as onchocerciasis and lymphatic filariasis, and has been mass
administered for the treatment of scabies (Babalola, 2011; Laing et al., 2017; Romani et
al., 2015; Strycharz et al., 2008; Victoria & Trujillo, 2001). Through a high-throughput
drug screening approach, ivermectin was also identified as a general inhibitor of Imp-α/β1mediated nuclear import (Wagstaff et al., 2011). Several recent studies have explored
ivermectin as a means of abrogating nuclear localization of viral proteins and as an
inhibitor of viral replication (Tessier et al., 2019). Several RNA viruses, including HIV-1,
dengue virus (DENV), and Hendra virus (HeV) were potently inhibited in vitro by
ivermectin (Atkinson et al., 2018; Tay et al., 2013; Wagstaff et al., 2012). While findings
on ivermectin’s effects on DNA viruses are more limited, it has been shown to impair BK
polyomavirus (BKPyV) infection in vitro (Bennett et al., 2015).
In this study we sought to extend the exploration of ivermectin’s antiviral activity by
examining its effects on HAdV-C5 infection. We found that ivermectin inhibits the overall
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production of infectious HAdV-C5 progeny in a dose-dependent fashion. Multiple viral
proteins produced early during infection exhibited impaired nuclear localization.
Ivermectin treatment led to severely reduced levels of several HAdV-C5 mRNAs, protein
products, and progeny genomes post-infection. In addition, we show that ivermectin targets
the Imp-α/NLS interaction without disrupting Imp-β1 binding. Together, these findings
offer insight into ivermectin’s inhibitory effects on HAdV replication, as well as provide
new mechanistic details regarding ivermectin’s mode of action.

2.2

Materials and Methods

2.2.1 Cell lines, cell culture, and transfections
Human A549 (provided by Russ Wheeler, Molecular Pathology/Genetics, London Health
Sciences Centre), HEK293, and HT-1080 (purchased from the American Type Culture
Collection) cells were grown at 37°C with 5% CO2 in Dulbecco’s modified Eagle’s
medium (DMEM; Multicell Technologies) supplemented with 1% penicillin/streptomycin
(Multicell) and 10% fetal bovine serum (FBS; Gibco). Transfections of DNA into HT-1080
cells were done using X-tremeGENE HP (Roche) using a 2:1 ratio of X-tremeGENE HP
per μg of DNA. For treatment with ivermectin (MilliporeSigma, I8898) on transfected HT1080 cells, media was replaced 16 hours post-transfection with fresh DMEM containing
10% FBS and the indicated concentration of drug (or the corresponding volume of DMSO
as a control) and left for 1.5 hours prior to downstream harvesting for microscopy or
immunoprecipitation.

2.2.2 Viruses and infection of cells
Wild-type (WT) HAdV-C5 (dl309) was previously described (N. Jones & Shenk,
1979).WT serotypes of HAdV-E3 (strain GB, lot 11W), -E4 (strain RI-67, lot 3W) were
purchased from the ATCC via Cedarlane. A549 cells were infected at a multiplicity of
infection (MOI) of 5 plaque-forming units (PFU)/mL. Cell cultures were infected at ~50%
confluence for 1 hour at 37°C, and sub-confluent cells were collected at the indicated
timepoints for downstream experiments. For plaque assays, confluent HEK293 cells
infected with serially diluted samples for 1 hour at 37°C before being overlaid with DMEM
containing 1% SeaPlaque agarose (Lonza). For treatment with ivermectin on infected A549
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cells, infectious media was replaced after 1 hour with fresh DMEM containing 10% FBS
and the indicated working concentrations of drug (or the corresponding volume of DMSO
as a control) for the duration of the experiment.

2.2.3 Cell viability assay
Cells were seeded in 96-well plates at 2500 cells per well and left to adhere overnight.
Media containing ivermectin was added at concentrations ranging from 10 nM to 150 µM
and left for 72 hours before assessing viability. For each condition, three replicates were
used. Viability was indirectly measured using PrestoBlue reagent (ThermoFisher).
Normalized relative fluorescent units (RFUs) of the ivermectin-treated replicates were
calculated as a percentage of the mean RFU of control (DMSO-only) treatment replicates.
IC50 values, defined as the concentration at which the normalized RFU reached 50%, were
calculated by non-linear regression (Prism® 8 Graphpad Software, Inc).

2.2.4 Plasmids
All constructs were expressed in vectors under the control of the HCMV promoter. Fulllength E1A and TAg NLS constructs were built into pEGFP-C2. FLAG-tagged Qip1 was
cloned into pcDNA3 and contains a full-length WT importin-α3 (KPNA4) and was
previously described (Marshall et al., 2014). For a list of plasmids used in this chapter see
Table 2.1.

2.2.5 Co-immunoprecipitation and western blotting
Cells were pretreated with 25 µM ivermectin for 1.5 hours prior to lysis. Transfected HT1080 cells from 10cm plates were collected and lysed in 500 μL NP-40 lysis buffer (150
mM NaCl, 50 mM Tris-HCl pH 7.4, 1 mM EDTA, 1 mM EGTA, 0.1% NP-40, 10%
glycerol) supplemented with protease inhibitor cocktail (MilliporeSigma, P8340) along
with two freeze-thaw cycles on dry ice. Co-immunoprecipitation reactions were carried out
at 4°C for 4 hours in lysis buffer supplemented with either 25 µM ivermectin or an
equivalent volume of DMSO, using 20µl of washed magnetic FLAG beads
(MilliporeSigma, M8823).
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Table 2.1 Plasmids used in this chapter.
Clone
EGFP
TAg NLS
13S E1A
FLAG/HA-Qip1

Vector
pEGFP-C2
pEGFP-C2
pEGFP-C2
pcDNA3
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Lab ID
JMB4616
JMB4632
JMB1449
JMB4390

Two percent of the sample was kept as input control. After washing with lysis buffer,
samples were boiled in 25 µL of 2X LDS sample buffer (Thermofisher, NP0007)
supplemented with DTT, for 5 minutes. Samples were separated on NuPage Bis-Tris
gradient protein gels (Life Technologies, NP0321BOX) and transferred onto a
polyvinylidene diﬂuoride membrane (Amersham). Membranes were blocked in 5% skim
milk constituted in Tris-buffered saline (TBS) with 0.1% Tween 20. Primary antibodies
used include rabbit α-EGFP, mouse α-E1A, mouse α-DBP, mouse α-karyopherin β1, rabbit
α-HAdV-C5 capsid (Table 2.2). Horseradish peroxidase-conjugated secondary antibody
was detected using Luminata Crescendo or Forte substrate (Millipore).

2.2.6 Immunofluorescence microscopy
Cells were ﬁxed in 3.7% paraformaldehyde at room temperature for 20 minutes,
permeabilized on ice using 0.2% Triton X-100, and blocked using 3% BSA in phosphatebuffered saline (PBS). Samples were incubated in primary antibody that included rabbit αEGFP, mouse α-E1A, mouse α-DBP (Table 2.2) for 1 hour at room temperature and
another 30 minutes at room temperature with secondary antibody (Alexa Fluor 488; Life
Technologies). Samples were mounted with Prolong Gold reagent containing 4’,6diamidino-2-phenylindole (DAPI; Life Technologies). Confocal images were acquired
using a Fluoview 1000 laser scanning confocal microscope (Olympus Corp).

2.2.7 Reverse transcription and qPCR
Total RNA was prepared using the PureLink RNA Mini Kit (ThermoFisher) including oncolumn PureLink DNase treatment. RNA was reverse-transcribed into cDNA using the
Superscript VILO Mastermix (ThermoFisher). Relative cDNA levels were measured by
qPCR using Power SYBR green (ThermoFisher) with oligonucleotide sequences that
specifically recognize HAdV-C5 E1A, E1B, E2, E3, E4. GAPDH was used as an
endogenous cellular control for total cDNA along with no-RT and no-template negative
controls. All qPCR primers used in this chapter are listed in Table 2.3. Results were
normalized to cellular GAPDH, calculated using the ΔΔCt method, and set as relative to
DMSO-treated samples.

43

Table 2.2 Primary antibodies used in this chapter.
Reactivity

Purpose

Description

Supplier

EGFP
M73 (E1A)
B68 (DBP)
HAdV capsid
Actin
FLAG (F1804)
FLAG (M8823)
Kpnb1 (H-7)
Tubulin

IF, Western
IF, Western
IF, Western
Western
Western
Western
IP
Western
Western

Rabbit polyclonal
Mouse monoclonal
Mouse monoclonal
Rabbit polyclonal
Rabbit polyclonal
Mouse monoclonal
Mouse monoclonal
Mouse monoclonal
Mouse polyclonal

Takara (Living Colors)
In-house
In-house
Abcam
MilliporeSigma
MilliporeSigma
MilliporeSigma
Santa Cruz
MilliporeSigma
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2.2.8 Virus replication assay
A549 cells were infected with either HAdV-C5, -B3 or -E4 and then supplemented with
media containing 10 µM ivermectin. Total cell DNA was puriﬁed at 6- and 48-hours postinfection using a DNeasy Blood and Tissue kit (Qiagen). Viral DNA levels were quantiﬁed
by qPCR with Power SYBR green (ThermoFisher) using a forward (F) primer that
recognizes a conserved sequence in E1A in combination with a HAdV-C5-speciﬁc reverse
(R) primer Ad5E1A-R, HAdV-B3-specific Ad3E1A-R or HAdV-E4-specific Ad4E1A-R.
Values were normalized to genomic GAPDH and the fold increase of viral copy number at
48 hours was calculated by normalizing to input viral DNA at 6 hours post-infection. All
primers used for determining viral replication via qPCR are listed in Table 2.3. Viral
replication efﬁciency in the presence of ivermectin was presented as the relative value
compared to that for DMSO control-treated cells, which were normalized to 1.

2.2.9 Statistical analysis
All experiments were carried out with three biological replicates. Graphs represent means
and standard errors of the means (SEM) for all biological replicates. For western blotting,
a representative image was selected. Statistical signiﬁcance of numerical differences was
calculated using either t-tests or one-way analysis of variance and Holm-Sidak post hoc
comparisons between experimental conditions.
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Table 2.3 List of qPCR primers used in this chapter.
Method

Target

Orientation

Sequence

Lab ID

RT-qPCR

E1A HAdV-C5
E1A HadV-C5
E1B HadV-C5
E1B HadV-C5
E2 HadV-C5
E2 HadV-C5
E3 HadV-C5
E3 HadV-C5
E4 HadV-C5
E4 HadV-C5
GAPDH
GAPDH

forward
reverse
forward
reverse
forward
reverse
forward
reverse
forward
reverse
forward
reverse

ACACCTCCTGAGATACACCC
TTATTGCCCAGGCTCGTTAAGC
GACAATTACAGAGGATGGGC
CACTCAGGACGGTGTCTGG
GGGGGTGGTTTCGCGCTGCTCC
GCGGATGAGGCGGCGTATCGAG
GAGGCAGAGCAACTGCGCC
GCTCTCCCTGGGCGGTAAGCCGG
GCCCCCATAGGAGGTATAAC
GGCTGCCGCTGTGGAAGCGC
ACTGCTTAGCACCCCTGGCCAA
ATGGCATGGACTGTGGTCATGAGTC

JMO1238
JMO1239
JMO1240
JMO1241
JMO1262
JMO1263
JMO1244
JMO1245
JMO1250
JMO1251
JMO1023
JMO1024

Genome
replication

E1A (pan)
HAdV-C5
HAdV-B3
HAdV-E4
GAPDH
GAPDH

forward
reverse
reverse
reverse
forward
reverse

AGAGGCCACTCTTGAGTGC
CGTCACGTCTAAATCATAC
TACAGATCGTGCAGCGTAGG
AGCGAAGGTGTCTCAAATGG
ACTGCTTAGCACCCCTGGCCAA
ATGGCATGGACTGTGGTCATGAGTC

JMO1679
JMO1682
JMO1680
JMO1681
JMO1023
JMO1024
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2.3

Results

2.3.1 Ivermectin inhibits HAdV-C5 progeny production in a dosedependent manner
Ivermectin has been previously demonstrated to function as an antiviral agent against
several viruses that encode factors that rely on host Imp-α/β1-mediated nuclear transport
(Wagstaff et al., 2011). Ivermectin has been described as a general inhibitor of this pathway
and was shown to reduce nuclear import of viral proteins such as SV40 large TAg, HIV-1
integrase, DENV NS5, and BKPyV VP2 and VP3 (Atkinson et al., 2018; Bennett et al.,
2015; Tay et al., 2013; Wagstaff et al., 2012). To build upon these initial studies, we sought
to test this drug’s ability to affect HAdV replication, as it too encodes many proteins with
crucial nuclear functions (Charman et al., 2019).
A549 lung epithelial carcinoma cells were infected with HAdV-C5 at a multiplicity of
infection (MOI) of 5 over a range of ivermectin concentrations and harvested at various
timepoints post-infection to determine viral titers (Figure 2.1A). Compared to DMSO
control-treated cells, production of infectious progeny from cells treated with ivermectin
was significantly reduced. Observed differences emerged as early as 24 hours postinfection (hpi), continuing through to 60 hpi (Figure 2.1B). Notably, higher doses of
ivermectin corresponded with more potent inhibition of progeny production, indicative of
a dose-dependent response. The doses ranged from concentrations that did not affect cell
health (1 μM), up to its IC50 as indicated by cell viability assays performed 72 hours postadministration (Figure 2.1C). For experiments where longer exposures (12-60 hours) of
ivermectin were required, we chose 10 µM as our working concentration, whereas shortterm experiments (<6 hours) used higher doses, consistent with existing literature (Fraser
et al., 2014).
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Figure 2.1 Ivermectin inhibits production of infectious HAdV-C5 progeny in a dosedependent manner.
A549 cells were infected with HAdV-C5 (MOI 5) and treated with the indicated
concentration of ivermectin. Cells were collected at various timepoints up to 60 hours postinfection, when cytopathic effect had cleared most cells. Production of infectious progeny
virus quantitatively assayed by plaque formation on HEK293 cells. A) Data are shown over
24-60 hours for a range of ivermectin doses. B) Data at the 60-hour endpoint are
highlighted and statistical significance is shown relative to DMSO control-treated cells.
Values are represented as mean ± SEM. *p<0.01; n=3. C) A549 cells were subjected to a
72-hour dose of ivermectin at various concentrations to gauge long-term cell viability using
a PrestoBlue assay.
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2.3.2 Ivermectin abrogates nuclear localization of viral factors crucial
for the HAdV-C5 replication cycle
To determine how ivermectin was inhibiting HAdV-C5 replication, we examined its
impact on the subcellular localization of several HAdV-C5 proteins with known nuclear
functions. As proof of principle, we first sought to reproduce previously published findings
demonstrating ivermectin’s ability to block nuclear import of an EGFP-tagged TAg NLS.
The SV40 TAg NLS is one of the oldest and most well-characterized cNLSs and relies
exclusively on Imp-α/β1 for import (D Kalderon et al., 1984). HT-1080 fibrosarcoma cells
were transfected with either EGFP or EGFP-TAg NLS and subsequently treated for 1.5
hours with 25 µM ivermectin or DMSO control. As anticipated, EGFP localization was
unaffected by treatment with ivermectin (Figure 2.2A). While EGFP-TAg NLS protein was
predominantly nuclear in control treated cells, there was a noticeable shift to cytoplasmic
accumulation in ivermectin treated cells (Figure 2.2B). Importantly, 25 μM ivermectin for
1.5 hours did not elicit any observable cytopathic effects with the HT-1080 cell line. This
result confirms that ivermectin reduces nuclear import mediated by the classical SV40 TAg
NLS in this experimental system.
Next, we examined ivermectin’s effects on several HAdV-C5 early gene products during
infection of A549 cells. We specifically targeted E1A and DNA-binding protein (DBP),
two proteins which utilize the Imp-α/β1 machinery. Compared to control-treated cells, 10
µM ivermectin caused a dramatic increase in cytoplasmic localization of E1A at 20 hpi
(Figure 2.2C). HAdV DBP is a single-stranded DNA-binding protein encoded by the viral
E2A early gene and coats single-stranded viral DNA intermediates during HAdV genome
replication (van Breukelen et al., 2003). In addition, visualization of DBP in HAdV-C5infected cells serves as a surrogate marker for virus replication centres (Hidalgo &
Gonzalez, 2019). Like E1A, DBP also contains a cNLS (Morin et al., 1989). While
treatment of cells with 10 µM ivermectin did not elicit a drastic shift of DBP to the
cytoplasm like it did with E1A (Figure 2.2D), noticeably smaller and fewer virus
replication centres were present in the nuclei of infected cells at 20 hpi (Figure 2.2E).
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Figure 2.2 Ivermectin blocks Imp-α-mediated nuclear localization of proteins crucial
for HAdV infection.
A and B) HT-1080 cells were transfected with either EGFP (vector) or EGFP-tagged Tantigen NLS and treated with 25 µM ivermectin (IVM) for 1.5 hours prior to fixation and
immunofluorescence imaging. Cytoplasmic relocalization of T-antigen NLS in the
presence of ivermectin serves as a positive control for IVM’s function. C and D) A549
cells were infected with HAdV-C5 (MOI 5) and treated with 10 µM IVM for 20 hours until
cells were fixed and processed for imaging. C) Subcellular localization of E1A during
infection in the presence of ivermectin. D) DBP immunofluorescence, a surrogate for viral
replication centres, reveals smaller and fewer virus replication centres. E) Quantification
of viral replication centres in panel C as determined by DBP immunofluorescence
(displayed as means ± SEM, *p<0.001; n=50). Scale bars represent 25 μm.
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2.3.3 Ivermectin impairs viral transcription, genome replication, and
protein synthesis
To further gauge ivermectin’s effects on the molecular kinetics of HAdV-C5 infection, we
analyzed multiple aspects of the HAdV-C5 replication cycle. The decreased levels of
infectious progeny produced after ivermectin treatment (Figure 2.1) could be due to
reduced expression of crucial viral proteins. We first examined overall levels of both early
(E1A and DBP) and late (hexon, penton, protein V and VII) HAdV-C5 proteins across
multiple infection timepoints (Figure 2.3A). We observed numerous defects in HAdV-C5
protein production in the presence of 10 µM ivermectin. While the initial burst (12–18 hpi)
of E1A synthesis appeared unaffected, subsequent timepoints (24–36 hpi) displayed a large
reduction in E1A protein levels as shown by western blot. Similarly, DBP and all late
proteins were expressed at lower levels in cells treated with ivermectin across all time
points.
We next tested if ivermectin was affecting replication of the viral DNA genome itself. As
a consequence of the reduced levels of DBP and lower numbers of virus replication centres
(Figure 2.2D), we suspected that viral genome copy numbers would be reduced. Indeed,
when compared to DMSO treated cells, ivermectin treatment caused a significant decrease
in viral genome replication efficiency at 48 hpi as measured by qPCR for HAdV-C5
(Figure 2.3B). To determine if ivermectin is effective against other clinically relevant
HAdV species, we tested genome replication efficiency for both HAdV-B3 and HAdV-E4
(Figure 2.3C). Similar to HAdV-C5, a significant reduction in HAdV-B3 genome
replication was observed. However, HAdV-E4 was unaffected by ivermectin in these
conditions.
E1A is a necessary transcriptional activator of HAdV-C5 early gene expression (King,
Zhang, et al., 2018). We hypothesized that ivermectin-mediated abrogation of its nuclear
localization and overall expression (Figures 2.2C and 2.3A) would

51

Figure 2.3 Ivermectin impairs the molecular kinetics of HAdV infection on multiple
levels.
A549 cells were infected (MOI 5) with HAdV-C5 (panels A, B, D), HAdV-B3 or -E4
(panel C) and treated with 10 µM ivermectin (IVM). A) Cells were harvested at 12, 18, 24,
and 36 hpi and viral protein synthesis was assayed by western blot using antibodies against
representative proteins from various HAdV-C5 transcription units. Actin was used a
loading control. B and C) DNA was isolated at 6 hpi as a measure of viral input and at 48
hpi. Relative viral genomic DNA levels were quantified by qPCR using a forward primer
recognizing a conserved sequence in the left end of the HAdV genome in combination with
specific reverse primers for HAdV-C5, -B3 and -E4. To determine viral genome replication
efficiency 48 hpi was normalize to the 6 hpi input. IVM treatment significantly impaired
of HAdV-C5 and -B3 genome replication efficiency, represented as mean ± SEM,
*p<0.005; n=3. D) RNA was isolated at 24 hpi and cDNA was generated using random
primers. RT-qPCR was performed targeting HAdV-C5 early gene products and results
were normalized to cellular GAPDH. Fold change as compared to control-treated cells is
shown, displayed as mean ± SEM, *p<0.05, NS=not significant; n=3.
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cause reduction of E1A-regulated viral transcripts. We examined infected cells at 24 hpi
(when E1A protein levels showed a large difference between DMSO and ivermectin
treatment [Figure 2.3A]) for expression of the E1A, E1B, E2, E3, and E4 HAdV-C5
transcription units using RT-qPCR (Figure 2.3C). All early genes displayed reduced levels
of mRNA expression in the presence of ivermectin, consistent with our hypothesis.

2.3.4 Ivermectin inhibits the Imp-α/NLS interaction, but not the Impα/β1 interaction
Although ivermectin directly targets the classical nuclear import pathway, the exact
molecular mechanism by which it inhibits nuclear import remains unclear. Ivermectin’s
mode of action could be via blocking NLS recognition by Imp-α, blocking the Imp-α/β1
interaction, or possibly both. To provide mechanistic insight into ivermectin’s impact on
nuclear import, we tested its effects on the protein-protein interaction between cNLSs and
Imp-α. We co-transfected HT-1080 cells with FLAG-tagged Qip1 (Imp-α3) and either
EGFP-tagged TAg NLS or HAdV-C5 E1A and subjected whole cell lysates to coimmunoprecipitation

(CoIP)

in

the

presence

of

ivermectin

(Figure

2.4).

Immunoprecipitation of Qip1 showed significantly reduced binding to either the TAg NLS
or E1A in the presence of ivermectin compared to the DMSO control. Since nuclear import
of cargo by Imp-α depends on Imp-β1, we also tested for Qip1’s ability to pull down
endogenous Imp-β1 (Kpnb1) using the same CoIP samples. In contrast to cargo
interactions, the concentration of ivermectin sufficient to inhibit TAg NLS or E1A binding
was not sufficient to block binding of endogenous Imp-β1 to Qip1. These results suggest
that ivermectin specifically inhibits the ability of Imp-α to recognize a cNLS, without
affecting the Imp-α/β1 interaction.
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Figure 2.4 Ivermectin blocks NLS binding, but not the Imp-α and -β1 interaction.
HT-1080 cells were co-transfected with either EGFP-tagged TAg NLS or HAdV-C5 E1A
as well as FLAG-tagged Qip1 (Imp-α3). Prior to co-immunoprecipitation cells were pretreated with 25 μM ivermectin (IVM) or DMSO and then immunoprecipitated (FLAG) in
the presence of 25μM IVM or DMSO. Western blots for both EGFP constructs and
endogenous

Kpnb1

(Imp-β1)

were

performed

on

the

same

FLAG-Qip1

immunoprecipitated samples. In the presence of ivermectin Qip1 is unable to recognize
both TAg NLS and E1A protein. Under these conditions, the interaction between Qip1 and
Imp-β1 was unaffected by IVM.
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2.4

Discussion

Cellular pathways controlling nuclear-cytoplasmic transport of viral proteins have emerged
as attractive targets for antiviral intervention. The search for new targets is partly due to
existing limitations of directly-acting antivirals, which often utilize a “one drug, one bug”
approach (Bekerman & Einav, 2015). Most of the approved antivirals target virally
encoded enzymes (De Clercq & Li, 2016), which inherently have a narrow spectrum of
activity when considering the vastness of viral diversity. Emerging viruses such as SARSCoV, MERS-CoV, and SARS-CoV-2 have no directly-acting antiviral treatments,
highlighting an area where broadly acting antivirals could have profound impact (De Wit
et al., 2016; P. Zhou et al., 2020).
One approach to developing broadly acting antivirals is through targeting host factors upon
which the virus depends. Evolution of resistance to a drug is expected to be much slower,
or even non-existent, for a host factor than for a virus. Targeting these weak points of virushost interfaces is a strategy being aggressively explored for numerous viruses (Baillie,
2014; S. M.-Y. Lee & Yen, 2012; Warfield et al., 2019). Success has even been achieved
with antiretroviral compounds that target the host coreceptor CCR5, blocking HIV-1
replication (Brelot & Chakrabarti, 2018).
Intracellular pathways, such as protein nuclear import, are exploited by many RNA and
DNA viruses. Many viruses replicate their genomes within the nucleus of infected cells
and/or encode trans-acting viral proteins with important nuclear functions. Also, many
protein components of nuclear transport pathways are directly hijacked by diverse viruses
(King, Zhang, et al., 2018; Tessier et al., 2019). Among these is the classical nuclear import
pathway mediated by Imp-α/β1, making it an actionable host target for broadly acting
antivirals. Several drugs, including small molecules and peptides, have been shown to
target this pathway (Kosyna & Depping, 2018). However, only two of these, ivermectin
and mifepristone, are FDA approved, albeit for non-viral indications (Jans et al., 2019;
Kosyna & Depping, 2018; S. Yang et al., 2019). A novel high-throughput screening
approach identified ivermectin as a specific inhibitor of nuclear import of HIV-1 integrase
via inhibition of this pathway (Wagstaff et al., 2011). To date, ivermectin has been shown
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to inhibit nuclear import of viral proteins from a range of viruses in vitro (Jans & Martin,
2018; Lv et al., 2018; Tay et al., 2013; Thomas et al., 2018; Varghese et al., 2016; Wagstaff
et al., 2012; S. Yang et al., 2019; S. N. Y. Yang et al., 2020) and is currently being used in
a clinical trial for the treatment of pediatric dengue virus patients (NCT03432442). Further
highlighting the potential application of ivermectin is recent evidence demonstrating that
ivermectin can inhibit replication of SARS-CoV-2 (Caly et al., 2020). Together, these
findings map a new direction for studying these classes of drugs, particularly ivermectin,
as potentially useful broad-spectrum antiviral agents.
Here we sought to examine ivermectin’s effects on HAdV infection, using HAdV-C5 as a
model. Treatment of cells with ivermectin after infection with HAdV-C5 resulted in a dosedependent decrease in the production of infectious progeny virus as determined by plaque
assay. This reduction was most severe in the presence of 10 µM ivermectin, which caused
a nearly 2-fold log reduction in viral titers at 60 hpi compared to DMSO treated control
cells. While this dose of ivermectin did begin to negatively affect cell health at 72 hours
post-administration, this is unlikely to account for the near 100-fold reduction in viral
output, especially as experimental samples were collected earlier than 72 hours. These
results parallel recent findings demonstrating ivermectin can inhibit production of
infectious progeny from other viruses, including flaviviruses such as West Nile virus, Zika
virus, and DENV (S. N. Y. Yang et al., 2020).
To begin to understand how ivermectin inhibits HAdV-C5 replication, we explored the
impact of ivermectin on intracellular localization of HAdV proteins during infection. We
first confirmed ivermectin’s ability to block Imp-α-mediated nuclear import by using the
well-characterized SV40 TAg cNLS as a control. Like TAg, the HAdV-C5 E1A protein
also contains a cNLS that utilizes Imp-α/β1 to drive nuclear import (Cohen et al., 2014).
After infection with HAdV-C5, treatment with 10 µM ivermectin caused a shift in E1A
subcellular

localization

from

its

predominantly

nuclear

localization

to

a

nuclear/cytoplasmic one, similar to that observed for a mutant E1A containing a deletion
of its C-terminal NLS sequence (King, Gameiro, et al., 2018). While most E1A was
relocalized to the cytoplasm, some remained in the nucleus. This may be due to insufficient
drug, or E1A’s small size, which may allow some passive diffusion into the nucleus.
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Additionally, E1A has several non-cNLSs, which may allow entry into the nucleus during
inhibition of the classical nuclear import pathway (Marshall et al., 2014). Nevertheless, use
of such alternative nuclear import pathways is clearly not sufficient for the virus to
overcome the negative effects caused by ivermectin mediated inhibition of classical nuclear
import.
We also examined the localization of HAdV-C5 DBP, a single stranded DNA-binding
protein. DBP is a larger (~72kDa) protein crucial for replication of the viral genome and is
frequently used as a marker for visualizing virus replication centres (van Breukelen et al.,
2003). Interestingly, ivermectin did not affect DBP nuclear localization as dramatically as
E1A, despite the known presence of two cNLSs within its N-terminus. This was not
entirely unexpected, as a previous study showed that mutant DBP lacking its NLSs was
still strongly nuclear (Morin et al., 1989). Since ivermectin only targets Imp-α cargo, it
remains possible that DBP utilizes an Imp-α-independent nuclear import pathway.
Nevertheless, ivermectin treatment affected the formation of virus replication centres, as
they were smaller and fewer in number, in concordance with the observed lower levels of
viral progeny production.
In addition to infectious progeny, we surveyed the impact of ivermectin treatment on
HAdV-C5 early and late proteins as well as replication of its DNA genome. On the protein
level, synthesis of E1A at early timepoints during infection remained unchanged. This may
be due to E1A’s initial expression being driven by a strong, constitutive enhancer sequence
in the left-end of the HAdV genome (Hearing & Shenk, 1983). It also suggests that the
earliest parts of HAdV-C5 infection may be unaffected by disruption of the Imp-α/β1
pathway. This is different from the effect of ivermectin on infection by BKPyV, another
small DNA tumor virus. BKPyV utilizes cNLSs to facilitate nuclear entry of incoming viral
particles (Bennett et al., 2015), while HAdV capsids transit to the nucleus via microtubules
in an NLS-independent manner (Bremner et al., 2009; Dodding & Way, 2011). Despite the
initial burst of E1A expression in the presence of ivermectin, subsequent timepoints
showed a severe loss of E1A protein synthesis after 24 hours. This suggests that the positive
feedback loop whereby newly synthesized E1A protein would enter the nucleus to transactivate additional expression of itself may be disrupted by ivermectin. Levels of DBP were
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decreased across infection, consistent with the lower amounts of virus replication centres
previously observed. Expression of various late proteins, including hexon, penton, pV and
pVII, were also greatly reduced in the presence of ivermectin. As expected, overall
replication of the HAdV-C5 genome was severely decreased upon ivermectin treatment.
This aligns with observations of smaller and fewer virus replication centres and overall
lower expression levels of DBP protein. The combination of reduced viral genome
templates and early proteins also likely accounts for the subsequent reduction in HAdVC5 late gene expression.
In addition to HAdV-C5, we tested genome replication efficiency for HAdV-B3 and -E4,
both of which represent clinically relevant HAdV species. Like HAdV-C5, ivermectin
dramatically reduced HAdV-B3 genome replication. HAdV-B3 is commonly associated
with acute respiratory illness, therefore ivermectin could have significant clinical
relevance. For HAdV-E4, overall levels of replication were lower than for -B3 and -C5
even in DMSO-treated cells, but its relative genome replication of HAdV-E4 was
unaffected by ivermectin treatment. Although initially surprising, the lower replicative
ability of this virus could obscure ivermectin’s effects. Alternatively, HAdV-E4 is unique
among HAdVs as it more closely resembles simian adenoviruses (Dehghan et al., 2013).
Past studies examining HAdV-E4 genome replication suggest that HAdV-E4 relies on a
different repertoire of host factors than other HAdV species (King, Gameiro, et al., 2018).
For example, knockdown of host protein kinase A severely inhibits genome replication of
HAdV-B3, -C5, -D9 and -A12, but not -E4. Furthermore, in vitro evidence has
demonstrated that the E1A protein of HAdV-E4 uses a non-cNLS located in conserved
region 3. Indeed, E1A from HAdV-B3 and -C5 also possess this non-cNLS however,
nuclear import studies have shown this region of HAdV-E4 E1A to be a much more potent
stimulator of nuclear import than -B3 or C5 (Marshall et al., 2014).
Lastly, we probed for relative expression levels of mRNAs from all HAdV-C5 early
transcription units (E1A, E1B, E2, E3, and E4). At 24 hpi, we detected lower levels of
mRNA for each of these early genes. This is expected given the lower levels of E1A
expression, which would otherwise drive higher expression of these genes (King, Zhang,
et al., 2018). Together, these findings suggest ivermectin’s inhibition of HAdV-C5
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replication stems mostly from lower expression of crucial viral gene products, particularly
E1A, via disruption of its nuclear localization.
Despite the growing interest in studying ivermectin as an antiviral agent, relatively little is
known about its molecular mode of action. The original high-throughput drug screen
unequivocally demonstrated ivermectin’s ability to inhibit the binding of HIV-1 integrase
and TAg NLS to the Imp-α/β1 complex. Recent in vitro data published by Yang et al.,
suggests that ivermectin induces structural changes in Imp-α that prevents NLS
recognition, as well as binding to Imp-β1 (S. N. Y. Yang et al., 2020). Our data derived
from CoIP experiments confirm that ivermectin blocks NLS recognition. However, our
results suggest that concentrations of ivermectin sufficient to block NLS binding to Imp-α
are not sufficient to disrupt formation of the Imp-α/β1 complex. The IBB domain of Impα acts as an auto-inhibitory NLS that binds its own NLS binding region in a fashion that
mimics cNLS binding (Harreman, Cohen, et al., 2003). Ivermectin could theoretically
block or weaken this intramolecular interaction the same way it blocks NLS binding, while
leaving the αIBB/Imp-β1 intermolecular interaction unaffected. It would be interesting to
determine if Imp-β1 is still carrying unloaded Imp-α into the nucleus in the presence of
ivermectin, causing futile cycles of import that may have consequence beyond simple
inhibition of NLS/Imp-α interactions. Although we examined Qip1 (Imp-α3) in detail, as
it is the preferred importin for E1A (Kohler et al., 2001), it will be important to consider
how ivermectin may influence NLS binding to other Imp-α isoforms. Differences among
isoforms can influence both the binding of NLSs and the auto-inhibitory potential of the
IBB (Pumroy & Cingolani, 2015). This could be achieved by studying the broader effects
of ivermectin with a panel of different Imp-α isoforms and a variety of cNLSs.
Based on the data presented here, we conclude that the effect of ivermectin on nuclear
import of E1A can explain the significant reduction in viral replication (Figure 2.5). Upon
HAdV infection, E1A is the first viral gene transcribed and is responsible for setting the
stage for viral replication to proceed (Montell et al., 1982; Winberg & Shenk, 1984).
Inhibition of E1A nuclear import at early time points during infection would impair its
ability to trans-activate viral early genes, including itself, ultimately resulting in the
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Figure 2.5 Ivermectin-mediated inhibition of the HAdV replication cycle.
Proposed model of how ivermectin (IVM) inhibits adenovirus replication. Black arrows
indicate normal viral processes. Those processes inhibited directly or indirectly by IVM
are labelled with red. A) HAdV virions are trafficked to the nuclear pore complex (NPC)
via microtubules and viral genomes are released into the nucleus. B) E1A is transcribed
immediately and its corresponding mRNA is translated within the cytoplasm. In the
presence of IVM, E1A protein cannot bind importin alpha (α, green), therefore preventing
the formation of a competent E1A/importin-α/β1 import complex. C) In the presence of
IVM E1A protein is not efficiently imported into the nucleus, indirectly preventing further
transcription of E1A and induction of other viral early genes. D) Reduced expression of
viral gene products leads to reduced genome replication, late proteins, and ultimately the
assembly of viral progeny within the nucleus.
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downstream consequences observed here: impaired production of other early proteins,
genome replication, late proteins, and infectious progeny. Supporting this, orthogonal
experiments using HAdV encoding an NLS-deleted E1A showed a similar reduction in
overall viral replication as we see here with ivermectin (Crisostomo et al., 2017).
In summary, this study provides evidence that disruption of classical Imp-α/β1-mediated
nuclear import has promise in combating at least a subset of HAdV infections. Importantly,
these data support the growing body of literature suggesting ivermectin has utility as a
broadly acting antiviral agent. In addition, these findings demonstrate the strategic
advantage of targeting host factors for antimicrobial action. Genetically distinct viruses
often share important, potentially druggable features as a result of their co-dependence on
host processes, including the classical nuclear import pathway (Bennett et al., 2015;
Howley & Livingston, 2009; Tao et al., 2003; Tessier et al., 2019). In addition to
repurposing ivermectin for treatment of viral infections that have no current therapeutic
options (including HAdV), these results support the idea that targeting host nuclear import
by other drugs or means could be a valid strategy as well.
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Chapter 3
3

Piggybacking on classical import and other nonclassical mechanisms of nuclear import appear highly
prevalent within the human proteome

3.1

Introduction

Nucleocytoplasmic transport of proteins across the nuclear envelope is an essential cellular
process unique to eukaryotic organisms. The nuclear envelope spatially separates the
contents of the nucleus from the cytoplasm and provides a physical mechanism for
regulating numerous cellular events such as transcription, translation and the cell cycle.
Transport of proteins and RNA across the nuclear envelope is a tightly orchestrated process
that requires all molecules to pass through the NPC, a large multimeric complex built from
multiple copies of approximately 30 different proteins called nucleoporins (Hoelz et al.,
2011; Knockenhauer & Schwartz, 2016). In essence, the NPC functions as a semipermeable barrier, selectively allowing passage of certain molecules while simultaneously
preventing passage of others (Timney et al., 2016). Proteins of varying sizes are able to
diffuse through the central channel of the NPC; however, this is influenced by several
factors. Notably, the rate at which a protein can diffuse into the nucleus is inversely related
to its size. As protein size increases from less than 30–40 kDa, its ability to diffuse
diminishes rapidly (Mohr et al., 2009; Schmidt & Görlich, 2016). Other factors such as a
proteins shape and surface composition also have a significant effect on passive diffusion
(Frey et al., 2018; Schmidt & Görlich, 2016). Nevertheless, despite proteins having the
capacity to diffuse through the NPC, proteins of all sizes employ the assistance of NTRs
for rapid and efficient nuclear import or export (C. F. Chen et al., 1996; Ribbeck et al.,
1998).
Bidirectional transport of proteins through the NPC is carried out by a group of soluble
transport receptor proteins belonging to the Kapβ superfamily, which can be further
subdivided into importins or exportins (O’Reilly et al., 2011). The human genome encodes
20 Kapβ proteins; 10 are importins that shuttle proteins into the nucleus, 7 are exportins
and shuttle proteins out of the nucleus, 2 are bidirectional transporters and 1 currently has
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no known function (Kimura & Imamoto, 2014). Kapβ proteins recognize a cargo’s NLS
for import, or NES for proteins which undergo export (Soniat & Chook, 2015; Wen et al.,
1995). Following cargo binding, Kapβ can facilitate transport through the NPC where
cargo is released into either the cytoplasm or nucleus. Importantly, the loading and unloading of cargo onto Kapβ is aided by the RanGTPase system, where cargo is released
within the nucleus upon RanGTP binding to Kapβ (Cautain et al., 2015). Conversely,
binding of export cargo is aided by binding of RanGTP, where subsequent release of cargo
into the cytoplasm is triggered by RanGTP hydrolysis.
Not all Kapβ’s recognize their cargo directly. For example, Imp-β1 mainly recognizes its
cargo through the adapter Imp-α. This pathway is commonly referred to as the classical
nuclear import pathway and involves recognition of a cargo’s NLS by one of the 7 human
Imp-α isoforms, which are then shuttled through the NPC by Imp-β1 as a heterotrimeric
complex (Goldfarb et al., 2004b; Dirk Görlich et al., 1995). NLSs recognized by Imp-α are
referred to as cNLSs, are rich in basic amino acids and come in two forms, monopartite or
bipartite (Lange et al., 2007). Monopartite cNLSs are comprised of a single cluster of basic
amino acids while bipartite cNLS have two clusters of basic amino acids separated by a
linker region of variable length and composition. These motifs can be exemplified by the
SV40 large TAg (PKKKRKV) and NP (KRPAATKKAGQAKKKK) cNLS, respectively
(D Kalderon et al., 1984; Robbins et al., 1991). Structurally, Imp-α is composed of 10 ARM
domains which form two pockets, referred to as the major and minor groove (Conti et al.,
1998; Conti & Kuriyan, 2000). These grooves accommodate the basic clusters of amino
acids characteristic of a cNLS. Monopartite motifs primarily bind the major groove.
However, several NLSs, both cellular and viral, can bind the minor groove exclusively
(Kosugi et al., 2009; Lott et al., 2011; Nakada et al., 2015; Pang & Zhou, 2014). Bipartite
cNLSs occupy both the major and minor grooves, with the smaller N-terminal basic cluster
bound to the minor groove and the larger basic cluster bound to the major groove (Conti &
Kuriyan, 2000).
Another class of NLS that has been characterized is the PY-NLS, which is recognized by
TNPO1 and TNPO2, both importin Kapβ members (B. J. Lee et al., 2006; Soniat & Chook,
2015). The PY-NLS is not as well characterized as the cNLS; however, some general rules
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have emerged. These include an N-terminal motif, either hydrophobic or basic, a Cterminal R/K/H-X2-5-PY motif and are found within a structurally disordered region with
overall basic charge (B. J. Lee et al., 2006). An additional Kapβ, transportin-SR2 (also
known as TRN-SR or TNPO3) has been shown to import SR splicing factors by binding to
their arginine-serine (RS) domains (Maertens et al., 2014). In regard to exportin Kapβs,
only one class of NES has been characterized and this is mediated by exportin-1 (XPO1,
also known as CRM1), which recognizes 8-15 amino acid long leucine rich motifs (Dong
et al., 2009; Fornerod et al., 1997; Fukuda et al., 1997). Similar to the classical nuclear
import pathway, XPO1/CRM1-mediated export has been extensively studied with
hundreds of characterized cargo from human and model organisms (Kırlı et al., 2015).
The classical nuclear import pathway is assumed to handle the majority of nuclear import
as it is the best characterized and has many documented cargos and cNLSs (Bernhofer et
al., 2017; Lange et al., 2007). Sequence attributes of cNLSs have made them highly
predictable and this has led to the development of numerous NLS prediction programs
(Bernhofer et al., 2017; Brameier et al., 2007; Kosugi et al., 2009; J. Lin & Hu, 2013;
Nguyen Ba et al., 2009). Interestingly, early estimates using PSORT II demonstrated that
only ~55% of nuclear proteins in S. cerevisiae have a predictable cNLS (Lange et al.,
2007). As more NLS prediction programs emerged, the fraction of yeast and human nuclear
proteins with predictable cNLSs unexpectedly remained between 30–40% (Bernhofer et
al., 2017; Marfori et al., 2011). These observations likely reflect a combination of nonclassical import pathways, alternative cNLSs and piggybacking into the nucleus indirectly
via physical interaction with other proteins that directly bind the nuclear transport
apparatus. In fact, data from yeast shows that up to 50% of proteins that bind Srp1 (the
only yeast Imp-α) do not have a predictable cNLS, providing strong circumstantial
evidence that their association with Srp1 and subsequent nuclear import occurs via
piggybacking or alternative NLSs (Lange et al., 2007).
Whether or not these observations hold true in humans has not been explored. With the
development of databases such as the Human Protein Atlas (HPA) and Human Reference
Interactome (HuRI), as well as the abundance of publicly available high-throughput mass
spectrometry data, it may be possible to establish a more accurate picture of nuclear
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transport mechanisms (Deutsch et al., 2016; Luck et al., 2020; Thul et al., 2017; Uhlén et
al., 2015). While examples of piggybacking into the nucleus using Imp-α have been
documented for several distinct nuclear proteins, widespread identification of potential
piggybacking proteins or estimates of the extent to which this nuclear import strategy is
used remain poorly characterized (Asally & Yoneda, 2005; Bange et al., 2013; Czeko et
al., 2011; Di Croce, 2011; Kressler et al., 2012; Trowitzsch et al., 2015). Using a collection
of resources and NLS prediction programs, I aimed to acquire information regarding the
prevalence of piggybacking and use of alternative nuclear import pathways in eukaryotic
cells. My analyses show that nearly 50% of nuclear proteins in the human proteome do not
have a predictable cNLS. I identify a large cohort of proteins found in both the nucleus and
cytoplasm which have a predicted NES, but not a predicted cNLS. Examination of binary
interactions for 6 of the 7 known Imp-α isoforms demonstrates that 20–50% of interactors
also do not have a predictable cNLS. Furthermore, a reanalysis of publicly available mass
spectra files for protein interactions mediated by several Imp-α isoforms showed that up to
50% of cargos do not have a predictable cNLS. Finally, using this data I specifically focus
on several nuclear protein complexes involved in transcription, and show that the majority
of proteins belonging to the mediator of RNA polymerase II transcription (Mediator)
complex interact with at least one Imp-α, yet do not have a predictable cNLS.

3.2

Materials and Methods

3.2.1 Datasets for nuclear, cytoplasmic and nucleocytoplasmic
proteins
Proteins with experimental evidence of being localized to the nucleus or cytoplasm were
downloaded from the HPA (Thul et al., 2017). According to the HPA nuclear localization
dataset, this includes the nucleoplasm, nuclear speckles and nuclear bodies, while
cytoplasmic localization includes the aggresome, cytosol, cytoplasmic bodies, rods and
rings. Proteins present in both the nucleus and cytoplasm were additionally grouped
together as nucleocytoplasmic proteins. From here all canonical protein sequences were
retrieved from UniprotKB/Swiss-Prot (UniProt Consortium, 2021).
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Proteins known to associate with yeast Srp1 were downloaded from BioGrid while
interactors for human Imp-α1, α3, α4, α5, α6 and α7 were retrieved from IntAct (Orchard
et al., 2014; Oughtred et al., 2019). Only physical interactions were kept, removing any
interactions identified through genetic studies or post-translational modifications. Proteins
with binary, or direct, interactions with Imp-α were retrieved from the HuRI database for
Imp-α isoforms α1, α3, α4, α5, α6 and α7 (Luck et al., 2020). All interactors were combined
together, and redundant interactors were removed before screening against the HPA
nuclear dataset to obtain those with evidence of nuclear localization only.

3.2.2 NLS and NES prediction
For identifying cNLSs using regular expression matching, I used the regular expressions
provided through the ELM database corresponding to monopartite core (ELME000270),
monopartite core with C-terminal preferences (ELME000278), monopartite core with Nterminal preferences (ELME000271) and bipartite (ELME000276) (Kumar et al., 2020).
The criteria for having a cNLS only required a protein to have at least one of these regular
expressions satisfied.
For predicting NLSs using NLStradamus, each protein was searched for both monopartite
and bipartite NLSs using a threshold score of 0.6 (Nguyen Ba et al., 2009). All hits were
combined and duplicate protein ID matches were removed to end up with a list of unique
proteins containing either a monopartite or bipartite NLS. For searches using cNLS
Mapper, the default cut-off score of 0.5 was used and included searching the entire region
of the protein for bipartite NLS with a long linker region (Kosugi et al., 2009). Since
NLSdb searches for matches within its own library of potential or experimentally
confirmed NLSs no threshold or cut-off scores could be used a priori and any matches to
NLSdb were taken as a hit (Bernhofer et al., 2017). Predictions made with NESmapper
used the default threshold score of 2 to identify potential NESs (Kosugi et al., 2014).
Similar to NLS prediction, any duplicate protein IDs were removed to obtain a list of
unique proteins with at least one predicted NES. For more detailed cNLS analysis PONDR
and DisEMBL were used to screen for intrinsic disorder (Linding et al., 2003; Peng et al.,
2006). PONDR (VSL2) was used to find short (<30 residues) or long (>30 residues) regions
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of predicted disorder where a given cNLS was located. Similarly, DisEMBL was used to
identify regions with a high degree of mobility that overlap the cNLS in question.

3.2.3 Identification of novel motifs with MEME and SLiMSearch
Imp-α interactors from the HuRI dataset without a cNLS were combined into a single group
and all duplicate protein identifications were removed as well as any nucleoporins or Impα proteins. This produced a group of 10 unique proteins which were then analyzed using
the motif elicitation program MEME (Bailey et al., 2009). MEME settings were set to
identify three clusters with zero or one occurrence per sequence with a minimum length of
6 amino acids. The top scoring cluster was subsequently used for further analysis. Using
the motif defined as KxRxHxK I searched the human proteome with SLiMSearch
(Krystkowiak & Davey, 2017) for any motif matches that are located within a predicted
IDR (disorder cut-off set to 0.4). Identifications retrieved with SLiMSearch then underwent
gene ontology analysis using Metascape (Y. Zhou et al., 2019) to identify enriched cellular
processes.

3.2.4 Proteomics analysis
Raw mass spectra were downloaded from the Proteomics Identification database (PRIDE)
corresponding to project PXD007976 titled “Landscape of nuclear transport receptor cargo
specificity” (Mackmull et al., 2017; Perez-Riverol et al., 2019). Specifically, mass spectra
corresponding to wild-type control, BirA* control, Imp-α1 (N- and C-terminal BirA* tag),
Imp-α5 (N- and C-terminal BirA* tag), and Imp-α6 (C-terminal BirA* tag) were retrieved
for samples that were digested on-bead. Tandem mass spectra were searched using MSGF+ against the human Swiss-Prot entries from UniProtKB (release 03/2020, 20,305
entries) and included common contaminants in addition to BirA and streptavidin.
Additionally, a reverse decoy database was used for false discovery rate estimation (Elias
& Gygi, 2007). MS-GF+ search parameters were as follows: full tryptic specificity,
precursor mass tolerance of 20 ppm, and dynamic modifications for methionine oxidation,
N-terminal acetylation and biotinylation of lysine.
Proteins were identified using a target-decoy strategy with IDPicker and filtered at a false
discovery rate (FDR) of 1% and a minimum of two unique peptides per protein (Ma et al.,
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2009). Experiments where Imp-α was expressed with BirA* either on the N- or C-terminus
were combined to establish a unique set of interactors encompassing both experiments.
Proteins identified from each experimental sample were analysed separately with
SAINTexpress (Teo et al., 2014) using wild-type and BirA* samples as controls. To further
increase the statistical strength of identifying co-purifying bait proteins I used additional
controls provided through the CRAPome (CC532) (Mellacheruvu et al., 2013). Peptides
identified through SAINTexpress with an FDR less than 5% were considered statistically
relevant. Finally, all interactors for Imp-α1, α5 and α6 were combined and reduced into a
list of non-redundant proteins (available upon request) that could be screened against the
HPA for evidence of nuclear localization, unless otherwise stated. Only those with
evidence of nuclear localization were used for analysis. For TAF-Imp-α interactions,
spectral counts and FDR values produced by SAINTexpress were submitted to ProHits-viz
for visualization (Knight et al., 2017).

3.3
3.3.1

Results
Many nuclear localized proteins do not have a predictable
cNLS

The classical nuclear import pathway is assumed to handle the majority of protein nuclear
import. Extensive research into this pathway has established a defined set of rules for the
cNLS-Imp-α interaction, making them highly amenable to computational prediction
(Kosugi et al., 2009; Marfori et al., 2011). To estimate the fraction of nuclear proteins with
a predictable cNLS, I first retrieved a list of proteins from the HPA that are localized to the
nucleus. Additionally, I collected proteins that localize to the cytoplasm in order to capture
proteins present in both compartments that could potentially shuttle bidirectionally across
the nuclear envelope. From the HPA, 6542 nuclear and 4493 cytoplasmic proteins were
identified. These nuclear and cytoplasmic proteins demonstrated substantial overlap, with
over 2100 proteins found in both the nucleus and cytoplasm (Figure 1A). This number
represents almost a third of nuclear proteins and one-half of cytoplasmic proteins that
localize to both cellular compartments.

69

Analysis of proteins which localize to the nucleus, nucleus and cytoplasm, and cytoplasm
using NLStradamus for NLS prediction and NESmapper for NES prediction indicated that
NLSs are more frequently predicted in nuclear proteins and NESs are more frequently
predicted in cytoplasmic proteins, as anticipated (Figure 1B). The difference in frequency
of identifying a predicted cNLSs for nuclear proteins or a predicted NESs for cytoplasmic
proteins is particularly intriguing. Over 80% of cytoplasmic proteins have a predictable
NES, while only ~40% of nuclear proteins have a predictable cNLS.
As less than half of the nuclear proteins have a predicted cNLS, I questioned if this was
due to NLS prediction being too specific. To search for cNLSs with greater sensitivity, I
used simple regular expression (RegEx) matching to search all nuclear proteins, including
those that are nucleocytoplasmic. For RegEx matching I used experimentally validated
motifs corresponding to monopartite core, monopartite N-extended, monopartite Cextended, and bipartite from the ELM resource (Kumar et al., 2020). As expected, RegEx
matching increased cNLS prediction sensitivity; however, putative cNLSs were still
identified in only 53% of nuclear proteins, compared to 37% using NLStradamus (Figure
1C). Comparison of proteins with a predicted cNLS from RegEx matching or NLStradamus
shows significant overlap; with the majority of NLStradamus hits also being identified by
RegEx matching (Figure 1D). My prediction with NLStradamus agrees with previous
findings (Bernhofer et al., 2017), and less stringent searches for cNLSs using RegEx
matching still fail to predict a cNLS in almost 50% of nuclear proteins.
While other NLSs such as the PY-NLS exist, only a limited number of PY-NLSs have been
characterized in detail, and no reliable prediction models exist. Most PY-NLSs
characterized to date possess the sequence motif R\K\H-X2-5-PY, where a positively
charged amino acid (Arg, Lys, His) can be found up to 5 amino acids N-terminal to a PY
motif (Xu et al., 2010). While this motif is one of several PY-NLS attributes, it is not
sufficient to predict a PY-NLS and on its own would be highly over-predictive.
Nevertheless, I used this motif to search proteins that do not contain a cNLS using RegEx
matching and found only 30% of these proteins contained this minimal PY-NLS motif
(Figure 1E), leaving a substantial portion of the nuclear proteome without a predictable
cNLS or PY-NLS.
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Despite the HPA characterizing protein subcellular localization in several cell lines, this
does not rule out additional cytoplasmic proteins that could potentially localize to the
nucleus under different cellular conditions, or other cell types not captured by the HPA. As
previously demonstrated, putative cNLSs can be found in over 20% of cytoplasmic proteins
(Figure 1B). With this subset of cytoplasmic proteins, I used NucPred to predict each
proteins probability of localizing to the nucleus (Brameier et al., 2007). NucPred scores
range from 0 to 1, with higher scores having a greater probability of a protein being nuclear.
As expected, most cytoplasmic proteins had a lower NucPred score; however, many
proteins still scored greater that 0.8 (Figure 1F). As these scores are only probabilities,
NucPred performance is further enhanced if a protein also has a predicted NLS. Proteins
with a NucPred score greater than 0.8 and a predicted NLS have been shown to be correctly
identified as nuclear with over 90% accuracy (Brameier et al., 2007). Taking the 380
cytoplasmic proteins that scored equal or greater than 0.8 and filtering with NLStradamus
resulted in nearly 25% of these proteins having a potential cNLS. Indeed, it’s possible
many of these proteins have nuclear functions despite being classified as cytoplasmic based
on Protein Atlas data. Nevertheless, these observations suggest that substantially more
cytosolic proteins may have under characterized, context specific occupancies within the
nucleus than anticipated, which cannot be captured by immunofluorescence alone.
Based on data from the HPA, these findings point to a conservative estimate where almost
50% of nuclear proteins lack a predictable cNLS, and this estimate increased to over 60%
using more stringent NLS prediction programs. Furthermore, analysis of cytoplasmic
proteins using nuclear localization and NLS prediction demonstrates a substantial portion
of cytoplasmic proteins may have currently uncharacterized, potentially context dependent
roles within the nucleus. Taken together, these findings emphasize the discrepancy in cNLS
prediction for established human nuclear proteins and highlight an intriguing inconsistency
between the frequencies of NES and NLS prediction.
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Figure 3.1 The majority of human nuclear proteins do not contain a predictable
cNLS.
A) Nuclear and cytoplasmic proteins were retrieved from the Human Protein Atlas (HPA)
for the identification of distinct nuclear, cytoplasmic and nucleocytoplasmic proteins. B)
cNLS and NES prediction of nuclear, nucleocytoplasmic (Nuc/Cyto) and cytoplasmic
proteins from the HPA using NLStradamus and NESmapper, respectively. The majority of
Nuc/Cyto and cytoplasmic proteins have a predictable NES in contrast to nuclear and
Nuc/Cyto proteins where the majority do not have a predictable cNLS. C) Comparison of
cNLS prediction approaches using NLStradamus and regular expression matching (RegEx)
on nuclear proteins from the HPA. All motifs corresponding to cNLSs in the ELM resource
were used for RegEx matching where any protein with at least one match is counted as a
hit. Comparing approaches shows that somewhere between 47–63% of nuclear proteins do
not have a predictable cNLS. D) Prediction of proteins with a cNLS using either RegEx
matching or NLStradamus demonstrates significant overlap. The majority of NLStradamus
predictions are also predicted by RegEx matching. E) Proteins without a cNLS, as
determined by RegEx matching, were searched for a minimal PY-NLS (R/H/K-X2-5-PY),
demonstrating that a substantial portion of nuclear proteins also do not contain a PY-NLS.
F) Cytoplasmic proteins were analyzed with NucPred to predict nuclear localization and
those with a score greater than 0.8 were searched for cNLSs. Those with a cNLS are
considered to have a high probability of nuclear localization, highlighting the potential for
additional nucleocytoplasmic localizations not supported by the HPA.
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3.3.2 Many Imp-α binding partners do not have a predictable cNLS
Protein nuclear import is mediated by a variety of different importins, ranging from Imp-α
and the classical nuclear import pathway to alternative import pathways using importin
Kapβs (Lange et al., 2007; Xu et al., 2010). The lack of predictable cNLSs in nuclear
proteins may partly be reflected by the diversity of nuclear import pathways; however,
previous observations in yeast have shown that up to 50% of proteins which bind Imp-α do
not have a predictable cNLS (Lange et al., 2007). To evaluate if this holds true for human
Imp-α isoforms, I specifically looked at proteins that have documented interactions with
an Imp-α family member. To obtain a list of these physical interactors, proteins were
retrieved from BioGrid and IntAct databases for the only yeast Imp-α, Srp1, and all seven
human Imp-α isoforms (Orchard et al., 2014; Oughtred et al., 2019). To determine which
cargos have a predictable cNLS, I used the less stringent RegEx matching to come up with
a list of proteins that interact with Imp-α, but do not have a predicted cNLS (Figure 2A).
In yeast, approximately 50% of the proteins which associate with Srp1 have a predictable
NLS and this is in agreement with previous reports (Lange et al., 2007; Marfori et al.,
2011). Human Imp-α1 shows a similar trend to Srp1, where just over 50% of interactors
have a predictable NLS. This is in contrast to Imp-α3, α4, α5, α6 and α7, where roughly
25% of their identified interactions do not have a predictable cNLS. Based on these
findings, I conservatively estimate that roughly 25–50% of Imp-a cargo in humans do not
have a predictable cNLS.
Not all protein interactions reported in databases such as BioGrid or IntAct are binary,
making it difficult to determine if a protein is directly binding Imp-α or by indirectly
piggybacking on a protein that interacts directly with Imp-α. To evaluate direct binding
partners of Imp-α, I explored the recently published HuRI database (Luck et al., 2020).
This project involved a Y2H pipeline that tested roughly 17,000 human open reading
frames (ORFs) in an ‘all-by-all’ format. From this dataset I was able to retrieve 102 nonredundant binary interactions from all Imp-α isoforms, except Imp-α8 which had no data
available. Further refinement ultimately reduced this down to 59 proteins, as only 67 have
evidence of nuclear localization from the HPA and another 8 of which are either
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Figure 3.2 Many Imp-α cargo do not have a predictable cNLS.
A) Physical protein interactions, either direct or indirect, for yeast Srp1 and the indicated
human Imp-α isoforms were retrieved from BioGrid and IntAct and analyzed for cNLSs
using RegEx matching. Prediction shows between 50 and 80% do not have a predictable
cNLS. B) Direct protein interactions for all Imp-α isoforms except Imp-α8 were retrieved
from the Human Reference Interactome (HuRI). Interactors were pooled to remove
redundant proteins and checked against the HPA for evidence of nuclear localization before
cNLS prediction. Several prediction programs were used to determine a range of predicted
cNLSs, which demonstrated between 50 and 80% do not have a cNLS. C) Proteins without
a predicted cNLS from any of the prediction programs were processed with MEME to
identify novel motifs common amongst each protein that might interact with Imp-α.
Several of the motifs identified were rich in basic amino acids but did not resemble a cNLS.
Disorder prediction using PONDR (VSL2) and DisEMBL shows these motifs are also
found within predicted disordered protein regions. D) The motif KxRxHxK was searched
against the human proteome using SLiMSearch, identifying 37 proteins, which were then
analyzed with Metascape. Proteins bearing this motif are most enriched in core nuclear
processes like RNA pol II transcription and DNA repair. E) Proteins with the KxRxHxK
motif were also checked against the HPA for evidence of subcellular localization. Of the
30 proteins with localization information, two-thirds have evidence of nuclear localization.
F) Reanalysis of tandem mass spectra for protein interactions corresponding to Imp-α1, α5
and α6 from the Nuclear Landscape dataset. All significant interactions were checked
against the HPA for nuclear localization before cNLS prediction. Between 50 and 75% of
Imp-α cargo do not have predictable cNLS when analyzed with NLStradamus and RegEx
matching, respectively. G) Identified proteins from the Nuclear Landscape dataset were
compared to those from HuRI and IntAct. Comparison shows that the majority of protein
identifications from the Nuclear Landscape dataset are not represented within these
databases and that these interactions show similar results in the number of proteins without
predictable cNLSs.
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nucleoporins or importins. Searching these proteins for potential cNLSs using several
approaches revealed that between 20–50% do not have a predictable cNLS (Figure 2B).
Both RegEx matching and cNLS Mapper predicted cNLSs in roughly 80% of proteins,
while NLSdb and NLStradamus predicted 50–60% with a cNLS, likely putting the range
of true cNLSs somewhere between the two extremes.
Despite the HuRI dataset being relatively small compared to the number of potential
nuclear proteins that may bind Imp-α, these findings demonstrate that a potentially large
fraction of Imp-α binary interactions may be mediated by a non-typical cNLS. To explore
this idea further, I used the motif elicitation program MEME to determine if this group of
proteins from the HuRI dataset have any common motifs (Bailey et al., 2009). First,
proteins without a predictable cNLS from each prediction program were combined and
reduced into a group of 10 non-redundant proteins. These proteins were then evaluated
using MEME to look for minimal motifs that occur once in each protein. Interestingly, the
top scoring motif was still enriched with positively charged amino acids despite no
resemblance to a true cNLS (Figure 2C). This 7 amino acid motif has the strongest
preference for Lys at positions 1 and 7 and His at position 5. Position 6 was consistently
either Trp, Arg or Ala and position 3 has a minor preference for Arg. Since short motifs,
like the cNLS, are most frequently found within intrinsically disordered regions of a
protein, I next searched each protein using the disorder prediction programs DisEMBL and
PONDR (Linding et al., 2003; Peng et al., 2006; Van Roey et al., 2014). Results from
PONDR (VSL2) show that many of the motifs are within a predicted region of disorder,
based on their score being greater than 0.5. Analysis with DisEMBL was similar, with most
motifs residing in predicted disordered loops/coils or hot-loops. Overall, this data from a
small subset of proteins shows that an alternative motif, divergent from a cNLS, yet
possessing several basic residues, may be present.
From the motif generated with MEME, I searched the human proteome for KxRxHxK,
since these were the prominent basic amino acids, using SLiMSearch (Krystkowiak &
Davey, 2017). This resulted in 37 proteins where this motif could be found within a
predicted IDR. Gene ontology analysis of these proteins using Metascape (Y. Zhou et al.,
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2019) shows that they are most enriched for core nuclear processes involving RNA
polymerase II transcription and DNA repair (Figure 2D). In total, 30 of the 37 proteins had
subcellular localization data from the HPA, with 20 having evidence of nuclear localization
(Figure 2E). Taken together, these findings suggest that most proteins bearing the
KxRxHxK motif are likely nuclear.
Proteins known to associate with Imp-α that can be collected from databases such as IntAct
or BioGrid likely only represent a fraction of Imp-α cargo. To extend these findings further
I explored datasets which were not available, or not utilized, during previous attempts at
characterizing the classical nuclear import pathway in this manner (Bernhofer et al., 2017;
Lange et al., 2007). To do this, I reanalyzed publicly available raw mass spectra files
published by Mackmull et al., that were obtained through PRIDE and are referred to here
as “Nuclear Landscape” (Mackmull et al., 2017). This dataset includes interaction data for
Imp-α1, -α5 and -α6 that was acquired through in situ proximity ligation (BioID). In their
experiments, Imp-α1 and -α5 were expressed as N- and C-terminal BirA* fusions, while
Imp-α6 was only expressed with C-terminal BirA*. This approach is highly sensitive and
allows protein-protein interactions to be mapped under normal cellular conditions. Briefly,
raw tandem mass spectra were searched using MS-GF+ with a reverse target-decoy
strategy and the resulting peptides were assembled into proteins using IDPicker, with a
global protein FDR < 1% (Elias & Gygi, 2007; Kim & Pevzner, 2014; Ma et al., 2009).
Statistically significant interactions were identified using SAINTexpress, with additional
background controls provided through the CRAPome, ultimately resulting in a combined
502 high-confidence interactions (Mellacheruvu et al., 2013; Teo et al., 2014). This list of
interactors was then compared to proteins localized to the nucleus according to the HPA,
resulting in a final list of 403 interactors. Many of the proteins omitted have evidence of
nuclear localization; however, for consistency only proteins with evidence in the HPA were
used. To establish an estimate of cargos without a predictable cNLS, I used RegEx
matching and NLStradamus to determine that roughly 20–25% and 50% of proteins did
not have a predicted cNLS, respectively (Figure 2F). These findings echo the results
obtained from the HuRI and IntAct datasets (Figure 2A and B), which show a similar
number of proteins without a cNLS when using both prediction approaches. It remained
possible that these similarities arise due to the analysis of overlapping/redundant proteins
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within their respective datasets. However, a comparison of Imp-α interactors from each
source demonstrated minimal overlap between proteins identified through my reanalysis
and IntAct or HuRI (Figure 2G). Thus, reanalysis of the Nuclear Landscape dataset using
both a different mass spectrometry pipeline and statistical protein-protein interaction
analysis identified significantly more Imp-α cargos, many of which are novel, yet also do
not have a predictable cNLS.
Overall, using several different cNLS prediction programs, 20–50% of proteins which
directly bind Imp-α do not have a predicted cNLS. Importantly, these observations are
independently observed in the reanalysis of the Nuclear Landscape dataset, which
represents hundreds of new Imp-α cargos. When taken together, these data highlight
potentially new Imp-α binding motifs and are also highly suggestive that piggybacking
strategies are used extensively for Imp-α interactions.

3.3.3 Identification of putative piggybacking proteins
As shown above, roughly 50–60% of proteins known to localize to the nucleus do not have
a predictable cNLS. Some of these proteins without a cNLS may instead target one of the
importin Kapβs directly. However, there remain many nuclear proteins that associate with
Imp-α as determined by proteomic studies, which do not have a predictable cNLS. One
situation that would satisfy nuclear import via Imp-α, without the use of a cNLS is through
piggybacking, which is simply the indirect association with Imp-α via an intermediary
protein (Czeko et al., 2011). Despite a few specific examples of piggybacking as a
mechanism of nuclear import, the prevalence of this process remains poorly characterized.
To identify putative piggybacking proteins I used Metascape to first establish a general
overview of the cellular processes associated with non-cNLS nuclear proteins from the
HPA (Y. Zhou et al., 2019). The rational being that proteins involved in similar cellular
processes are most likely to function together. Of the top 10 non-redundant enriched
clusters I identified, the top three processes were RNA polymerase II transcription
initiation, DNA repair and RNA splicing, which are all nuclear processes (Figure 3A).
Further inspection of members within the RNA polymerase II transcription initiation
cluster revealed multiple groups of proteins with related functions (Figure 3B). The first

79

major group consists of proteins belonging to the type-II nuclear receptor family, a class
of ligand-regulated transcription factors (Sever & Glass, 2013). Interestingly, most nuclear
receptor proteins identified have a predicted cNLS by cNLS Mapper. However, these
predicted cNLSs do not align with those identified by experimentation and are likely
incorrect. Interestingly, many nuclear receptors have been shown to contain an NLS within
their DNA binding domain, specifically within the linker region between zinc-finger
domains (Chopin-Delannoy et al., 2003; Hsieh et al., 1998; Prüfer & Barsony, 2002). These
motifs appear in many nuclear receptors; however, they do not resemble any previously
identified cNLS or non-cNLS (Figure 3C).
Additionally, several proteins were identified that function together in large multi-protein
complexes, including subunits of RNA polymerase II (RNAPII), transcription factor II D
(TFIID) and Mediator. Identification of RNAPII subunits is encouraging, as RNAPII is
already suspected to assemble within the cytoplasm prior to nuclear import (Boulon et al.,
2010; Czeko et al., 2011; Di Croce, 2011). Similar to RNAPII, the assembly of TFIID has
been proposed to occur within the cytoplasm and subsequently enter the nucleus through a
piggybacking mechanism. Specifically, the cTAF subcomplex, consisting of TAF2-TAF8TAF10 has been shown to shuttle into the nucleus via Imp-α1 (Trowitzsch et al., 2015).
My reanalysis of the Nuclear Landscape dataset using SAINTexpress supports these
observations, showing statistically significant interactions (FDR < 0.05) between Imp-α1
and several TAF proteins, including TAF2 and TAF8 (Figure 3D). Visualization of these
interactions using ProHits-viz shows the highest number of spectral counts between Impα1 (C-terminal BirA* fusion) and various TAF proteins (Knight et al., 2017). The Nterminal BirA* fusion of Imp-α1 produced many similar interactions, but with fewer
spectral counts. Likewise, Imp-α5 N- and C-terminal BirA* constructs identified similar
hits with varying spectral counts, while Imp-α6 produced the fewest hits overall. Despite
positive identification of peptides corresponding to TAF10, the interaction between Impα1 and TAF10 was not statistically significant according to SAINTexpress. However, with
prior knowledge of a TAF2-TAF8-TAF10 complex and a number of other interactions
between Imp-α1 and several
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Figure 3.3 Identification of putative piggybacking proteins in non-cNLS nuclear
proteins.
A) Nuclear proteins from the HPA without a predicted cNLS were analyzed using
Metascape to identify enriched cellular processes. B) Many of the proteins within the RNA
polymerase II (RNAPII) transcription initiation cluster belong to related protein groups,
such as the nuclear receptors, and distinct multi-protein complexes like transcription factor
II D (TFIID), RNAPII and Mediator. Underlined proteins have a predicted cNLS as
determined by cNLS Mapper. RNAPII is known to use piggybacking as well as several
subunits of TFIID. C) Although not suspected to piggyback, multiple sequence alignment
with Clustal Omega of the identified nuclear receptors shows conservation of a motif (red)
that has been previously shown to mediate nuclear import (bolded black) (Sievers et al.,
2011). D) Visualization of TAF interactions with Imp-α1 and 5 (N- and C-terminal BirA*
fusions) and Imp-α6 (C-terminal BirA* fusion) shows many TAFs are strongly associated
with Imp-α1. Several have a cNLS Mapper score ≥ 7 (green) while others have weaker
cNLS Mapper scores that are < 7 but still greater than 5 (yellow). Those in red have scores
below 5. Importantly, many of these predicted cNLSs are found within disordered regions
(green) as determined by PONDR (VSL2).
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TAFs, the Imp-α1-TAF10 interaction is likely accurate. Additionally, many individual
subunits of the 5TAF (TAF4, 5, 6, 9, 12) and sTAF (TAF1, 7, 11, 13 and TBP)
subcomplexes appear to preferentially associate with Imp-α1. Interestingly, despite ample
evidence in support of piggybacking, many TFIID subunits have predictable cNLSs within
a predicted intrinsically disordered region. With the exception of TAF15 which has a PYNLS, only TAF6 has no predictable cNLS (Marko et al., 2012).
Based on these findings, my analysis of nuclear proteins without a predictable cNLS
identified protein subunits of RNAPII and TFIID already shown to piggyback into the
nucleus. In contrast, many of the Mediator proteins identified do not have a predictable
cNLS, a particular area that has remained largely unexplored and could possibly represent
a novel example of piggybacking.

3.3.4 Mediator proteins associate with Imp-α and do not have a
predictable cNLS
Mediator, like RNAPII and TFIID, is a multiprotein complex consisting of up to 30
subunits. Despite being relatively well characterized with respect to its role in
transcriptional coactivation, nuclear import of Mediator proteins has not been studied
extensively. Furthermore, evidence of cytoplasmic assembly prior to nuclear import via a
piggybacking mechanism has not been previously proposed.
To investigate the Mediator complex further, I first inspected each Mediator subunit for a
predictable cNLS using RegEx matching, NLStradamus and cNLS Mapper (Figure 4A).
Of the 30 Mediator subunits evaluated, RegEx matching was the most sensitive, identifying
12 proteins with a cNLS, most of which were confirmed with NLStradamus and/or cNLS
Mapper. For the remaining 18 Mediator subunits without a RegEx predicted cNLS, only 3
were predicted to have a cNLS using one of the other prediction programs. Overall, using
each cNLS prediction method only 11 of the 30 proteins have a cNLS predicted by at least
two approaches, suggesting many subunits may use alternative nuclear import pathways,
alternative cNLSs, or possibly piggyback into the nucleus.
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In addition to cNLS prediction, I inspected the Nuclear Landscape dataset along with a
literature search for interactions between Mediator proteins and NTRs. In addition to Impα1, α5 and α6, the Nuclear Landscape dataset also contains information for other NTRs
and includes several importin Kapβ proteins (Kpnb1, IPO4, IPO5, IPO11 and IPO13) as
well exportin Kapβs (NXT1, NXT2, XPO1, XPO2 and XPO7). From this dataset, 22
components of the Mediator complex were identified as having an association with at least
one NTR (Figure 4A). Although most Mediator subunits interact with at least one Imp-α
protein, many do not have anything resembling a cNLS. For MED7 and MED27
specifically, putative cNLSs were identified using RegEx, but not by NLStradamus and
cNLS Mapper, suggesting these cNLSs may not be valid. Interestingly, while many
Mediator proteins associate with multiple Imp-α isoforms, or importin Kapβ transporters
like TNPO1 and 2, and IPO4, 5 and 11, none exclusively associate with only Kapβ proteins.
In other words, these Mediator associations always co-occur with an Imp-α.
Due to the physical limitations imposed by the NPC, nuclear import of larger proteins
requires facilitated nuclear transport pathways. Individual Mediator components range
from 13kDa to over 200kDa. Not surprisingly, as molecular weight increases, so does the
likelihood of a protein having a predictable cNLS (Figures 4A & B). Most Mediator
subunits without a predictable cNLS are less than 50kDa, and in theory may enter the
nucleus via passive diffusion. In contrast, both MED23 and MED25 exceed the NPC
diffusion limit and lack a predicted cNLS. Given the extensive number of interactions made
within the Mediator complex (Figure 4C), it’s plausible that MED23, MED25 and many
of the smaller components lacking cNLSs piggyback into the nucleus with the larger cNLSbearing subunits.
Based on these analyses, it appears that the classical nuclear import pathway is responsible
for nuclear import of the majority of Mediator subunits, while alternative pathways using
Kapβs may be used to a lesser extent. It’s particularly interesting that most Mediator
subunits associate with the classical NTR Imp-α, yet do not have anything resembling a
cNLS, suggesting that Mediator components may piggyback into the nucleus as complexes
as described for RNAPII and TFIID.
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Figure 3.4 Mediator complex subunits may utilize a piggybacking mechanism for
nuclear import.
A) Mediator subunits were analyzed for cNLSs using different cNLS prediction programs,
and data was tabularized using Microsoft Excel. Many subunits have a predicted cNLS
(green) from more than one program while the majority do not have a predicted cNLS
(red). Data from the Nuclear Landscape dataset and other published NTR interactions show
that many subunits associate with Imp-α, as well as transportin (TNPO). B) Mediator
subunits vary in molecular weight, with larger subunits more frequently having a predicted
cNLS. Subunits with a cNLS predicted from two programs or more are shaded in dark
green (2 NLS) and those with a prediction from only one program are shaded in light blue
(1 NLS). Although imprecise, a passive diffusion limit of 50kDa (dotted line) shows many
subunits without a cNLS are below this cut-off. C) A model figure of Mediator was adapted
from Soutourina, 2018, to show corresponding subunits with predicted cNLSs as well as
Imp-α associations.
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3.4

Discussion

Here, I performed a general analysis of protein nuclear import and highlight several novel
and interesting observations. In general, my results extend previous findings found in
model organisms and provides evidence that nuclear import signals are absent in a major
fraction of the human nuclear proteome.
Overall, my approach used RegEx matching to identify predicted cNLSs within the human
nuclear proteome, which demonstrated that approximately 50% of nuclear proteins from
the HPA have a predictable cNLS. Importantly, these findings are based on the assumption
that each predicted cNLS is accessible to Imp-α and resides within a predicted IDR. Indeed,
many predicted cNLSs likely reside within an IDR and are non-functional. However, the
primary objective was to identify proteins without a cNLS. Applying IDR prediction to
proteins without a predictable cNLS would not provide any additional information
therefore, these assumptions were necessary for creating a high confidence, conservative
list of non-cNLS bearing nuclear proteins. Based on these findings, NLS predictions using
RegEx matching and NLStradamus suggests that somewhere between 47–63% of nuclear
proteins from the HPA do not have a predictable cNLS.
Analysis of nuclear proteins obtained through the HPA showed a large discrepancy
between the presence of predicted cNLSs (<40%) in nuclear proteins and predicted NESs
(>80%) in cytoplasmic proteins. It’s unlikely cNLS prediction is simply worse than NES
prediction, given the fact that both types of motifs have been extensively studied. Rather,
this could reflect the diversity in pathways that control protein import or export. All
proteins are translated within the cytoplasm, therefore nuclear proteins require a process to
reliably pass through the NPC, in contrast to cytoplasmic proteins that function in the same
subcellular compartment they are translated in. Interestingly, over 80% of cytoplasmic
proteins have a predictable NES, when in theory this is unnecessary. Possibly, many NESs
serve to simply export cytoplasmic proteins that may drift into the nucleus or become
localized to the nucleus upon nuclear envelope reformation after mitosis. In these instances,
it’s possible that the XPO1 pathway is responsible for dealing with these scenarios. In fact,
this line of reasoning is supported by experimental evidence suggesting XPO1-mediated
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export functions as a countermeasure to help define the nuclear and cytoplasmic
compartments (Kırlı et al., 2015).
In contrast to NESs, less than 40% of nuclear proteins have a predicted cNLS.
NLStradamus uses a relatively stringent statistical model to predict NLSs and this includes
both cNLSs and non-cNLSs that could bind Kapβs. For this reason, I also used a nonstatistical approach that uses simple RegEx matching, which likely over-predicts many
cNLSs. Paradoxically, the over-predictive nature of this approach is well suited for finding
proteins without anything resembling a cNLS. Surprisingly, RegEx matching only
identified cNLSs in 53% of nuclear proteins, whereas NLStradamus predicted cNLSs in
only 38% of proteins, which is similar to results obtained from analysis of 2163 human
nuclear proteins with NLSdb (Bernhofer et al., 2017). Based on these findings, I
conservatively estimate that at least 50% of nuclear proteins in humans do not have a cNLS.
Roughly one-third of these proteins are predicted to meet one of the requirements of a PYNLS by having a R/H/K-X2-5-PY motif. However, this is only one of the criteria of a PYNLS and the large majority of these are probably not true PY-NLSs (Soniat & Chook,
2015). Nevertheless, even if these were true PY-NLSs, this leaves a substantial portion of
the nuclear proteome without any predictable NLS. Other variants of the PY-NLS exist
that do not have the PY motif, or instead have PL in place of PY; however, only a few
examples of these exist and there is no way to determine how abundant these motifs are
within the nuclear proteome (Kressler et al., 2012; Soniat et al., 2013; Soniat & Chook,
2016).
The discrepancy between cNLS and NES prediction is also apparent in nucleocytoplasmic
proteins. Hypothetically, these proteins should possess both targeting motifs; however,
roughly only 30% contain a cNLS while ~80% have an NES (Gama-Carvalho & CarmoFonseca, 2001). Interestingly, this leaves more than 10% of nucleocytoplasmic proteins
without either a predictable cNLS or NES. In addition, up to 25% of cytoplasmic proteins
have predicted nuclear localization, as well as a putative cNLS. Although
immunofluorescent imaging is highly informative for protein localization, a single image
— or even several — only provide information at a particular point in time and context. It
is possible that at least some proteins documented as cytoplasmic have short tenures within
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the nucleus in response to a particular stress or stimulus that is not captured through tissue
culture-based experiments.
To date, cNLS prediction on human Imp-α binding partners has not been performed. In
yeast, it has been shown that 50% of Srp1 binding partners do not have a cNLS (Lange et
al., 2007). However, because these data were collected using yeast proteins in a yeast
system, indirect binding to Srp1 cannot be ruled out. Analysis of Imp-α interactors from
BioGrid and IntAct show that between 50–70% do not have a predictable cNLS. However,
whether or not these interactions are direct remains unclear. Imp-α data taken from the
HuRI database is less likely to be impacted by indirect binding, since binary interactions
of human proteins were tested in yeast, and it is less likely for yeast proteins to facilitate
human protein interactions. Using either RegEx matching or cNLS Mapper, I determined
that at least ~20% of human Imp-α interactors do not have a predictable cNLS. This raises
the possibility that a novel, as yet unidentified binding motif is responsible for a subset of
Imp-α interactions.
A widely used computational approach for identifying novel motifs is based upon the
assumption that multiple unrelated proteins that interact with the same protein are likely to
use the same, or highly similar, interaction motif (Davey et al., 2010; Gibson et al., 2015;
Neduva et al., 2005). Using proteins from the HuRI dataset without a putative cNLS, I
attempted to find a consensus motif using MEME (Bailey et al., 2009). This identified a
motif that was rich in positively charged amino acids. This motif doesn’t conform to a
typical cNLS; however, it shares important properties such as basic amino acids and
localization within predicted disordered protein regions. Using this consensus, I searched
the human proteome for the motif KxRxHxK. Interestingly, proteins with this motif are
enriched in nuclear processes and have evidence of nuclear localization. The consensus
motif identified should be taken with careful consideration, since many of the positions do
not have a clear amino acid preference. Additionally, the sequences identified in Figure 2C
may be reminiscent of importin-α C-terminal binding segment (iCBS)-NLSs, which bind
a C-terminal region of Imp-α instead of the major or minor grooves, are rich in basic amino
acids, but do not appear to conform to any regular pattern (Arjomand et al., 2014).
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Data available through resources such as IntAct and HuRI only provide a limited number
of Imp-α interactions. For example, the HuRI dataset tested each Imp-α isoform against
17,000 human ORFs, yet reported only ~250 interactions for all Imp-α isoforms combined.
These numbers are surprisingly low, considering thousands of proteins are localized to the
nucleus. This prompted us to search for additional Imp-α interactions by reanalyzing
proteomic data from mass spectrometry repositories, such as PRIDE. Here, I identified a
dataset (referred to as Nuclear Landscape) that used BioID, a proximity ligation technique
designed to capture protein interactions in situ, with Imp-α1, -α5 and -α6 (Gingras et al.,
2019; Mackmull et al., 2017). In these experiments, Imp-α was expressed as a fusion
protein with BirA* on either the N- or C-terminus. In the presence of exogenously supplied
biotin, Imp-α-BirA* will biotinylate proximal proteins in vivo, which can then be
subsequently identified through streptavidin-based affinity purification and mass
spectrometry. Since proximal and directly interacting proteins are biotinylated directly, this
approach is more sensitive to detecting piggybacking interactions than standard affinity
purification approaches, as stable interactions are not required during sample preparation.
The majority of Imp-α-associated proteins identified through this reanalysis are not
represented in the HuRI or IntAct datasets. Importantly, RegEx matching shows at least
20–25% do not have a predictable cNLS, in agreement with cNLS prediction performed
on proteins retrieved from HuRI and IntAct. Thus, this independent, experimentally based
method of detecting Imp-α-associated proteins confirms that many nuclear proteins do not
have a predicted cNLS. This may reflect piggybacking into the nucleus, since these
interactions would not necessarily be detected through binary interaction studies performed
in yeast.
Having established that many nuclear proteins and Imp-α cargo do not have a predictable
cNLS, I next wanted to identify putative piggybacking proteins. A Metascape analysis of
the cellular processes enriched with nuclear proteins without a predictable cNLS identified
the RNA polymerase II transcription initiation pathway. Within this group were many
proteins belonging to a subfamily of the nuclear receptors. Although not suspected of
piggybacking, alignment of the region located between zinc-fingers shows conservation of
an experimentally validated NLS. This NLS has been shown to be active in other nuclear
receptors like the vitamin D receptor, RXR and NR1D1/2 (Rev-Erbα/β) (Chopin-Delannoy
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et al., 2003; Hsieh et al., 1998; Prüfer & Barsony, 2002). The non-classical appearance of
this motif, and divergence from other NLSs in general, makes it interesting from a nuclear
import perspective and warrants further investigation.
Intriguingly, several proteins represented within the group of cargo without predicted
cNLSs are already known to use piggybacking and these mainly belong to the RNAPII
complex, where assembly has been shown to take place within the cytoplasm prior to
nuclear import (Boulon et al., 2010; Di Croce, 2011). Additionally, several TAF proteins
belonging to the TFIID complex were identified in this group. TAF8 and TAF10 assemble
co-translationally within the cytoplasm and shuttle into the nucleus along with TAF2
(Kamenova et al., 2019; Soutoglou et al., 2005; Trowitzsch et al., 2015). Similarly, TAF6
and TAF9, as well as TAF1 and TBP assemble co-translationally and may also piggyback
into the nucleus (Antonova et al., 2018; Kamenova et al., 2019; Patel et al., 2020). Analysis
of TAF proteins identified in my reanalysis shows that most subunits have a cNLS with a
cNLS Mapper score greater than 7, which is considered sufficient to localize EGFP to the
nucleus. This is an interesting observation, considering many of these proteins are
suspected to piggyback into the nucleus as subunits of larger multi-protein complexes.
Whether or not these cNLSs are functional or even accessible to Imp-α is unknown.
However, based on my reanalysis of the Nuclear Landscape dataset, the majority of these
subunits associate with Imp-α, suggesting some of these cNLSs may be accessible for
binding. It’s possible that pre-assembled TFIID is imported into the nucleus in a manner
where multiple pre-assembled subunits are able to independently contact Imp-α.
In contrast to RNAPII and TFIID, components of the Mediator complex have not been
reported to piggyback into the nucleus. Mediator is an evolutionarily conserved multiprotein complex composed of up to 30 subunits and is a key component of transcription
regulation (Bourbon, 2008; Soutourina, 2018). Mediator’s main function is to bridge
interactions with transcription factors at enhancer regions with transcriptional machinery
assembled at promoters (Poss et al., 2013). The composition of Mediator can be subdivided
into the head (MED6/8/11/17/18/20/22/28/30), middle (MED1/4/7/9/10/19/21/26/31), tail
(MED15/16/23/24/25/27/29) and kinase module (MED12/13, CCNC and CDK8 or
CDK19). Intriguingly, the large majority of Mediator proteins do not have a predictable
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cNLS but were still observed to associated with Imp-α according to my analysis of the
Nuclear Landscape dataset. Based on these findings, it is highly likely that Mediator
subunits utilize a piggybacking mechanism similar to that employed by RNAPII and
TFIID. Furthermore, there appears to be a trend across all Mediator modules where smaller
subunits may piggyback on their larger cNLS-bearing binding partners. Although these
smaller subunits could diffuse into the nucleus, active transport via piggybacking may
preserve stoichiometric ratios and import rates necessary for this essential function.
Furthermore, association between the smaller Mediator subunits and Imp-α clearly support
active transport and not passive diffusion. Of the individual modules, the head module may
represent a good starting point to explore piggybacking, as it had the fewest subunits with
a predicted cNLS. MED14, which links the head, middle and tail modules contains a cNLS
and could possibly nucleate piggybacking of several Mediator proteins as well (Tsai et al.,
2014).
The fact that RNAPII, TFIID and potentially Mediator use piggybacking for nuclear
localization is interesting, given that they all function in formation of the PIC. The
assembly of such multi-subunit complexes in the cytoplasm and subsequent co-transport
via piggybacking into the nucleus suggests that this may be important for their respective
functions. Transport through the NPC is rapid; however, proteins of different sizes
transport at different rates (Lolodi et al., 2016). Pre-assembled complexes can traffic at a
uniform rate and arrive at the nucleus as a complete functional unit, rather than import
individually at different rates with subsequent piece-by-piece assembly at an enhancer or
promoter.
Overall, my data highlights several interesting observations regarding nuclear transport.
Using just RegEx’s, more nuclear proteins with a predicted cNLS are identified than
previously reported. However, at least ~50% of human nuclear proteins do not have a
predictable cNLS. I also showed for the first time that at least 20% of proteins that bind a
variety of human Imp-α isoforms do not have a predictable cNLS. Taken together, many
nuclear proteins likely localize by extensive use of non-classical nuclear import pathways,
as well as by piggyback mechanisms. Analysis of nuclear proteins without cNLSs provides
additional support for piggybacking of the TFIID complex into the nucleus and suggests
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that the Mediator complex similarly piggybacks into the nucleus. Overall, these results
demonstrate the need for deeper investigation into alternative NLSs and nuclear
piggybacking mechanisms.

93

Chapter 4
4

A novel protein nuclear import-based approach for
discovery of short linear motifs

4.1

Introduction

The molecular composition and functional diversity of a cell consists of several layers that
extend far beyond that of the genome. Notably, ‘omics’-based approaches have revealed a
non-linear relationship in complexity between the genome, transcriptome, proteome and
interactome (Bludau & Aebersold, 2020). The human genome for instance, which encodes
roughly 20,000 protein-coding genes, is currently estimated to express >84,000 annotated
protein-coding transcripts (Frankish et al., 2019). At the proteomic level, the number of
proteoforms easily increases into the hundreds of thousands considering the number of
possible PTMs and additional sources of protein variation (Aebersold et al., 2018). Most
importantly, how these proteins interact with one another to make a network, or
interactome, is a fundamental attribute underlying the complexity of biological organisms.
Efforts in characterizing the human protein interactome, such as through the HuRI, has
produced a map of over 60,000 binary PPIs (Luck et al., 2020). Similarly, the most recent
update from the Bioplex Interactome project now includes nearly 120,000 PPIs from
roughly 15,000 human proteins (Huttlin et al., 2015). Importantly, these efforts also reveal
that our understanding of the protein interactome is still within its infancy given that
statistical estimates suggest there are roughly 650,000 PPIs (Stumpf et al., 2008).
Historically, PPI studies have been dominated by globular protein domains, which form
stable, well-folded tertiary structures. More recently however, it has become clear that
protein functionality can exist independent of structure. Roughly one-third of the human
proteome is intrinsically disordered and yet despite being the smaller fraction, this is where
much of the proteomes signalling information is routed via events such as PTMs and PPIs
(Darling & Uversky, 2018; Iakoucheva et al., 2004; Van Roey et al., 2014). The most
common functional units found within IDPRs are stretches of short amino acid sequences,
often less than 10 amino acids in length, known as SLiMs (Davey et al., 2012). Within a
typical SLiM, only a few amino acids are necessary for function. This makes SLiMs
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evolutionarily plastic, and likely explains why they are essential for both cellular and viral
protein function (Davey et al., 2011; Hu et al., 2017). According to the ELM resource,
whose aim is to catalogue experimentally verified SLiMs, there are over 3500 motif
instances, spanning a wide range of cellular processes (Kumar et al., 2020).
In contrast to studying stable PPIs between two globular protein domains, interactions
mediated through SLiMs are often transient in nature, making them much less amenable to
experimental discovery (Davey et al., 2012; Gibson et al., 2015). In light of these
difficulties, it’s anticipated that roughly 100,000 SLiMs (not including PTMs) may reside
within the human proteome, presenting a large discrepancy between the number of
currently identified and predicted SLiMs (Tompa et al., 2014). This incongruity highlights
an important need for high-throughput SLiM discovery approaches. Indeed, several SLiM
discovery methods employing bioinformatic and experimental approaches have been
utilized to great success (Neduva et al., 2005). However, computational power cannot be
fully realized when so few of the predicted motifs have been identified, further
emphasizing the need for high-throughput experimental approaches to identify novel
functional SLiMs.
Experimental approaches such as protein/peptide arrays, phage display of peptides derived
from disordered regions of the human proteome (ProP-PD) or spectrally encoded beads
presenting peptides (MRBLE-pep) allow for high-throughput screening of peptides that
can bind a specific protein domain (Davey et al., 2017; K. Meyer & Selbach, 2020; Nguyen
et al., 2019). These approaches employ a “one-vs-many” framework, where one protein
domain is screened against a library of peptides. Given that thousands of protein domain
families exist within the human proteome a “one-vs-many” model is not well suited to
address these questions on a larger scale (El-Gebali et al., 2019). More recently, an
approach termed protein interaction screen on peptide matrix (PRISMA) allows for “manyvs-many” peptide-protein interaction screens (Dittmar et al., 2019). This approach
significantly increases throughput compared to previously established methods. However,
only a few hundred different peptides have been tested so far, and like peptide/proteinarrays these experiments are carried out in vitro. Based on these limitations, I have
developed a novel “many-vs-many” approach using the model organism S. cerevisiae. This
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system exploits the cellular protein nuclear import pathway and is built on the assumption
that if a peptide can mediate nuclear import, or interact with a nuclear protein, it can be
genetically selected for and identified.
Transport across the nuclear envelope occurs exclusively through the NPC (Wente & Rout,
2010). This process is highly regulated and uses a group of proteins called karyopherins,
which have the unique ability to shuttle proteins through the NPC (Christie et al., 2016;
Otsuka et al., 2008). The most well-defined transport pathway is the highly conserved
classical nuclear import pathway, which is facilitated by the karyopherin proteins Imp-α
and Imp-β1 (Goldfarb et al., 2004b; Lange et al., 2007). Yeast express a single Imp-α
(Srp1) while humans express 7 different isoforms, all of which bind Imp-β1 through their
IBB domain (Lott & Cingolani, 2011; Pumroy & Cingolani, 2015). Imp-α recognizes a
protein’s NLS, a class of SLiM characterized by one (monopartite) or two (bipartite)
clusters of basic amino acids. These NLSs are formally known as cNLSs. Following cNLS
recognition, the Imp-α-cNLS complex is transported through the NPC via Imp-β1
(Moroianu et al., 1995). Although other karyopherin-mediated import pathways exist, the
classical pathway is widely accepted to be responsible for the majority of protein nuclear
import (Christie et al., 2016; Lange et al., 2007). Interestingly, however, many nuclear
proteins do not have predictable cNLSs, yet still bind Imp-α in yeast and human cells.
These observations suggest that alternative pathways such as piggybacking, or novel
SLiMs which could facilitate nuclear import, are present (Lange et al., 2007; Tessier et al.,
2020).
Based on these observations, I designed a selection-based assay in yeast that exploits
protein nuclear import to identify novel SLiMs. Here, randomly generated peptides are
selected for their ability to either mediate nuclear import or possibly bind a nuclear protein
and enter the nucleus via a “piggybacking” mechanism. To enrich selection for non-cNLS
motifs, peptides are generated based on a semi-degenerate codon library that eliminates
arginine and most lysine codons. This novel “many-vs-many” approach is unique since it
allows for high throughput testing of peptides against the yeast nuclear proteome in a
functional, in vivo setting.
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4.2

Material and Methods

4.2.1 Yeast culture, transformation and β-galactosidase assay
Prior to transformation, yeast (Table 4.1) were streaked onto plates containing standard
YEP media (yeast extract, peptone and 2% glucose) and grown at 30°C until individual
colonies became fully visible. A single colony was chosen and grown overnight in YEP
liquid culture at 30°C. The following morning, cultures were diluted if overgrown,
allowing them to grow until reaching an OD600 between 0.5 and 1. For a single
transformation, 1 mL of overnight culture was washed in 1 mL of sterile double distilled
water (ddH2O) and resuspended in 100 mM lithium acetate; which was then incubated at
30°C for 5 minutes. Yeast were pelleted and resuspended in 50 μL ddH2O before adding a
solution containing 240 μL of 50% polyethylene glycol (PEG) 3350, 36 μL of 1 M lithium
acetate, 25 μL of 2 mg/mL salmon sperm DNA, and 100–500 ng of plasmid (see Table 4.2
for list of plasmids used in this chapter). This mixture was vortexed and incubated at 42°C
for 30 minutes. Following incubation, yeast were pelleted and resuspended in 100 μL
ddH2O and plated on appropriate synthetic drop-out (SD) media containing 2% glucose.
For the Gal4 repression assays, W303-1A yeast were transformed with 100–500 ng of both
a Gal4 responsive lacZ reporter plasmid (JMB1404) and Gal4DBD peptide fusions and
plated on SD media containing glucose and grown at 30°C until colonies were large enough
to pick (1-2 mm). The selected colonies were grown overnight at 30°C in SD media
containing 2% raffinose. The following morning yeast cultures were diluted 1:5 into fresh
SD media with raffinose and then supplemented with galactose (0.25% final concentration)
for 4 hours to induce endogenous Gal4 expression.
For β-galactosidase assays, transformed yeast colonies were picked and grown overnight
in 5 mL of appropriate liquid culture at 30°C on a rotating drum. The following morning,
OD600 values were recorded for yeast cultures and if necessary, cultures were diluted to an
OD600 between 0.2–0.4 and allowed to grow until values were between 0.5–1.0. For each
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Table 4.1 Yeast strains used in this chapter.
Strain
L40
W303-1A

Genotype
MATa leu2 his3 trp1 ade2 GAL4 gal80
LYS2::(lexAop)4-HIS3 URA3::(lexAop)-lacZ

Purpose
pNIA2 nuclear import

MATa leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his311,15

Gal4 repression assay
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Table 4.2 Plasmids used in this chapter.
Clone

Vector

Description

LexA-Gal4 (2μ)

pNIA (Rhee et
al., 2000)
pNIA
pNIA
pNIA (Marshall et
al., 2007)
pNIA (Marshall)
pNIA (Marshall)

Original vector obtained for Rhee et al., 2000

LexA-Gal4-MBP (2μ)
LexA-Gal4 TAg NLS (2μ)
LexA-Gal4 (CEN)
LexA-Gal4-MBP (CEN)
LexA-Gal4 TAg NLS (CEN)
pNIA2

Backbone created by Marshall et al., 2007 for
expressing pNIA in a low copy CEN plasmid

Reassembled pNIA system used for expressing
peptides internally

pNIA2-TAg NLS (Internal)
pNIA2-TAg NLS (C-terminal)
pNIA2-E1A NLS (Internal)
pNIA2-E1A NLS (C-terminal)
pNIA2-NP
pNIA2-cMYC
pNIA2-Tat
pNIA2-SGSG
pNIA2-AIR2
pNIA2-PAP2
pNIA2 NM1–34

pNIA2
pNIA2
pNIA2
pNIA2
pNIA2
pNIA2
pNIA2
pNIA2
pNIA2
pNIA2
pNIA2

Gal4DBD
Gal4DBD NM1–34

pAS1
pAS1

Gal4DBD-E1A (1-82)
Gal4DBD-E1A (1-29)
Gal4DBD-TAg NLS
lacZ reporter

pAS1
pAS1
pAS1

EGFP

pEGFP-C2

Human cMYC NLS
HIV-1 Tat protein NLS
Serine-glycine (SG) linker

Isolated plasmid from pNIA2 screen, with
peptides.
Peptides from pNIA2 selection cloned onto
Gal4DBD
Transactivation positive control
Transactivation negative control
Used in Gal4 repression assay, contains 5 Gal4
binding sites. Acquired from Dr. Chris Brandl.
Multiple cloning site of EGFP (JMB925) has
been adjusted so BamHI is in-frame.
NLS from simian virus 40 large T antigen
NES from HIV-1 Rev

EGFP TAg NLS
pEGFP-C2
EGFP Rev NES
pEGFP-C2
EGFP NM-9
pEGFP-C2
EGFP NM-34
pEGFP-C2
FLAG-Imp-α1
pcDNA3
FLAG-Imp-α3
pcDNA3
FLAG-Imp-α5
pcDNA3
NLS (nuclear localization signal); NES (nuclear export signal); 2μ (high copy); CEN (low copy)
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β-galactosidase experiment, 500 μL of liquid culture was pelleted and resuspended in 1 mL
Z-buffer (60 mM Na2HPO4•7H2O, 40 mM NaH2PO4•H2O, 10 mM g KCl, 0.1 mM,
MgSO4•7H2O, in dd H2O). β-mercaptoethanol (BME) (27 μL BME per mL Z-buffer) was
added fresh to the appropriate amount of Z-buffer before use. Next, 20 μL each of 0.1%
SDS and chloroform were added to each sample, vortexed for 30 seconds and incubated at
30°C for 15 minutes. Following incubation, 200 μL of ortho-nitrophenyl-β-galactoside
(ONPG; 4 mg/ml diluted in Z-buffer with BME) was added, samples were vortexed for 30
seconds and incubated at 30°C until samples developed a visible yellow colour. At this
point, time (minutes) was recorded and 500 μL of 1 M sodium carbonate was added to stop
the reaction, samples were centrifuged at max speed for 5 minutes and OD420 was recorded
using 200 μL of each sample’s supernatant. β-galactosidase activity was expressed in
Miller units using the formula:
𝑀𝑖𝑙𝑙𝑒𝑟 𝑢𝑛𝑖𝑡 = 1000 ∗

OD420
OD600 ∗ volume (ml) ∗ time (min)

4.2.2 Plasmid construction
Construction of pNIA2 followed the same methods used to build pNIA (Marshall et al.,
2007). However, MBP was cloned onto the C-terminus of a LexADBD-Gal4AD recombinant
protein. Positive control NLSs (TAg, E1A, cMYC, NP and Tat) and negative control
peptides (AIR2, PAP2, SGSG) were cloned into pNIA2 using self-annealed
oligonucleotides with EcoRI compatible overhangs (Table 4.3).
For Gal4 repression assays and EGFP immunofluorescence, the region encoding peptides
selected for in pNIA2 were amplified using forward (Fw) and reverse (Rv) NHS BamHI
primers (Table 4.4) PCR products were gel purified and digested with BamHI and cloned
into the same sites of Gal4DBD and EGFP. This produces Gal4DBD and EGFP C-terminal
peptide fusions with flanking SGSG linkers.

4.2.3 Yeast plasmid isolation and western blotting
Plasmid isolation from yeast was performed using the “smash and grab” method (Robzyk
& Kassir, 1992). From the yeast cultures grown for β-galactosidase assays, 2 mL was
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Table 4.3 Self-annealing oligonucleotides used in this chapter.
Oligonucleotide

Sequence

Amino acid (motif)

TAg NLS

AATTGTCTGGATCAGGTCCTCCAAAAAAGAAGAGAAAGGTATC
AGGATCTGGTC
AATTGTCTGGATCAGGTCTGTCTTGTAAACGCCCCAGGCCATC
TGGATCAGGAC
AATTGTCTGGATCAGGTCCGGCGGCCAAAAGGGTGAAATTAG
ATTCTGGATCAGGTC
AATTGTCTGGATCAGGTTCAGGTC

PPKKKRKV

E1A NLS
cMYC NLS
SGSG linker
Tat NLS
Nucleoplasmin NLS
AIR2
ELM accession
ELMI002850
PAP2
ELM accession
ELMI002849

AATTCTCTGGATCAGGTAGGAAGAAGCGGAGACAGCGACGAA
GATCTGGATCAGGTG
AATTCTCTGGATCAGGTGCTGTTAAAAGACCAGCTGCAACTAA
AAAGGCAGGTCAAGCTAAAAAGAAGAAATTGGATTCTGGATCA
GGTG
AATTCTCTGGATCAGGTTTAAGAGCTCTTAGAGGGCAGGGTA
GATATTTTGGCGTAAGCGATGATGACAAGGATGCCTCTGGATC
AGGTG
AATTCTCTGGATCAGGTACATATATCACTGTCTCTAGCGAAGA
TGATGATGAAGATGGATATAATCCTTATACCCTTTCTGGATCA
GGTG
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LSCKRPRP
PAAKRVKLD
SGSGSG
RKKRRQRRR
AVKRPAATKKAGQAKKKKLD
LRALRGQGRYFGVSDDDKDA

TYITVSSEDDDEDGYNPYTL

Table 4.4 Primers used in this chapter.
Primer

Sequence

NHS Ultramer

TGAAGGGCTGGCGGTTGGGGTTATTCGCAACGGCGACTGGCTGGAATTCT
CTGGATCAGGTNHS(x10)TCTGGATCAGGTGAATTCAATTTTAATCAAAGTGG
GAATATTGCTGATAGCTCATTGTC

Fw Ultramer

TGAAGGGCTGGCGGTT

Rv Ultramer

GACAATGAGCTATCAGCAATATTCCC

Fw NHS
BamHI
Rv NHS
BamHI

AACGGCGACTGGCTGGGATCCTCT
TATTCCCACTTTGATTAAAATTGGATCCACC
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Description

Used to amplify NHS Ultramer

PCR NHS codons from pNIA2
with BamHI site

pelleted and resuspended in 100 μL STET (8% sucrose, 50 mM Tris-HCl pH 8, 50 mM
EDTA, 5% Triton X-100) and an equal volume of acid washed glass beads
(MilliporeSigma; G8772). Samples were vortex for 30 seconds, followed by 30 seconds on
ice, ten times. An additional 100 μL of STET was added and samples were vortexed for an
additional 30 seconds before incubation in a 95°C heat block for 5 minutes. Samples were
cooled briefly on ice and centrifuged at max speed in a microcentrifuge for 10 minutes at
4°C. One hundred μL of supernatant was added to 200 μL of cold 95% ethanol, vortexed
and incubated on ice for 2 minutes. DNA was pelleted by centrifuging samples at 4°C for
15 minutes at max speed. Supernatant was removed and the pellet was rinsed with 200 μL
of cold 70% ethanol. Finally, samples were dried at room temperature, resuspended in 20
μL ddH2O and transformed into competent DH5α E. coli.
For western blot analysis of protein extracts from yeast, the appropriate amount of liquid
culture was used that corresponded to an OD600 of 0.5 per mL. For example, if liquid
cultures were measured to have an OD600 of 1.0, then 500 μL would be used for lysis since
diluting 500 μL in 1 mL would produce an OD600 of 0.5. This process ensured a relatively
equal number of cells were used for each protein preparation. Next, protein was isolated
according to the method outlined by von der Haar, 2007 (von der Haar, 2007). In brief,
cells were resuspended in 200 μL lysis buffer (0.1 M NaOH, 0.05 M EDTA, 2% SDS, 2%
BME) and heated at 95°C for 10 minutes. Next, 5 μL of 4 M acetic acid was added to each
sample and vortexed for 30 seconds before heating to 95°C for an additional 10 minutes.
Cells were then pelleted, and supernatant was transferred to a fresh tube containing 50 μL
loading buffer (0.25 M Tris HCl pH 6.8, 50% glycerol, 0.05% bromophenol blue).

4.2.4 Ultramer™ amplification and peptide selection with pNIA2
Random peptides were generated from oligonucleotide Ultramers™ (Integrated DNA
Technologies) that contained 10 NHS codons, where N = any base, H = A, C, or T and S
= G or C (Table 4.5). When synthesized, each individual oligonucleotide will have a region
with 10 random codons. Ultramers were amplified by standard PCR using 2 μL NHS
Ultramer (2 μM) and 2 μL forward and reverse Ultramer primers (5 μM each) in 50 μL
total
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Table 4.5 NHS codon table.
Amino acid

Codons (unavailable codons are crossed out)

Alanine

GCT GCC GCA GCG

Arginine

CGT CGC CGA CGG AGA AGG

Asparagine

AAT AAC

Aspartic acid

GAT GAC

Cysteine

TGT TGC

Glutamic acid

GAA GAG

Glutamine

CAA CAG

Glycine

GGT GGC GGA GGG

Histidine

CAT CAC

Isoleucine

ATT ATC ATA

Leucine

CTT CTC CTA CTG TTA TTG

Lysine

AAA AAG

Methionine

ATG

Phenylalanine

TTT TTC

Proline

CCT CCC CCA CCG

Serine

TCT TCC TCA TCG AGC AGT

Threonine

ACT ACC ACA ACG

Tryptophan

TGG

Tyrosine

TAT TAC

Valine

GTT GTC GTA GTG

Stop codon

TAA TAG TGA
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reaction volume using Phusion DNA polymerase (New England Biolabs). Samples were
denatured for 1 min at 98°C for 1 min, followed by 20 cycles of 98°C/60°C/72°C for 8
seconds each and a final extension stage of 2 minutes. Ten PCR reactions were done in
parallel and amplification products were pooled. For expression of random peptides in
pNIA2, 1 mL of L40 yeast (OD600 = 0.8) were transformed with 400 ng of EcoRI digested
pNIA2 and 64 ng amplified NHS Ultramer. This corresponds to an 8:1 molar ratio of
Ultramer to pNIA2. Yeast were plated directly onto SD media lacking leucine and
histidine.

4.2.5 Human cell lines, cell culture, and transfections
Human HT-1080 cells (purchased from the American Type Culture Collection) were
grown at 37°C with 5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM; Wisent)
supplemented with 1% penicillin/streptomycin (Wisent) and 10% FBS (Wisent).
Transfections of DNA into HT-1080 cells was done using X-tremeGENE HP (Roche)
using a 2:1 ratio of X-tremeGENE HP per μg of DNA.

4.2.6 Immunofluorescent microscopy
HT-1080 cells were seeded onto glass cover slips prior to transfection. Following
transfection, cells were ﬁxed in 3.7% paraformaldehyde at room temperature for 20
minutes, permeabilized on ice using 0.2% Triton X-100, and blocked using 3% BSA in
PBS. Samples were incubated with rabbit α-EGFP for 1 hour at room temperature, washed
three times for 5 minutes in PBS, followed with 30 minutes at room temperature with
secondary antibody (Alexa Fluor 488; Life Technologies), and finally another three 5
minute washes in PBS (For a list of primary antibodies used in this chapter see Table 4.6).
Cover slips were then mounted on glass slides using ProLong™ Gold Antifade Mountant
with DAPI (Thermofisher). Confocal images were taken with a Nikon Eclipse Ti2 under
60x magnification using the NIS Elements acquisition software.

4.2.7 Nuclear fractionation and quantification
HT-1080 cells were seeded onto 10 cm plates in triplicate and transfected the following
day when cells reached approximately 80% confluency. Eighteen to 24 hours after
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Table 4.6 Primary antibodies used in this chapter.
Reactivity
(clone)

Purpose

Description

Supplier

Product number

LexA
HA (3F10)
G6PD
EGFP
FLAG (M2)
FLAG (M2)
Lamin A/C
Tubulin (DM1A)

Western
Western
Western
IF, Western
Western
IP
Western
Western

Rabbit polyclonal
Rat monoclonal
Rabbit polyclonal
Rabbit polyclonal
Mouse monoclonal
Mouse monoclonal
Rabbit polyclonal
Mouse monoclonal

MilliporeSigma
MilliporeSigma
MilliporeSigma
Takara (Living Colors)
MilliporeSigma
MilliporeSigma
Proteintech
MilliporeSigma

06-719
11867423001
A9521
632592
F1804
M8823
10298-1-AP
T9026
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transfection cells were harvested for isolation of nuclear and cytoplasmic compartments
using the REAP method (Suzuki et al., 2010). First, cells were pelleted at 10,000 rpm in a
microcentrifuge for 30 seconds and resuspended in 900 μL lysis buffer (0.1% NP40 in
PBS). From here, 300 μL was collected and labelled as whole cell extract (WCE). Samples
were immediately centrifuged and 300 μL of supernatant was collected and labelled as
cytoplasm. The remaining supernatant was aspirated, and pellets were resuspended in 1
mL lysis buffer. Samples were centrifuged once again, the supernatant was aspirated and
the pellet was resuspended in 150 μL 1X LDS sample buffer (Thermofisher) and labelled
as nuclear. Importantly, each resuspension step involved slowly pipetting up and down
exactly ten times. This ensured that pellets were fully resuspended in a time efficient
manner. Fifty μL of WCE and cytoplasm were mixed with 50 μL 2X LDS sample buffer.
WCE and nuclear fractions were sonicated using the Bioruptor Pico (Diagenode) set to 4
cycles of 30 seconds on/30 seconds off at 4°C. Finally, all samples were boiled for 2
minutes and 12 μL nuclear, 18 μL cytoplasmic, and 18 μL WCE (corresponding to a
roughly 2:1:1 ratio of extract) was used for loading samples on protein gels.

4.2.8 Co-immunoprecipitation and western blotting
Transfected HT-1080 cells from 10 cm plates were collected and lysed in 500 μL NP-40
lysis buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.4, 1 mM EDTA, 1 mM EGTA, 0.1%
NP-40, 10% glycerol) supplemented with protease inhibitor cocktail (MilliporeSigma,
P8340) and sonicated as described above. Two percent of sample was kept for use as input
control. Co-immunoprecipitation reactions were carried out at 4°C for 4 hours in lysis
buffer using 20 µl of washed magnetic FLAG beads (MilliporeSigma, M8823). Samples
were washed twice in 1 mL lysis buffer (no protease inhibitor) and boiled in 25 µL of 2X
LDS sample buffer (Thermofisher, NP0007) supplemented with DTT (0.2 M final), for 5
minutes.
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4.3

Results

4.3.1 Construction of a yeast-based protein nuclear import assay
Previously, the Mymryk laboratory modified and enhanced a yeast-based system for
measuring nuclear import activity of proteins and/or specific regions within a protein of
interest (Marshall et al., 2007; Rhee et al., 2000). This system, referred to as pNIA, utilizes
plasmid-based expression of a recombinant protein consisting of the LexA DNA-binding
domain (DBD) and maltose binding protein (MBP) from E. coli, and the S. cerevisiae Gal4
transcriptional activation domain (Gal4AD), from N- to C-terminus, respectively (Figure
4.1A). Here, pNIA refers to both the plasmid vector and recombinant protein expressed
from it. Importantly, this system is designed to work in the S. cerevisiae L40 yeast strain,
which contains a genomic HIS3 selectable marker and lacZ reporter that are both under the
control of a LexA responsive promoter. Together, these features allow for the selection and
quantification of nuclear import, respectively. With the addition of MBP, pNIA is greater
(~80 kDa) than the passive diffusion limit of the NPC and unable to enter the nucleus;
therefore, nuclear import and subsequent activation of expression of lacZ only results by
fusing a nuclear targeting signal onto the C-terminus of pNIA.
The pNIA system was initially designed to test larger protein segments of known sequence
for their ability to direct nuclear import; therefore, to make this system suitable for
screening short random peptides several adjustments were necessary. The first adjustment
involved identifying a putative location for expressing peptides. Using IUPred2A to predict
IDPRs, it was determined that placing LexA in frame with the Gal4AD created a region of
predicted disorder within the linker region connecting these domains (Figure 4.1B). The
second adjustment was to relocate MBP to the C-terminus to preserve the overall size. To
reflect these modifications, I have renamed this system pNIA2. Importantly, since the
peptides to be expressed and tested are randomly generated, occurrences of stop codons
and cleavage sites would result in expression of truncated motifs in the context of pNIA.
Therefore, when expressed internally the presence of a stop codon or cleavage site should
prevent pNIA2-mediated reporter gene expression due to the absence of the Gal4AD.
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Figure 4.1 Construction and testing of pNIA2.
A) Depiction of the recombinant protein, pNIA, that was previously developed by Marshall
et al, 2007. Only in the nucleus can pNIA bind and activate reporter gene expression via
the LexA DBD and a Gal4AD. The addition of MBP increases the size of pNIA (~80 kDa)
to prevent diffusion into the nucleus. B) pNIA was reorganized to express candidate test
peptides internally and renamed pNIA2. The IUPred2A disorder prediction program shows
a region of predicted disorder between the LexA DBD and Gal4AD where peptides could
likely be expressed with minimal influence by the structures of the adjacent LexA DBD
and Gal4AD. C) Reconstruction of pNIA2 shows that expression from a low copy CEN
plasmid and the addition of MBP significantly decreases background β-galactosidase
activity compared to expression from a high copy 2μ plasmid. When expressed with the
SV40 TAg cNLS, pNIA2 nuclear import activity increase over 100x compared to pNIA2
without an NLS. D) To assess potential positional effects of NLSs expressed in pNIA2, I
tested the HAdV-C5 E1A cNLS and SV40 TAg cNLS, which are natively located Cterminally and internally, respectively. Both NLSs function in either position in pNIA2;
however, they work best when expressed in a location similar to their natural position. E
and F) Several NLSs (E) and non-NLSs (F) were expressed in pNIA2 to determine
specificity for nuclear localization signals. NLSs tested included a bipartite cNLS (NP),
two monopartite cNLS (SV40 TAg and HAdV-C5 E1A) and a non-cNLS (HIV-1 Tat), all
of which produced significant nuclear import activity. Non-NLS motifs, including an
SGSG linker, did not show significant nuclear import activity compared to pNIA2.
Experiments were performed in triplicate and results were analyzed using a one-way
ANOVA and Dunnett’s multiple comparisons test where each NLS/peptide was compared
to pNIA2.
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Initially, I built this system into a high-copy-2μ based shuttle plasmid. However, high-level
expression of just the LexA-Gal4AD fusion from this backbone resulted in significant
background activity. The addition of MBP minimally decreased this background activity
and the addition of the strong and well characterized SV40 large TAg monopartite cNLS,
PKKKRKV, resulted in only a modest, 1.6 fold increase in activity compared to the MBP
construct (Figure 4.1C).
Expressing the pNIA2 cassette from a low-copy CEN shuttle plasmid showed much lower
activity overall compared to the 2μ-based expression system. Importantly, the addition of
MBP to LexA-Gal4AD reduced background activity to nearly undetectable levels and when
expressed with the SV40 TAg cNLS, activity increased over 100-fold (Figure 4.1C). These
results demonstrate that combining expression from a low copy plasmid and the addition
of MBP to limit diffusion through the NPC creates a system with minimal background and
high sensitivity necessary for identifying SLiMs that confer nuclear localization.
The region within a given protein sequence where an NLS may reside is not restricted to
any particular area. Based on this, I next evaluated if positional effects could influence
NLS activity when expressed in pNIA2. To evaluate this, I compared the SV40 TAg cNLS,
representing an internally derived motif, and the well-studied human adenovirus 5 (HAdVC5) E1A cNLS (LCSKRPRP), a motif located at the extreme C-terminus of E1A. Both
cNLSs were expressed internally within pNIA2, as well as on the C-terminus, and
respective nuclear import activity measured (Figure 4.1D). As expected, both cNLSs
performed well when expressed in a position that reflected their native locations. When
expressed in the alternative positions, nuclear import activity was significantly lower;
however, cNLS activity for both motifs was still easily detectable compared to pNIA2
control vector lacking any NLS. These findings indicate that the linker between the LexA
DBD and the Gal4AD of pNIA2 is a suitable position to test motifs from both internal and
C-terminal derived motifs. Importantly, pNIA2 is sensitive enough to detect established
motifs like the E1A cNLS even when localized within a suboptimal position.
In order to test the specificity of pNIA2 to detect nuclear import activity of peptides
conferring nuclear import, I expressed a range of experimentally validated cNLSs within
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pNIA2 and tested their respective nuclear import activity by β-galactosidase assay (Figure
4.1D). In addition to the TAg cNLS, I tested the bipartite NP ( KRPAATKKAGQAKKKK)
and monopartite cMYC (PAAKRVKLD) cNLS (Dang & Lee, 1988; Robbins et al., 1991).
Each cNLS tested demonstrated significant nuclear import activity compared to pNIA2
control (Figure 4.1E). Interestingly, the HIV-1 Tat protein NLS (RKKRRQRRR), is a noncanonical NLS that binds Imp-β1 directly, bypassing Imp-α (Truant & Cullen, 1999). S.
cerevisiae express several different Imp-β proteins that are conserved in humans. Since the
Tat NLS can mediate nuclear import, this further reinforces the high degree of conservation
of nuclear import across eukaryotes. These results demonstrate that different cNLSs
function when expressed in pNIA2 and that this system is also sensitive enough to detect
non-classical nuclear import pathways.
So far, only well characterized NLSs I expected to work had been tested and it remained
unclear whether or not pNIA2 is specific to nuclear import. To test this, I expressed several
other irrelevant, non-NLS SLiMs, as well as a comparably sized serine-glycine linker
(SGSG) (Figure 4.1F). Yeast derived SLiMs, from proteins AIR2 and PAP2, that have no
relation to nuclear import were also chosen from the ELM resource and expressed in
pNIA2. Neither PAP2, AIR2, nor the SGSG linker showed significant nuclear import
activity (Figure 4.1E and F). Lack of nuclear import activity from these motifs is not due
to lack of protein expression, as each motif was comparably expressed. Taken together,
these results demonstrate that the pNIA2 system appears selective for peptides with the
ability to mediate nuclear import.

4.3.2 Selection of peptides conferring nuclear import using pNIA2
Having established pNIA2 can reproducibly detect nuclear import mediated by multiple
different NLSs, I next extended this system to develop a selection for random peptides
conferring nuclear import in the L40 yeast strain. I took advantage of yeast homologous
recombination to recombine a duplex DNA fragment containing randomly synthesized
codons into the linker region between the LexA DBD and Gal4AD (Figure 4.2A). Using
standard PCR, DNA fragments were amplified from an oligonucleotide Ultramer
containing 10 codons designated NHS. Additionally, I flanked both ends of the NHS codon
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Figure 4.2 Outline of peptide selection with pNIA2.
A) NHS Ultramers have homology to the LexA DBD-Gal4AD linker region within pNIA2,
allowing for recombination when co-transformed into L40 yeast. Since pNIA2 carries the
LEU2 marker, successful recombinants can be selected for on media lacking leucine. When
expressed, the pNIA2 fusion protein will contain an in-frame fusion of 10 random amino
acids flanked with an SGSG linker on both sides. B) The first step in selecting for peptides
involves co-transforming L40 yeast with linearized pNIA2 and amplified NHS Ultramer.
pNIA2 is digested with EcoRI, which cuts specifically between the LexA DBD and
Gal4AD. C) Transformed yeast are plated onto media without leucine and histidine and
supplemented with 10 mM 3-AT to increase the stringency of HIS3 selection. If a random
peptide confers nuclear localization, pNIA2 will activate expression of HIS3 allowing
growth on selective media. D) Yeast which have been directly selected for on media
lacking leucine and histidine undergo two sequential β-galactosidase assay screens for
nuclear import activity. The first screen directly tests yeast which have undergone selection
for nuclear import on media lacking leucine and histidine. After this screen plasmids are
isolated, sequenced, and retransformed into L40 and grown under non-selective conditions
(media contains histidine). These yeasts are used for a secondary nuclear import activity
screen to identify statistically significant peptides. E) Background activity was sampled by
randomly picking L40 yeast with recombined pNIA2 and NHS Ultramer which and have
not undergone selection for nuclear import on media lacking histidine. pNIA2-NHS was
compared to pNIA2 using the Welch’s t test (p < 0.05). F) To determine if this approach
selects for nuclear import, L40 yeast were transformed with either pNIA2, a 10:1 mixture
of pNIA2 and pNIA2-TAg, or pNIA2-TAg. Yeast were grown directly in liquid culture
and passaged twice, measuring nuclear import activity by β-galactosidase activity after
each passage. After the second passage the pNIA2/pNIA2-TAg samples showed similar
activity to pNIA2-TAg, indicating nuclear import is being selected for. Experiments were
done in triplicate and analyzed using a one-way ANOVA and Tukey multiple comparison
test (p < 0.05).
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region with SGSG-linkers to avoid potential accessibility issues and 60 nucleotides of
homologous flanking sequence corresponding to the LexA DBD and Gal4AD region of
pNIA2. Since this system utilizes nuclear import, I also developed a strategy to minimize
the occurrence of motifs representing cNLSs, as this pathway is the predominant protein
nuclear import pathway and would likely be overrepresented during selection. To
overcome this, I specifically used oligonucleotide templates with NHS codons (NHS
Ultramer) where: N = any base, H = A, C, or T and S = G or C. This eliminates codons
representing the amino acids arginine, cysteine, glycine and tryptophan while also limiting
the occurrence of lysine codons (Table 4.5). This approach effectively eliminates the
possibility of motifs to arise that represent a cNLS, while maintaining many of the codons
for nearly all other amino acids. Another benefit of this strategy is that 2 of the 3 possible
stop codons are also eliminated.
Transformation of yeast using a pool of amplified NHS Ultramer and linearized pNIA2
will trigger gap repair and the resulting recombination will generate yeast colonies
expressing a pNIA2 protein with a unique 10 amino acid sequence insert between the LexA
DBD and Gal4AD (Figure 4.2B and C). Successful recombinants were selected using media
lacking leucine, as the pNIA2 plasmid contains a LEU2 selectable marker. To select for
successful recombinants with peptides mediating nuclear import, yeast were grown on
media lacking both leucine and histidine (Figure 4.2C). Only if pNIA2 can enter the
nucleus will it drive expression of the genomically integrated HIS3 and lacZ reporter
cassettes.
Yeast selected for based on pNIA2 nuclear import underwent a primary and secondary
activity screen that measures nuclear import by β-galactosidase assay (Figure 4.2D). At
this stage, pNIA2 plasmid could be easily isolated from corresponding yeast cultures and
sequenced to determine the amino acid sequence encoded by the random NHS region.
Since primary nuclear import activity is derived from a single colony, biological replicates
cannot be tested appropriately. Additionally, the pNIA2 negative control cannot grow on
media lacking histidine. Therefore, to resolve this issue the sequenced pNIA2 plasmids
were transformed back into L40 yeast and grown on media lacking only leucine. This
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additional step avoids any selective pressure that nuclear import may impose when grown
on media lacking both leucine and histidine, reflecting nuclear import activity more
accurately.
To detect if homologous recombination introduced any obvious background activity, L40
yeast were first transformed with amplified NHS Ultramer and linearized pNIA2 and
grown under non-selective conditions (media containing histidine, but lacking leucine).
Twenty colonies from the NHS-transformed group of yeast were chosen at random and
compared to pNIA2 control for nuclear import activity using β-galactosidase assays
(Figure 4.2E). Overall, no statistical differences were observed; however, several
individual colonies chosen from the NHS transformed group displayed slightly higher
activity that would still be considered background based on previous experiments using the
SGSG linker alone.
To demonstrate if the conditions selective for nuclear import actually select for peptides
capable of mediating nuclear import, L40 yeast were transformed with plasmid
corresponding to either pNIA2, pNIA2-TAg cNLS and a 10:1 mixture of pNIA2 and
pNIA2-TAg cNLS. Transformed yeast were grown directly in liquid culture and passaged
twice, consecutively, from non-selective to selective media (without histidine) with nuclear
import activity being measured after each passage (Figure 4.2F). Following the first
passage, the mixture of pNIA2/TAg showed roughly 25% of the activity of pNIA2-TAg
alone. However, after a second passage the pNIA2/TAg mixture had nearly equal activity
to that of pNIA2-TAg, indicating that yeast expressing pNIA2-TAg cNLS are being
selected for under these growth conditions. Taken together, these results demonstrate that
the pNIA2 system produces minimal background when tested under non-selective
conditions for nuclear import and that when placed under selective pressure pNIA2
containing inserts that confer nuclear import can be effectively selected for.

4.3.3 pNIA2 selects for novel peptide motifs conferring nuclear
import
Using my outlined pNIA2 selection protocol, I next performed a small-scale selection to
determine if novel peptides with the ability to mediate nuclear import can be selected for.
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Transformed L40 yeast were plated onto leu-his- media containing 10 mM 3-amino-1,2,4triazole (3-AT) and primary nuclear import activity was determined for several dozen
colonies, named NM-1 through 34 (Figure 4.3A). Interestingly, almost all colonies sampled
showed a similar degree of nuclear import activity compared to pNIA2-TAg cNLS.
Plasmids were isolated from their respective yeast cultures and sequenced so that each
individual peptide sequence could be inferred (Table 4.7). As expected, based on my NHS
Ultramer design, none of these peptides showed any resemblance to a cNLS. Finally, all
plasmids were transformed back into L40 yeast for a secondary nuclear import test with
appropriate controls and biological replicates under non-selective nuclear import
conditions (Figure 4.3B). For greater stringency all motifs were compared to pNIA2 with
an SGSG linker (pNIA2-SG), as this construct shows slightly higher background activity
than pNIA2. Under non-selective conditions (leu-his+) most motifs did not exhibit
statistically significant nuclear import activity; however, several motifs, NM-9, -15, -21, 27, -28, -30, -33 and -34, continued to demonstrate significantly greater nuclear import
activity. Furthermore, nuclear import activity did not appear to correlate with protein
expression, as many motifs showed similar expression levels, but did not mediate nuclear
import (Figure 4.3C). For example, NM-12, -13, -9 and -34 all show similar protein
expression levels; however, statistically significant nuclear import activity was only
observed with NM-9 and -34.

4.3.4 Several peptides identified appear to function modularly
The motifs generated thus far have been selected for in the context of pNIA2. To extend
my findings, I next wanted to determine if any of these putative nuclear import motifs are
modular. Here, motifs deemed as modular will be able to function in the context of a
different protein that shares no sequence similarity to pNIA2. To test this, I expressed each
of these motifs fused to the C-terminus of the Gal4 DNA-binding domain (Gal4DBD) in the
galactose inducible W303-1A yeast strain. Growth in media supplemented with galactose
will induce expression of endogenous Gal4, which in turn will drive expression of a
plasmid based Gal4 responsive lacZ reporter (Figure 4.4A, left panel). Expressing the
Gal4DBD with an NLS, in place of the activation domain, will lead to Gal4DBD nuclear
accumulation and competition with endogenous Gal4 for DNA
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Figure 4.3 Primary and secondary nuclear import activity screen.
A) Primary nuclear import activity screen: L40 yeast transformed with linearized pNIA2
and amplified NHS Ultramer were selected for on media lacking leucine and histidine.
Colonies were picked and grown overnight in media lacking leucine and histidine to test
nuclear import activity by β-galactosidase activity (n = 1). At this stage statistically
significant changes cannot be determined, and peptide sequences are unknown. B)
Plasmids were isolated from yeast cultures, sequenced, and retransformed into L40 yeast
and grown under non-selective conditions in media lacking only leucine. β-galactosidase
activity was determined (n = 3) for each sample and compared to pNIA2-SG (SGSG linker)
using t tests and not correcting for multiple comparisons (p < 0.05). Peptides with
statistically significant increases (p < 0.05) are indicated and labelled with their
corresponding amino acid sequence. C) Protein lysates from each sample were analyzed
by western blot using LexA DBD primary antibody and G6PD (glucose-6-phosphate
dehydrogenase) as loading control. pNIA2 protein expression was variable but doesn’t
appear to qualitatively correlate with nuclear import activity.
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Table 4.7 Peptides identified in primary
nuclear import screen.
Peptide
NM-1
NM-3
NM-4
NM-5
NM-7
NM-8
NM-9
NM-10
NM-12
NM-13
NM-14
NM-15
NM-16
NM-17
NM-19
NM-20
NM-21
NM-22
NM-25
NM-26
NM-27
NM-28
NM-29
NM-30
NM-31
NM-32
NM-33
NM-34

Amino acid sequence
HVDHFTTEDQ
SVMSPDPLAE
IPLPTMHHNV
SKLATVEQDS
ALPVSATKSK
SMVHVLLLMV
MQADKVMEPT
SHPDLATTDS
EIQTPTDSTS
PAYTNQEMAK
HLDDDTSQVL
TPLMTTDLTP
QLDLAQEYPS
PLSELPSLEP
DVDQVVVSEA
AELHPLLHMD
DPFSEYIPDA
LSIPPDAKHA
EQVMDKAQFS
AHETATKDTA
EEVMAPADQP
LALVPNEADM
LKVTEMTDLA
ASVAHAYESF
MVDIEAHPAS
FDFYNAAEMK
SDNTHKFPTH
NKVLMLAYSD
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binding (Figure 4.4A, right panel). Therefore, based on this system the reduction in βgalactosidase activity will be a functional measure of nuclear import activity.
As a positive control for this second confirmatory assay, I tested the SV40 large TAg NLS.
As expected, expression of the Gal4DBD-TAg cNLS fusion resulted in a significant
reduction in β-galactosidase activity compared to just the Gal4DBD (Figure 4.4B).
Interestingly, several of the motifs identified in the pNIA2 selection also repress βgalactosidase activity when fused to the Gal4DBD. Thus, they appear to mediate nuclear
import in this system, and function modularly in both systems (Figure 4.4B, indicated in
green). In addition, this assay also identified motifs which mediate nuclear import that were
not significant when tested in the secondary pNIA2 screen (NM-3, -16, -19 and -31). These
observations possibly reflect the positional effects I observed with pNIA2 when expressing
C-terminally derived NLSs internally. However, unlike expressing these motifs in pNIA2,
expression on Gal4DBD produced inconsistent protein expression (Figure 4.4C).
Nevertheless, peptides like NM-9 appear to function despite lower protein expression
levels.
Based on my results from the pNIA2 selection and Gal4 competition assay, I chose NM-9
and NM-34 for further analysis. Motif NM-9 functioned in both experiments and although
NM-34 nuclear import could not be reproduced when expressed on Gal4DBD, I chose to
pursue this motif due the significant activity observed with pNIA2. However, it also
remains possible that some of these motifs themselves function as transactivation domains.
Therefore, before pursuing these peptides further, I first wanted to rule out whether
transactivation was a factor. To test this, I repeated the Gal4 competition assay using
Gal4DBD NM-9 and -34 except I did not induce endogenous Gal4 expression (Figure 4.4D).
In doing so, I could test these motifs for transactivation directly. In comparison to the
HAdV-C5 E1A N-terminal region (1-82), a potent transactivator, as well as region 1-29
which lacks this ability, NM-9 and -34 do not appear to have any capacity to transactivate
(Yousef et al., 2009). This is particularly important since performing screens with pNIA2
could alternatively select for motifs which function as unusually potent transactivators,
rather than facilitate PPIs.
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Figure 4.4 Testing NHS derived peptides in a Gal4 repression assay shows some
function in a modular fashion.
A) Using the galactose inducible W303-1A yeast strain, endogenous Gal4 will bind and
activate expression from a plasmid-based lacZ reporter when grown in media containing
galactose (left panel). Expressing the Gal4DBD, which lacks the transactivation domain,
with peptides that facilitate nuclear localization will result in nuclear accumulation and
competition with endogenous Gal4, resulting in a decrease of lacZ expression (right panel).
B and C) Peptides identified in the pNIA2 selection were cloned onto the C-terminus of
Gal4DBD and tested for their ability to compete with endogenous Gal4 by β-galactosidase
assay (n = 3) (B). Peptides which functioned in both pNIA2 and on Gal4DBD are shaded in
green. Protein expression was determined by western blot using αGal4 antibody (C).
Statistically significant decreases (p < 0.05), compared to Gal4DBD, were identified using t
tests and not correcting for multiple comparisons. D) Peptides NM-9 and -34 were tested
for their ability to transactivate (n = 3). Experimental conditions were the same as in (A),
except yeast were grown in media without galactose; therefore, expression of lacZ depends
on transactivation by the exogenously expressed Gal4DBD fusion. Amino acids 1-82 and 129 of HAdV-C5 E1A were used as a positive and negative control for transactivation,
respectively. Neither NM-9 nor -34 were able to transactivate. Statistically significant
increases (p < 0.05) were determined using a one-way ANOVA and Dunnett’s multiple
comparison test.
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Overall, my data show that this screening approach is able to select for short, 10 amino
acid peptide motifs which can putatively mediate nuclear import in yeast. Importantly,
none of the identified peptides resemble a cNLS and several appear to be modular based
on their ability to function as fusions to both pNIA2 and Gal4DBD.

4.3.5 Peptides NM-9 and NM-34 can localize EGFP to the nucleus
in mammalian cells
Nuclear import pathways among eukaryotes are highly conserved (Mason et al., 2009;
O’Reilly et al., 2011; Pumroy & Cingolani, 2015). Based on this, I next determined if
peptides NM-9 and -34 can mediate nuclear import in mammalian cells. I transfected HT1080 cells with C-terminal EGFP fusions expressing NM-9 and NM-34 to determine
subcellular localization via confocal microscopy (Figure 4.5A). Intriguingly, both NM-9
and NM-34 have a nucleocytoplasmic localization, compared to EGFP, which is almost
exclusively cytoplasmic in HT-1080 cells. In comparison to EGFP-TAg cNLS, which is
highly nuclear as expected, NM-9 and -34 appear to act as weak NLSs. Whether or not
these are true, direct acting NLSs is unclear, as it’s possible these peptides confer
interactions with other nuclear proteins that confer piggyback transport into the nucleus.
To alternatively confirm the subcellular localization of NM-9 and -34 EGFP fusions, I
biochemically isolated nuclear and cytoplasmic compartments of transfected HT-1080
cells using the well-established REAP method (Nabbi & Riabowol, 2015; Suzuki et al.,
2010). Cells expressing either EGFP, EGFP TAg cNLS, HIV-1 Rev nuclear export signal
(NES), NM-9 and NM-34 were analyzed by western blot at a 2:1:1 ratio of nuclear,
cytoplasmic and WCE (Figure 4.5B). Standard cytoplasmic and nuclear compartment
controls corresponding to tubulin and lamin were used, respectively. However, to better
reflect my experimental approach, I also used EGFP TAg cNLS and EGFP Rev NES as
additional nuclear and cytoplasmic compartment controls. As expected, EGFP TAg
showed a strong nuclear localization, while EGFP and EGFP-Rev did not. Importantly, the
absence of EGFP Rev NES, as well as tubulin, from the nucleus was an important indicator
demonstrating leakage from cytoplasm to nucleus was not an issue during sample
preparation. Comparison of nuclear and cytoplasmic compartments from
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Figure 4.5 Peptides NM-9 and NM-34 can localize EGFP to the nucleus in human
cells.
A) Human HT-1080 cells were transfected with either EGFP or EGFP C-terminal fusions
with TAg NLS, NM-9 or NM-34. Cells were stained with DAPI to determine nuclear
localization by confocal immunofluorescence microscopy. B and C) Nuclear (N),
cytoplasmic (C) and whole cell extracts (W) from transfected HT-1080 cells were analyzed
by western blot at a 2:1:1 ratio of N:C:W. SV40 TAg NLS and HIV-1 Rev NES were used
as positive and negative controls for nuclear localization, respectively. Tubulin and lamin
A/C western blots were used to test sample preparation efficiency. Additionally, 2% of
whole cell extract (WCE) from each sample was tested simultaneously by western blot to
compare protein expression. D) Western blots in (B) were quantified using ImageJ and
nuclear localization was expressed as percentage of N and W. Statistically significant
increases were identified using a one-way ANOVA and Dunnett’s multiple comparison
test. E) Nuclear extract from EGFP and EGFP NM-34 samples were analyzed by western
blot at a 2, 4 and 6:1:1 ratio of N, C and W.

125

126

EGFP NM-9 and -34 samples confirmed their nuclear localization. Although nuclear
localization was weak, these findings agree with my observations based on confocal
microscopy and yeast-based assays. These results also do not appear to be an artifact of
expression, as each construct was expressed at roughly equal levels (Figure 4.5C).
Additionally, western blots were quantified from three biological replicates using ImageJ
software. Comparing nuclear and WCE at a 2:1:1 ratio shows significantly greater nuclear
localization for EGFP NM-9, but not NM-34, compared to EGFP (Figure 4.5D).
At a 2:1:1 ratio, nuclear EGFP NM-9 and -34 were only weakly detectable by western blot.
To test this further, I loaded increasing amounts of nuclear extract from EGFP and EGFP
NM-34 samples. At a 6:1:1 ratio EGFP NM-34, and likely NM-9 as well, could be easily
detected within nuclear extracts (Figure 4.5E). Interestingly, EGFP was still not detectable
within the nucleus at a 6:1:1 ratio despite roughly equal levels of nuclear lamin compared
to EGFP NM-34. Interestingly, despite western blot quantification showing EGFP NM-34
was not significant, western blots of increasing amounts of nuclear extract clearly indicate
EGFP NM-34 is more nuclear than EGFP.

4.3.6 Peptides NM-9 and NM-34 can associate with Imp-α
Evidence so far demonstrates that NM-9 and NM-34 are able to localize EGFP to the
nucleus; however, it’s unclear whether or not these peptides are promoting active nuclear
import or simply binding a nuclear protein after diffusing into the nucleus. It’s also possible
these peptides are piggybacking into the nucleus on a protein which uses one of the many
possible nuclear import pathways.
Since the classical nuclear import pathway mediated by Imp-α is well established, I first
decided to investigate its possible role, as this would be a logical first step before exploring
additional interactors. Humans express seven Imp-α isoforms that can be categorized into
three subfamilies based on sequence similarity: α1 (Imp-α1, and -α8), α2 (Imp-α3 and α4), and α3 (Imp-α5, -α6 and -α7) (Pumroy & Cingolani, 2015). To determine if NM-9 and
NM-34 interact with any of these Imp-α isoforms, I tested a representative member from
each subfamily for their ability to interact with EGFP NM-9 and -34 by co-
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immunoprecipitation. HT-1080 cells were co-transfected with either FLAG-tagged Impα1, -α3 or -α5 and EGFP, EGFP TAg NLS, NM-9 or -34, and immunoprecipitated using
anti-FLAG magnetic beads (Figure 4.6). These data show a strong interaction between the
TAg cNLS and each of the Imp-α isoforms tested. To my surprise, NM-9 and -34 appear
to interact with specific Imp-α isoforms. Neither peptide appear to interact with Imp-α3,
although evidence of a weak interaction might be inferred; however, both EGFP NM-9 and
-34 are able to bind Imp-α5. Furthermore, it appears that only EGFP NM-34 has specificity
towards Imp-α1.
These results are especially interesting due to the fact that neither NM-9 nor NM-34
resemble a cNLS. Taken together, these results demonstrate that peptides identified in my
yeast-based selection can localize EGFP to the nucleus in mammalian cells. Perhaps more
interesting is their ability to associate with Imp-α. How exactly they interact is unknown;
however, whether it is via a direct or indirect interaction, it’s evident these peptides are
mediating PPIs.
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Figure 4.6 Peptides NM-9 and NM-34 interact with human importin alpha.
Human HT-1080 cells were co-transfected with FLAG-tagged Imp-α isoforms 1, 3 or 5,
and either EGFP, EGFP NM-9 or EGFP NM-34. Samples were immunoprecipitated with
anti-FLAG antibody and western blots were performed using anti-EGFP antibody.
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4.4

Discussion

The protein interactome of living cells reflects a multitude of different PPIs.
Characterization of what proteins interact with one another greatly exceeds our
understanding of how these proteins actually interact. This makes our understanding of
how PPIs are facilitated an important step in realizing the complexity of network regulation
within living systems. One particular type of PPI module belongs to the class represented
by SLiMs (Van Roey et al., 2014). These are short motifs, often less than 10 amino acids,
that are integral to a variety of cellular processes. Roughly 100,000 SLiMs are predicted to
be found within the human proteome; however, only a few thousand have been documented
(Kumar et al., 2020; Tompa et al., 2014).
Here, I have developed a genetic, yeast-based selection system, that exploits protein
nuclear import to identify novel SLiMs. Additionally, I performed a small-scale selection
and demonstrated this system can successfully identify SLiMs in yeast that can localize
EGFP to the nucleus in human cells. This system was based off of a previous iteration,
pNIA, which was not suited to test random peptides (Marshall et al., 2007). To adapt this
system for expressing random peptides, I reorganized the protein domains to express
peptides internally, rather than on the C-terminus, and renamed it pNIA2. The major
advantage with this approach was that if an insert happened to encode a cleavage motif, or
contain a stop codon, the Gal4AD would no longer be tethered to the promoters of the
reporter construct and would not be recovered by the selection. This modification, as one
would theoretically predict, should result in reduced false positives identifications.
A variety of different NLSs were tested and shown to work in pNIA2. This also included
many cNLSs as well as the HIV-1 Tat NLS, which is known to bind Imp-β1 directly,
indicating this system is sensitive enough to detect non-cNLSs. Since S. cerevisiae express
a number of different Imp-β proteins that are functionally conserved with their human
homologs, it’s important that peptides targeting non-classical pathways can still be isolated.
Another advantage of this system was the extremely low background activity and wide
range of activity. When expressed in L40 yeast without an NLS, background activity was
almost undetectable, whereas addition of an NLS could increase activity over 100-fold.
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Intriguingly, two peptides, NM-9 and -34, identified in yeast by a small-scale selection
were demonstrated to function in human HT-1080 cells, by localizing EGFP to the nucleus
using both immunofluorescence microscopy and biochemical fractionation of subcellular
compartments. Additionally, co-immunoprecipitation experiments showed that both of
these peptides were able to interact with human Imp-α. In particular, both peptides were
able to interact with Imp-α5, which has the greatest sequence similarity to Srp1, the only
Imp-α in S. cerevisiae (Pumroy & Cingolani, 2015). My focus was to develop an assay that
could provide candidate SLiMs for further investigation. For this reason, I did not
investigate these PPIs further and it is unknown if these peptides directly bind Imp-α.
Nevertheless, these peptides appear to be facilitating PPIs involved in nuclear localization.
Several other advantages of this approach are worth discussing. First, because this system
works in yeast, it is inexpensive and highly accessible. Only oligonucleotides are required,
with no need for specialized equipment. This is a far simpler approach compared to protein
or peptide arrays. Secondly, this is an in vivo system, albeit in yeast, that is also functional
since it exploits protein nuclear import. This is a major advantage over current SLiM
discovery methods, like phage display or peptide/protein arrays, which are exclusively in
vitro. Lastly, because this is a genetic system, no prior knowledge of the peptides being
tested is required. Plasmids can be easily isolated, like with phage display, from yeast and
sequenced to determine peptides which have been selected for. Pools of selected
recombinants could be sequenced in bulk using next-generation approaches, and in
combination with enrichment type analyses could identify thousands of high confidence
PPI motifs.
While this system is designed to select for peptides mediating protein nuclear import it
remains possible that alternative scenarios exist where selection may not reflect nuclear
import. For example, since LexA functions as a homodimer it’s possible that peptides
which enhance dimerization will be selected (Mohana-Borges et al., 2000). Alternatively,
peptides which promote nuclear import but negatively influence dimerization could be
missed due to poor reporter gene expression. Another scenario which could lead to the false
discovery of peptides is through selection of peptides with the ability to transactivate.
Transactivation domains are often enriched in acidic and aromatic/hydrophobic amino
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acids, leaving open the possibility these amino acids could be selected since they are
present within the NHS library design (Regier et al., 1993; Sigler, 1988; Staller et al.,
2018).
An important limitation to this approach is that it selects for nuclear localization. This
means that PPIs will be limited to nuclear proteins, in theory. However, despite this
limitation it’s important to consider that nearly 1500 proteins in S. cerevisiae localize to
the nucleus and it’s estimated that approximately 87% of protein domains in yeast are also
found within humans (Huh et al., 2003; Peterson et al., 2013). This number of potential
interactors is significant and greatly exceeds similar approaches. Phage display and
protein/peptide arrays typically utilize a one-vs-many approach, where a few peptides are
tested individually against many baits, or vice versa. A recently developed technique,
called PRISMA, has significantly expanded the number of peptides and baits which can be
tested (many-vs-many); however, experimental design still requires prior knowledge of the
peptides being tested (Dittmar et al., 2019).
Given the large discrepancy between the number of predicted and documented SLiMs
within the human proteome, more high-throughput techniques are required to fill this gap.
The system outlined here combines many of the advantages of other approaches. For
example, it has the genetic tractability of phage display, allowing thousands of peptides to
be screened and sequenced. Like PRISMA, it is high throughput, except significantly more
peptides can be tested with my approach. Although I tested randomly generated peptides,
my approach is highly complementary to other recently used methodologies. For example,
experiments expressing the human disordered proteome as overlapping short peptides
using phage display could be easily replicated with this system (Davey et al., 2017).
Furthermore, this approach can lend itself to fields such as synthetic biology. Using
randomly generated peptides, as I did here, completely unique motifs can be easily
identified.
Overall, the system I present here is an additional tool that can be added to the molecular
biologist’s toolbox. Depending on one’s goals, hundreds to thousands of random peptides
can be screened and selected for based on nuclear localization in yeast. Importantly, this
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can represent not only active nuclear import but also simply binding a nuclear protein and
piggybacking into the nucleus. Since this system utilizes a genetic selection, potential
candidate peptides can be rapidly identified for further investigation, as opposed to
screening only approaches. Although this approach is purposely biased towards nuclear
localization, of the tens of thousands of SLiMs yet to be documented, many will
undoubtedly have roles within the nucleus.
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Chapter 5
5

General Discussion

5.1

Thesis Summary

The work described within my thesis explores protein nuclear import from several different
perspectives. In Chapter 2 of this thesis, I demonstrated that targeting the classical nuclear
import pathway, mediated by Imp-α and -β1, using ivermectin, inhibits replication of
HAdV-C5 and -B3. To explore the effects of ivermectin in greater detail I used HAdV-C5
as a model. Treating infected A549 cells in vitro with ivermectin reduced viral early gene
transcription (transcripts for E1A, E1B, E3 and E4) as well as protein expression of several
early proteins (E1A and DBP) and late proteins (capsid proteins). Additionally, infected
cells treated with ivermectin no longer show the characteristic nuclear localization of E1A.
Interestingly immunoprecipitation experiments of Qip1 (Imp-α3) show that ivermectin
specifically targets the Imp-α-NLS interaction. Based on these findings I hypothesized that
the effect of ivermectin is likely a result of E1A’s inability to function within the nucleus.
In Chapter 3, I focused specifically on the classical nuclear import pathway in a cellular
context; however, due the intimate relationship between virus and host, these concepts
could also be applied to viruses. Chapter 3 is an extension of a previous analysis done in
yeast, which showed many nuclear proteins do not have a predicted cNLS, and many
proteins that bind Imp-α also do not have a cNLS (Lange et al., 2007). In my work, I
extended these findings to the human nuclear proteome for the first time. Using the latest
publicly available databases and datasets, I showed that at least 50% of nuclear proteins in
human do not have a predicted cNLS. Looking specifically at cargo for each Imp-α isoform
I also showed that many cargos also do not have a predicted cNLS. Thus, my results using
human proteins are remarkably similar to those found in the simple eukaryote S. cerevisiae.
To complement these findings, I reanalyzed raw mass spectrometry data from PPI studies
with several Imp-α isoforms, which generated very similar conclusions. Within this group
of nuclear proteins without a cNLS, I specifically identified the Mediator protein complex
and proposed that it is highly likely to use a piggyback mechanism to access the nucleus.
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In Chapter 4, my final data chapter, I used the connections between nuclear import and
SLiM-mediated PPI interactions via a yeast-based genetic selection assay to identify novel
SLiMs that also facilitate nuclear localization. Using this selection assay, I identified
several peptides that do not bear any resemblance to a cNLS. Further analysis with two of
these peptides showed they are able to localize EGFP to the nucleus in the human HT-1080
cell line. Furthermore, I demonstrated through co-immunoprecipitation experiments that
both of these peptides are able to interact with Imp-α.
Overall, my research showed that targeting the nuclear import pathway, specifically the
Imp-α-NLS interaction, is an effective target to inhibit viral replication of HAdV.
Additionally, I highlighted that the classical nuclear import pathway needs deeper
characterization, and this highlighted potential widespread use of piggybacking
mechanisms, as well as suggested that many potentially novel NLSs exist.

5.2

Nuclear import is an effective target for virus-host
SLiM-mediated interactions

Viruses are obligate intracellular parasites and therefore have an intimate relationship with
their host. Classically, antiviral drugs have been developed against virus-specific factors
like virally-encoded enzymes, such as polymerases, reverse transcriptases and proteases,
for example (De Clercq, 2009; De Clercq & Li, 2016). Although this approach has been
successful in many instances, drugs developed against virally-encoded factors can be
rendered obsolete due to the rapid emergence of resistance (Van Poelvoorde et al., 2020).
Alternatively, anti-viral drugs can be developed to target host factors, such as those that
can modulate the immune system and activate innate immune responses (Kaufmann et al.,
2018).
The inherent host dependency which viruses exhibit makes virus-host PPIs attractive
targets for treating viral infections. During HAdV infection, cellular PPI networks become
entangled with virus-host protein interactions (King, Zhang, et al., 2018). This results in a
completely unique intracellular environment, potentially exposing new vulnerabilities that
wouldn’t otherwise exist (Mast et al., 2020). One cellular pathway which many viruses,
both DNA and RNA, exploit is the protein nuclear import pathway (Tessier et al., 2019;
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Yarbrough et al., 2014). In Chapter 2 of this thesis, I demonstrated that the classical protein
nuclear import inhibitor, ivermectin, can inhibit replication of HAdV-C5 and -B3. These
findings add to increasing body of evidence suggesting ivermectin as a potential antiviral
(Fraser et al., 2014; Varghese et al., 2016; Wagstaff et al., 2012). Though I did not test the
effectiveness of ivermectin on additional HAdV species, HAdV-C5 and -B3 are both
clinically relevant viruses (Lion, 2014).
Importantly, these results only point towards a potential antiviral function and do not
conclusively prove that ivermectin will be clinically useful. Importantly, ivermectin is
widely used as an antiparasitic and has a well-established safety profile, representing a drug
that could be theoretically repurposed for the treatment of additional diseases with minimal
effort and cost (Laing et al., 2017). However, whether or not an effective concentration can
be achieved to treat viral infections is unknown. If ivermectin concentrations sufficient to
function as an anti-viral cannot be achieved clinically, it remains possible that ivermectin
can work synergistically with other antivirals. For example, the relocalization of cellular
proteins to the nucleus by E1A enhances viral replication (King, Cohen, et al., 2016).
Through ivermectin-mediated inhibition of E1A, nuclear import of interacting cellular
proteins will also be inhibited. In doing so, based on the concept of synthetic lethality, new
vulnerabilities are likely to be exposed (Mast et al., 2020). Following this line of reasoning,
future experiments should involve testing ivermectin in combination with other antivirals,
including those that target other host processes.
Additionally, I was able to show for the first time that ivermectin targets the Imp-α-NLS
interaction as a mechanism to inhibit import. Previously, based on in vitro assays
performed by another group, the function of ivermectin was assumed to target the Impα/β1

interaction

(Wagstaff

et

al.,

2012).

However,

my

results

using

co-

immunoprecipitation experiments show that the Imp-α-NLS interaction was lost, while the
Imp-β1 interaction was maintained. Exactly why these results differ from previous studies
is unclear; however, recently these findings have been supported based on structural
modelling of Imp-α and ivermectin, which showed ivermectin binding maps to the NLS
binding groove (P. S. Sen Gupta et al., 2020). Further experiments are still required to fully
understand ivermectin’s mechanism of action. In my work, I only tested the interactions
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between SV40 TAg cNLS and HAdV-C5 E1A with Qip1. As a class of SLiM, cNLSs bind
Imp-α in a similar fashion; however, residues outside the core motif can modulate SLiMmediated interactions. As a result, ivermectin may not influence binding of all Imp-α-NLS
interactions equally. Since I tested full-length E1A and not just it’s cNLS, these results also
suggest ivermectin can inhibit bipartite cNLS binding. E1A’s cNLS has classically been
referred to as a monopartite cNLS; however, more recently it was shown to in fact be a
bipartite cNLS. Additionally, I did not test cNLSs that specifically bind the minor groove
of Imp-α. Therefore, additional mutational studies, as well as interactions with additional
Imp-α family members using a variety of cNLSs will help to better understand ivermectin’s
mode of action.
Overall, the data presented in Chapter 2 demonstrates that virus-host SLiM-mediated
interactions can be targeted to interfere with virus infection. Many viral proteins from a
diverse range of viruses rely on SLiM-mediated PPIs. Targeting host proteins, like
targeting Imp-α versus targeting a viral NLS directly, could be an effective strategy for
finding new antivirals.

5.3

Identifying piggyback mechanism and novel NLSs

The classical nuclear import pathway is assumed to be responsible for handling the
majority of protein nuclear import. Interestingly though, it was previously demonstrated in
S. cerevisiae that up to 50% of Imp-α cargos do not have a predictable cNLS (Lange et al.,
2007). The cNLS SLiM has been extensively studied and this revealed well defined rules
for what may constitute a cNLS, making those observations particularly interesting
(Kosugi et al., 2009). Since these findings had not been extended to the human Imp-α
isoforms, this prompted me to address these questions with currently available datasets and
databases with human Imp-α PPI data.
Using a computational approach, I looked at nuclear proteins from the HPA, as well Impα interactors from various databases and datasets. Rather than using NLS prediction
programs, I specifically chose to look for regular expressions corresponding to cNLSs. This
approach was inherently over predictive and undoubtedly identified many false positives,
as many hits would likely be within structured and/or inaccessible regions. This means that
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proteins without a hit, truly represent those that do not have a motif that fulfills our current
definition of a cNLS. Using this approach, I estimated that roughly 50% of nuclear proteins
in human do not have an amino acid sequence resembling a cNLS.
Interestingly, when specifically looking at Imp-α interactors from the IntAct database, I
found that approximately 50–80% also do not have a predicted cNLS. I was also able to
confirm these results using an independent dataset of Imp-α interactors that involved
reanalysis of raw mass spectrometry files. When specifically looking at Imp-α interactors
without a cNLS, I identified several protein complexes which may use piggybacking as a
strategy to gain access to the nucleus. Intriguingly, RNAPII and TFIID already had existing
evidence in support of piggybacking-based mechanisms to access the nucleus; however, a
third group of proteins belonging to the Mediator complex did not (Di Croce, 2011;
Trowitzsch et al., 2015). Based on these findings, I specifically looked at each subunit of
Mediator to try and determine which protein subunits have a predicted cNLS and found
that over half of Mediator subunits do not have a predictable cNLS, yet interact with Impα. Since other protein complexes, also involved in RNAPII transcription initiation, appear
to use piggybacking, I proposed that nuclear import of Mediator may be mechanistically
similarly.
Conceptually, the concept of piggybacking into the nucleus is highly advantageous. In
theory, piggybacking can effectively increase the “mileage” of how many proteins a single
Imp-α, or nuclear transporter, can import. Since nuclear import is an energy dependent
process, one nuclear import cycle can effectively transport multiple proteins. Another
important factor to consider is the effect of size on the rate of nuclear import. As protein
size increases, the rate of transport through the NPC decreases (Lolodi et al., 2016). This
introduces a potential dilemma for multi-subunit protein complexes like Mediator, which
in this case is composed of proteins that range in size from less than 20 kDa to over 200
kDa. Having subunits import into the nucleus at different rates could have highly
detrimental effects on transcription initiation. A scenario where subunits are preassembled
in the cytoplasm, like RNAPII and TFIID, and piggyback into the nucleus could provide a
uniform rate of import and ensure correct stoichiometry of the subunits in this large
complex.
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Overall, the results presented in Chapter 3 demonstrate a significant number of proteins
associate with Imp-α, but do not have a cNLS. This highlights a need for identifying
piggybacking proteins, as well as novel NLSs in future studies of nuclear trafficking.

5.4

Exploiting protein nuclear import to discover novel
PPIs

As previously mentioned, many nuclear proteins in yeast, including those that interact with
Imp-α, do not have a predictable cNLS (Lange et al., 2007). These findings suggest
additional mechanisms by which proteins could be interacting with the nuclear import
machinery. This could be through direct interactions with Imp-α, or possibly piggybacking
on Imp-α cargos. Regardless of the scenario, both situations will inevitably involve PPIs.
However, how these PPIs might be mediated and how they can be discovered falls under a
much broader area of investigation, which is developing high throughput approaches to
discover SLiM-mediated interactions.
In order to address these questions experimentally, I identified a convenient scenario that
used a single approach to answer two not so disparate questions: 1) are there SLiMs other
than cNLSs that can mediate nuclear localization and 2) can I develop a high throughput
approach to identify these novel SLiMs. The approach that I developed involved a yeastbased (S. cerevisiae) genetic selection assay that uses a recombinant protein, pNIA2, that
is too large to diffuse into the nucleus. Only upon addition of a functional NLS to the
chimeric protein can pNIA2 enter the nucleus. Using this approach with randomly
generated peptides, I identified several functional peptides that bear no resemblance to
cNLSs. Interestingly, two of these peptides were able to localize EGFP to the nucleus and
interact with Imp-α in a human cell line, showing the high degree of conservation between
nuclear import across eukaryotes.
Experimental approaches that can be used to identify novel SLiMs follow a “one-vs-many”
or a “few-vs-many” approach (Blikstad & Ivarsson, 2015; K. Meyer & Selbach, 2020).
Current technologies, whether it be phage display or peptide/protein arrays, typically
classify peptide-domain interactions as bait and prey (or vice versa) and are thus limited to
examining only a few baits or preys at a time. Of course, these approaches can be scaled
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up to increase throughput; however, this comes with a proportional increase in labour. The
approach which I have outlined within Chapter 4 can effectively screen thousands of
peptides, via selection, in a single experiment that can be scaled with a nearly negligible
increase in labour. These advantages make this approach highly economical, as well as
equitable, since it doesn’t require specialized technology. Additionally, since this approach
is functional, it uses the yeast nuclear proteome as “prey”, making this a “many-vs-many”
approach.
However, like Y2H screens, this approach generated a significant number of false positives
(Blikstad & Ivarsson, 2015). During primary β-galactosidase assays, nuclear import
activity is noticeably higher than in the secondary screen under non-selective conditions.
Since nuclear import activity is most reflective under non-selective conditions (not
selecting for nuclear import), this presents a work-flow bottleneck. To address this, further
optimizations will be required. These could include replica plating yeast from media
selective for nuclear import onto non-selective media before screening for nuclear import
activity, or serially passaging selected yeast colonies in non-selective media. However,
despite the limitations with Y2H screens, this approach has been invaluable for performing
high-throughput proteome-wide screens, especially when combined with next-generation
sequencing technology (Suter et al., 2015). These advantages are also applicable to the
approach I have outlined in Chapter 4. Large-scale yeast transformations and selection,
followed by bulk PCR amplification of the NHS region within pNIA2, would allow for
high throughput identification of peptides.
My primary goal was to perform a small scale, proof-of-principle selection to determine if
this approach was viable. For this reason, I did not perform detailed follow up experiments
with the peptides identified in this study. Since they were generated at random, they bear
little resemblance to human cellular proteins. Before pursuing more detailed experiments,
mutational analysis should be performed to identify the amino acids necessary for function.
With this information, it will be easier to identify cellular proteins that share the same core
amino acids. Furthermore, in vitro binding assays using purified protein could be carried
out to determine if these peptides interact directly with Imp-α. If this was the case, these
peptides could be used as tools to explore Imp-α-NLS binding constraints. For example,
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neither peptides bind Imp-α1, but will both bind Imp-α5; furthermore, only NM-34 can
bind Imp-α3. Exploring why this is the case could potentially lead to a deeper
understanding of Imp-α-NLS recognition. Conversely, these peptides may not bind Imp-α
directly. To identify a list of potential interactors, affinity purification-mass spectrometry
would likely prove useful in this scenario.
Since the approach I took used random peptides, it’s also possible these motifs and others
may have no similarity to those found in cellular proteins. If this is the case and these
peptides are functional, they may be useful in unrelated areas of research, such as synthetic
biology. For instance, peptide NM-34 shows potent nuclear import activity in yeast, an
organism that has been at the forefront of synthetic biology (Z. Liu et al., 2019). Such a
peptide could be used to direct recombinant proteins to the nucleus to achieve any number
of desired functions.
Overall, whether peptides isolated using this approach directly bind importins is irrelevant.
All that is needed is a PPI that localizes the recombinant test protein to the nucleus. From
here, a list of peptides to pursue further can be rapidly generated. Importantly, this approach
is another strategy that can be used to identify novel SLiMs.

5.5

Concluding remarks

The work presented here highlights various aspects of protein nuclear import. Together,
my work aimed to address several outstanding questions within the field. I demonstrated
that inhibition of the classical nuclear import pathway, via ivermectin, can inhibit HAdV
replication. Interest in ivermectin as an antiviral has been steadily increasing; however, the
mechanism behind its ability to inhibit nuclear import has been unclear. With respect to
HAdV-C5 E1A and TAg cNLS, I demonstrated for the first time that ivermectin can disrupt
the Imp-α-NLS interaction. Ivermectin was first proposed to inhibit the Imp-α/β1
interaction; therefore, evidence that it can inhibit Imp-α/cNLS binding could be an
important factor when considering its use. As an antiviral, this drug is inhibiting the
interface between a virus and host PPI. If ivermectin blocked the Imp-α/β1 interaction, one
could assume that any viral NLS that binds Imp-α could be effectively inhibited. However,
if ivermectin is in fact inhibiting the Imp-α/cNLS interaction this could exhibit some level
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of selectivity that might have important implications. Specifically, determining if different
viral cNLS/Imp-α interactions are affected differently by ivermectin will be an important
step in determining its utility as a general antiviral.
Based on observations in yeast, I showed for the first time in humans that many Imp-α
cargos do not have a cNLS. These observations focus attention on the idea of piggybacking
and potentially new NLSs. Piggybacking into the nucleus would be a highly efficient
process; however, studying this process on a large scale would be difficult. One approach
to identify particular protein complexes was outlined in Chapter 3, which identified
Mediator as a candidate for piggybacking. Identifying and studying these potential
examples of piggybacking can provide deeper insight into basic, overlooked, cellular
processes. These observations also highlighted the idea of potentially novel NLSs that can
bind Imp-α. To address this, I developed a yeast-based selection to identify novel
NLSs/SLiMs. This novel selection is significant in that it allows high throughput
identification of short peptides (SLiMs) in a “many-vs-many” fashion, an area of SLiM
discovery devoid of such approaches. Using this genetic selection and increasing its scale,
one could identify a large number of motifs that facilitate nuclear localization through
novel, uncharacterized interactions. Given the immense disparity of annotated and
predicted SLiMs in the human proteome, such an approach, albeit with its own limitations,
can be used to help close this knowledge gap.
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